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Abstract: Recent developments in drug design and advances in mapping of the human 
genome have quickened the pace of development of peptide and protein drugs. Unfortunately, 
this class of compound often has specialised delivery requirements that preclude 
administration via traditional routes due to biological barriers, physicochemical drug 
properties, and issues of pharmacokinetics and pharmacodynamics. Transdermal drug 
delivery has advantages over other routes of administration. Also, the use of an external 
driving force, such as iontophoresis, is a technique that is well suited for delivery of these 
compounds. However, the large molecular size of peptides may limit the amounts of drug that 
can be delivered across the skin barrier. In this study the potential to enhance transdermal 
iontophoretic delivery of peptides was investigated. Two approaches to this were used: 
manipulating electrical field strengths to induce structural changes in the skin; and combining 
a chemical permeation enhancer with iontophoresis to determine if peptide delivery could be 
synergistically enhanced. In vitro permeability investigations were performed through human 
epidermal membrane (HEM) using the model peptide, luteinizing hormone releasing hormone 
(LHRH). Increasing the electrical field strength across the HEM resulted in marked porosity 
changes above 1 V. This was accompanied by dramatic increases in permeability enhancement 
of a small ionic solute, tetraethylammonium bromide (TEAB). However, the increases that 
were observed in LHRH permeability enhancement was several orders of magnitude less. The 
modified Nemst-Planck model, after correction for porosity changes, predicted results that 
matched the observed TEAB enhancement. However, LHRH enhancement predictions were 
markedly different from observed values indicating that the electrically-induced pafhways 
were largely unavailable for LHRH transport, a finding that is consistent with recent reports 
characterising these pores. The influence of the voltage-induced pores on electroosmosis was 
also studied, since this transport mechanism is more important as molecular size increases. 
Sucrose, a small non-ionic polar solute, was used as an electroosmotic flow marker during 
these investigations. The enhancement of sucrose closely mirrored porosity increases in the 
membrane indicating considerable electroosmosis occurs within electrically-induced pores. 
These two parallel investigations showed moderate voltage iontophoresis (> 1 V) causes the 
induction of pores in the HEM, however, transport through these pores, despite significant 
electroosmosis, is limited to small solutes. The potential for synergism between iontophoresis 
and chemical enhancers to improve peptide delivery was investigated. It was hypothesised 
that oleic acid (OA) may cause synergistic enhancement of LHRH during iontophoresis by 
increasing the pore sizes of the HEM. Synergistic enhancement of LHRH was observed. 
lV 
Permeability and conductance changes, in addition to strnctural investigations ( differential 
scanning calorimetry (DSC) and infrared spectroscopy (IR)) were also performed. OA 
treatment of the skin promoted the permeability of LHRH, sucrose, and TEAB during passive 
conditions. This suggests that pre-existing pores in the membrane increased in size. However 
when the enhancer was used in combination with iontophoresis, LHRH was the only solute to 
be co-enhanced. This finding was consistent with increases in pore size of the pre-existing 
pores in the stratum comeum as modelled using the hindered pore theory. Co-enhancement of 
LHRH may also be due to an effect of the enhancer on the accumulation of peptide in the 
stratum comeum. Interestingly, disrnption of the fixed negative charges on the skin by the 
enhancer may have negatively influenced transport via decreases in electroosmosis. The 
disordered effect caused by the action of oleic acid on the stratum comeum was confirmed 
using DSC and IR investigations. In summary, the transport of peptides across the skin during 
iontophoresis may become less restricted following the pre-treatment of the barrier with 
suitable chemical permeation enhancers. 
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1.1 Overview of the problem 
The rationale for controlled drug delivery is to optimise medicine release so that therapeutic 
benefits are maximised while potential toxic effects are minimised. Often physiological 
barriers, physicochemical drug properties, and drug toxicity prevent the development of 
delivery systems that adequately address the release requirements of a particular medicine. 
Novel routes of delivery and delivery systems are keenly sought to overcome these obstacles. 
The potential for using the skin as a portal for systemic drug delivery has been recognised for 
several decades. A transdermal drug delivery system has a number of advantages, among 
them the ability to avoid incompatibilities of the gastrointestinal tract and hepatic "first-pass" 
metabolism. Systems of this type also have the capacity to provide controlled release of drug 
for prolonged periods. These promising advantages have generated considerable interest in 
this drug delivery area and have even lead to several transdermal patch systems being brought 
into common use for certain therapies. However, problems in delivering molecules across the 
skin when certain drug physicochemical requirements are not met (specifically lipophilicity, 
molecular size, and potency requirements) are now well recognised. These limitations may 
preclude the use of many newly synthesised drug molecules in passive transdermal systems 
such as proteins and peptides that are now being produced by the biotechnology industry. 
Proteins and peptides are considered ideal medicines in many ways because they are involved 
in all biological processes and reactions and are innate specific and potent. These molecules 
have special delivery requirements and cannot, at present, be administered via traditional drug 
delivery routes. The transdermal route is very attractive for proteins and peptides for a number 
of reasons including the low metabolic capacity of the skin and the potential for prolonged 
release drug delivery. The recent flood of genetic information and the sequencing of the 
human genome is only likely to increase the number of protein and peptide drug candidates. 
The attractiveness of the transdermal route has encouraged continued interest and research 
into ways of overcoming the limitations of the skin barrier. Strategies used to promote the 
transport of molecules across the skin barrier include the incorporation of certain chemical 
permeation enhancers into the dosage form. These permeation enhancers have been shown to 
modify permeation of a large number of drugs and marker compounds. The mechanism by 
which they alter permeability is dependant on the physicochemical characteristics of the 
enhancer and drug. Despite a large volume of research in this area, few enhancers have been 
used successfully in vivo, and apart from those already tested in topical preparations none 




for the lack of success of these permeation enhancers including formulation difficulties and 
irritancy issues. However, as the understanding of the molecular mechanisms of permeation 
improves, these difficulties and questions are likely to be addressed. 
In addition to chemical enhancers, a small number of physical enhancement strategies have 
been employed. Electrically assisted transdermal drug delivery uses an electromotive force to 
increase the permeability of compounds across the skin. This novel enhancement technique 
known as iontophoresis, provides advantages over passive systems by virtue of a greater 
driving force for the transport of compounds across the skin barrier. Delivery rates can be 
improved and variable delivery profiles may be attained for ionic and higher molecular weight 
entities. These benefits, in combination with the traditional advantages of transdermal 
systems, make this approach particularly attractive for the delivery of protein and peptide 
drugs. Numerous in vitro, in vivo, and clinical trials have suggested that iontophoresis is a 
viable means of skin permeation enhancement (Prausnitz 1997) and it is envisioned that 
commercialisation of iontophoresis will occur in the next few years (Guy et al., 2000). 
Macromolecular delivery systems remain elusive. Recent reports of insulin delivery across 
animal skin using physical enhancement methods (Mitragotri 1995) and rapid progress in 
non-invasive monitoring of glucose across the skin in diabetic patients have fuelled the effort 
to develop such systems for large molecules (Hirvonen et al., 1996) 
This thesis investigates the mechanisms of several strategies to promote peptide iontophoresis 
across human skin. Specifically the potential of electrical fields to facilitate permeation 
enhancement of peptides during iontophoresis was investigated. Permeation studies and 
electrical investigations were conducted to determine the amount by which peptide transport 
across the skin may be increased. In the light of these investigations, and comparisons with 
the modified Nemst-Planck and hindered pore models, other approaches to promote peptide 
transport across the skin were deemed necessary. The incorporation of a model permeation 
enhancer into the iontophoretic system was considered. Potential synergy between these 
enhancement strategies was assessed with regard to biophysical investigations, theoretical 
modelling and permeation studies. 
3 
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1.2 Anatomy of the skin barrier 
1.2.1 Evolved Barrier 
From an evolutionary perspective, the primary role of the skin is a protective barrier. This 
function includes the maintenance of fluid balance, prevention of desiccation and 
microbiological invasion, and protection from physical, chemical, and ultraviolet induced 
injury. In general, the gross anatomical features of the skin reflect this function. The skin 
comprises two main layers: the epidermis and the dermis (Figurel.1) (Barry 1991). Other 
anatomical features that make up the anatomy of the skin are the skin appendageal structures: 
the hair follicles, nails and sweat glands. 
The epidermis is generally divided into five layers representing separate stages of cell 
differentiation. The outmost and fully differentiated layer is generally accepted as the primary 
barrier layer to percutaneous absorption. Hence the primary focus of the discussion on the 
anatomy of the skin will be this structure, the stratum comeum. 
1.2.2 Stratum corneum 
The thickness of the stratum comeum varies from site to site but on average it is comprised of 
about 20 cell layers where each layer is around 0.5µm thick (Cevc 1996). Despite the thinness 
of the barrier, it is remarkably impermeable under normal conditions. This is well illustrated 
by the low loss of water across the entire skin surface (water permeability is around 90 x 10-5 
cm/h) (Cevc 1996). A useful representation of the stratum comeum structure is a "brick wall". 
Fully differentiated comeocytes comprising the 'bricks', embedded in the 'mortar' created by 
the intercellular lipids (Walters 1989). The comeocytes are flat, functionally dead cells, with a 
cytoplasm filled with dense keratin fibres. The intercellular lipid matrix surrounding these 
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Figure 1.2. Schematic diagram of the structural components of the stratum comeum 
responsible for the barrier function (adapted from Barry 1987) 
1.2.2.1 Location of the stratum corneum barrier 
There is substantial evidence to suggest that the intercellular lipid matrix is critical for 
effective barrier :fimction (Wertz and Downing 1989). Firstly, it has been noticed that 
alterations to the composition or organisation of this layer results in a defective barrier that 
has increased permeability (Elias 1990). Removal of the lipids using organic solvents has a 
similar effect (Grubauer et al., 1989). Skin permeability at different body sites has been 
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correlated with local variations in lipid content (Lamp et al., 1983). It appears that the 
permeability barrier arises from those structures (impermeable comeocytes and tightly packed 
lipid matrix) that permit only very low passive diffusion through the intercellular pathway. 
This particular route is very tortuous possibly having a diffusion pathlength much longer than 
the thiclmess of the stratum comeum (Potts and Francoeur 1990, 1991). Both the pathway and 
the pathlength remain an issue of topical debate (Pellett et al., 1997, Bunge et al., 1999). 
Current opinion is that the stratum comeum is predominantly a lipophilic barrier, designed to 
inhibit passive loss of tissue water in an arid conditions. It is thought that the large surface 
area found within the stratum comeum may be responsible for its excellent prevention of 
moisture loss (Elias 1990, Bunge et al., 1999) 
1.2.2.2 Intercellular Matrix 
The matrix is formed when larnellar bodies of the upper granular cells (found in the stratum 
granulosum) extrude their contents into the extracellular space. Here the lipids fuse end to 
end. These intercellular lipids of the stratum comeum in contrast to almost all other 
biomembranes, have no phospholipid component and are comprised of almost equimolar 
mixture of cerarnides, cholesterol and free fatty acids (Table 1.1). Freeze fracture studies of 
the stratum comeum have given valuable insight into the structural details of this layer (van 
Hal et al., 1996, Bodde et al., 1990). These studies confirm the existence of multiple layering, 
alternating between hydrophilic and lipophilic regions within the stratum comeum. The 
composition of stratum comeum lipids has been reported by Wertz & Downing (1989) and 
Elias (1990). 
Table 1.1. Composition Of Mammalian Epidermal Lipids (Elias 1990). 
Lipid Type Living layers(%) Stratum comeum (%) 
Phospholipids 40 Trace 
Sphingolipids 10 35 
Cholesterol 15 20 
Triglycerides 25 Trace 
Fatty acids 5 25 
Other 5 10 
Totals 100 100 
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1.2.2.3 Corneocyte Envelope 
The comified envelope (CE) is associated with the lipid bilayers. This is a layer of lipid that is 
covalently bound to the comeocyte. The CE is found in all stratified squamous epithelia 
(Steinert and Merekov 1999). In the epidermis, the CE is found around the keratinocytes and 
its possible functions include interactions between comeocytes and surrounding lipids, 
permeability effects on individual cells, and desquamation (Wertz & Downing 1989). Under 
the transmission electron microscope the envelope appears to be a tmiform 12nm thick 
electron dense polar region. This macromolecular assembly is comprised of highly insoluble 
proteins of several types (Steinert and Marekov 1995, 1999, Steinert et al., 1998, Robinson et 
al., 1997). The inner portion of the envelope consists of cross-linked proteins (disulfide and 
garnma-glutamyl-epsilon-aminolysyl isopeptide bonds) (Greenberg et al., 1991, Reichert et 
al., 1993, Steinert and Marekov 1999). In the epidermis this stmcture has an additional 5 nm 
layer of lipids attached to the outer surface which appears to perform the water barrier 
function of this tissue (Wertz et al., 1989). The envelope persists after solvent extraction and 
represents the scaffolding for insertion of the keratin filaments thus comprising a highly 
resistant barrier to chemical and physical assault (Downing 1992). The structure has no 
intrinsic water barrier properties but is thought to assist in this function by organising the lipid 
lamellae, adhering comeocytes together, and/or functioning as a semi-permeable membrane 
(Behne et al., 2000). 
1.2.2.4 Keratin 
Comeocytes of the stratum comeum are flat and functionally dead cells with the cytoplasm 
filled with keratin. Keratins are a family of alpha-helical polypeptides between 40000 to 
70000 Dalton in size (Wertz & Downing 1989). They are synthesised heterogeneously as 
pairs of acidic and basic polypeptides. The individual keratin molecules aggregate to form 
super-helices facilitated by filaggrin. These filaments, many microns in length, are stabilised 
by disulphide bridges. It is thought that they are responsible for maintaining the flat hexagonal 
shape of the comeocyte which may contribute to the toughness and flexibility of the stratum 
comeum (Wertz & Downing 1989). 
1.2.3 Appendageal Structures 
Other structures located in the skin are the epidermal appendages, namely hair follicles, 
sebaceous glands, apocrine glands, and ecrine sweat glands. The hair follicle structure 
penetrates into the dermis where the epithelial lining of the lower portion is not keratinised 
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(Figure 1.1). A recent review on the hair follicle has been given by Lauer et al., (1995). The 
outer root sheath of the hair follicle originates from the epidennis and extends downward, 
becoming thinner towards the hair bulb. Between the hair and the shaft an opening exists 
(Cevc 1996). The pilosebaceous unit is the collection of the hair follicle, hair shaft and 
sebaceous glands. Its volume is normally filled with sebum and therefore may not be entirely 
available for transport (Cevc 1996). It is thought that this may provide a "shunt' for 
substances permeating through the stratum comeum. Several reports have suggested that 
follicles do contribute to permeation (Schaefer 2000), however the importance for drng 
delivery is uncertain because the follicles occupy a relatively insignificant fraction of the total 
surface area that is available for transport (-0.1 %). A similar argument can be made with 
respect to the sweat glands which cover a considerably smaller total area than the follicles. 
1.2.4 Dermis 
Beneath the epidermal layer is the dermis. This layer is much thicker than the epidennis 
(approximately 3 to 5 mm) consisting of connective tissue in a mucopolysaccaride ground 
substance. The dermis has a generous blood supply which branches from the arterial plexus. 
This system comes close to the surface of the skin (0.2mm) and serves to provide nutrients, 
remove waste, regulate temperature and blood pressure, allow activation of the immune 
system, and provide colour to the skin. The blood supply is efficient and subsequently acts as 
a 'sink' to penetrating molecules, giving rise to a concentration gradient, which is favourable 
for percutaneous penetration. The dermis also supports the skin's appendageal structures, 
specifically the hair follicles and sweat glands. 
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1.3 Routes of Permeation 
Skin permeation can occur through two 'macro' routes (Barry 1991) including traversing the 
intact comified layer, or passing through the sweat glands and hair follicles (shunt route). At 
steady state, it is believed that the stratum comeum is the most significant route for passive 
diffusion although many factors influence the importance of both pathways. For those 
substances transported through the stratum comeum the two compartment model of "bricks 
and mortar" is the generally accepted model for permeation. Substances may permeate 
through the intercellular (paracellular) pathway or the transcellular (intracellular) route. These 










Figure 1.3. Schematic diagram of proposed routes of penetration through the human 
stratum comeum. (Modified from Barry 1987). 
1.3.1 lntercellular route 
Morphological studies have shown that polar and non-polar solute molecules pem1eate 
primarily through the intercellular route, however the exact nature of pathway is still disputed 
(Menon & Elias 1997, Hatanaka et al., 1994, Potts & Guy 1992). It is possible that molecules 
travel through the polar head group or hydrophobic domains in the lamellae, or alternatively 
distinct 'microdomains' may facilitate transport within the stratum comeum interstices. Some 
of the most convincing evidence in support of the intercellular pathway has been repmied by 
Bodde et al., (1989, 1991). Diffused mercuric chloride was precipitated with an ammonium 
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sulfide buffer in the skin. Following diffusion and precipitation, transmission electron 
microscopy revealed that mercuric sulfide was primarily located in the intercellular space. 
Other investigations have shown the presence of microdomains in the lamellae and have 
demonstrated that they are related to the site of desmosomal dissolution (Hou et al., 1991). 
Recently ultrastructural investigations have suggested these domains are a possible pore 
pathway for both polar and non-polar solutes (Menon & Elias 1997). 
1.3.2 Transcellular route 
In the transcellular route the permeant must dissolve into and diffuse through lipid lamellae 
and the more hydrophilic keratinocytes in series (Amsden and Goosen 1995). This is the more 
direct pathway and favours a permeant with suitable partition coefficients for the lipid phase 
and protein phase. Direct experimental evidence in support of this pathway is lacking 
however (Amsden and Goosen 1995). The relative importance of the intercellular, 
transcellular, and shunt routes is still argued and will depend on penetrant physicochemical 
characteristics within these protein or lipid regions (Barry 1991). It has been suggested that 
there may be separate polar and non-polar pathways through the skin (Flynn 1989, Sims and 
Higuchi 1990, Peck and Higuchi 1998). Polar molecules appear to permeate the stratum 
corneum independently of their partition coefficient (Cooper 1984) while less polar molecules 
have flux rates dependent on partition coefficient (Scheuplein and Blank 1971). The free-
volume theory has been used to provide an explanation of this behaviour (Potts and Guy 
1992). This model assumes diffusion occurs through holes, or a free-volume region, that are 
in the area adjacent to the molecule (Amsden and Goosen 1995). It has been suggested that 
small polar molecules are transported through the extracellular lipids that undergo minor 
interfacial defects thus allowing the creation of free-volume regions to occur (Potts et al., 
1992). Despite disagreement regarding the mechanism, transdermal penneation is dependent 
upon the barrier function of the stratum corneum. This is illustrated by the vast quantity of 
literature that reports use of permeation enhancers which can alter the structure and 
organisation properties of the stratum corneum. 
1.3.3 Transport through skin appendages 
Appendages occupy around 0.1 % of the total surface area of the skin (Scheuplein, 1967) and 
therefore passive diffusion through these structures has been thought to be insignificant 
(Scheuplein and Blank 1971, Wertz & Downing 1989). More recent investigations with rat 
skin with and without hair follicles shows appendageal skin penetration may have greater 
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importance in passive transport across the skin (Illel et al., 1991). Earlier reports may have 
underestimated the absorption capabilities of these structures and further investigation is 
required (Lauer et al., 1995 Schaefer et al., 2000). However these structures, forming the 
"shunt pathway", are likely to have greater significance in drug delivery during iontophoresis 
and other specialised enhancing technologies are used to increase transdermal delivery 







1.4 Factors Affecting Skin Permeation. 
1.4.1 Variability 
Permeation rates can vary with respect to factors such as the anatomic site, disease, and age. 
There are several issues that arise when using human skin in permeation studies. It is often 
thought that human skin exhibits a high degree of variability requiring the use of many 
samples to attain statistical significance. This factor, in addition to the restricted availability of 
human skin, have lead to the widespread use of animal tissues as models for human skin. 
Barry has recently summarised the problems and caveats of working with animal tissues 
rather than human skin (1999). 
The permeability of human skin varies between individuals, between sites, and within sites on 
the same individual (Barry 1999). Although not extensively studied, this variability appears to 
be non-Gaussian (Barry 1999). The magnitude or fundamental reasons for variability have not 
been clearly identified but regional and individual lipid variations in the stratum comeum are 
thought to influence permeability (Lampe et al., 1983, Law et al., 1995) as are environmental 
factors that may alter the lipid composition (such as age and seasonal variation) (Rogers et al., 
1996). Reports have also suggested that skin permeability is higher in the evening and night 
than in the morning (Yosipovitch et al., 1998). Certain regions of the skin that are more 
permeable include the genitalia, the lower back, the face, the scalp, and behind the ear. 
Furthermore, racial origin has to be taken into account as reports have suggested that this 
affects stratum comeum barrier function (Kompaore et al., 1993). Therefore it is apparent that 
in performing permeation studies in vitro or in vivo on human skin, measures should be taken 
to ensure samples are as uniform as possible. 
1.4.2 Age 
The effect of age on permeability is of clinical importance since many transdermal systems 
will be designed for chronic geriatric therapy. Also, excised skin and cadaver tissue are often 
sourced from older patients. Evidence that age related permeability changes occur is not 
particularly extensive. In young skin (from soon after birth until early "old-age" of around 
42), there is little variation with age in the rate of transepidermal water loss across normal, 
intact skin (Roskos and Guy 1989). However older skin does show differences. Another 
consideration as the skin ages is the growing fragility of the banier. Injury resulting from 




manipulation of aged skin ex vivo is difficult since it is more susceptible to damage. Similar 
considerations should also apply with regard to neonatal skin. Premature neonates are at risk 
due to a poorly developed barrier (Williams and Feingold 1998). 
1.4.3 Skin condition and disease 
Changes in barrier function, due to skin disease, generally are the result of either an alteration 
of the lipid/protein composition of the stratum comeum or of abnormal epidermal 
differentiation (Wertz and Downing 1989). In psoriasis, the stratum comeum has a modified 
lipid composition, a lower resistance to transepidermal water loss, and an anticipated higher 
permeability to topically applied drugs (Hartop et al., 1978). Similarly, decreased barrier 
function has also been observed in eczema, superficial fungal infections, atopic and contact 
dermatoses, icthyosis, and UV-irradiated skin (Wertz and Downing 1989). Generally, the 
implications for transdermal delivery is that preparations are only applied to "normal" skin 
that is not diseased. 
1.4.4 Skin metabolism 
Pre-systemic metabolism in the skin can obviously modify transdennal drug bioavailability. 
The "cutaneous first-pass effect" for nitroglycerin, for example, has been estimated to be 15% 
to 20% (Guy et al., 1987). The viable epidermis is a biochemically active tissue with 
metabolic capability (Cullander and Guy 1992). The skin can perform most of the 
biotransformations that occur in the liver, however, the total enzy1natic capacity is thought to 
be less than one percent that of the hepatic system (Tauber 1987). The capacity of the viable 
epidermis, below a transdermal drug delivery system, to metabolise a delivered drug is limited 
and the role of biodegradation is likely to be minor (Cullander and Guy 1992). In particular 
this may be the case for compounds like peptides that penetrate tln·ough the intercellular route, 
avoiding the proteases and peptidases found intracellularly in the epidermis (Amsden and 
Goosen 1995). The peptide des-enkaphalin-y-endorphin was found to degrade during· 
transdermal permeation (Bodde et al., 1989). A study on the metabolism of luteinizing 
hormone releasing hormone (LHRH) in several intact tissues and tissue homogenates 
indicated that skin has very limited proteolytic activity, particularly when intact (Bi and Singh 
2000). Many degradation studies have been performed in animal tissue, which has different 
metabolic activity compared with human skin, therefore conclusions must be drawn with 
caution from these studies (Tauber 1989). As already mentioned, one of the advantages of 
transdermal delivery is avoidance of gastro-intestinal tract (GIT) and hepatic first pass 
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metabolism. The importance of metabolism in drug delivery across the skin depends upon the 
nature of the enzyme system, the substrate, the rate of diffusion across the skin, and the rate of 
bio-conversion (Pannatier et al., 1978). Enzymatic degradation is likely to be of most 
significance when transport fluxes are low because this metabolising capacity will generally 
be minimal. At faster delivery rates the metabolising enzyme system will be saturated and 
most of the drug will pass through intact. 
1.4.5 Skin turnover 
The epidermis replaces itself approximately every two to three weeks (Wertz and Downing 
1989). This continual process, results in the removal of the outmost cells by desquamation at 
an approximate rate of one layer of the stratum come1nn per day (given that the stratum 
comeum has approximately 20 comeocyte layers). This has potential impact for delivery and 
design of patches to be worn for periods greater than 24 hours because of problems of 
adhesion. Most patches, such as fentanyl, are directed to be used for a maximum of 72 hours 
(Payne et al., 1995), though recently seven day oestrogen patches have been used successfully 
(Gordon 1995). 
1.4.6 Cutaneous irritation 
Penneation through the skin may result in an inflammatory response. Such a reaction may be 
non-immunological irritation or an immune response. Irritant drugs are unlikely to be good 
candidates for transdermal delivery. Even compounds that induce mild erythema are not likely 
to be acceptable to patients during chronic administration. The local skin reaction at the 
application site is the most common adverse event associated with testosterone transdermal 
delivery (Wilson et al., 1998). To overcome such reactions, co-administration of anti-
inflammatory agents has been proposed (Wilson et al., 1998). Sensitisation is an equally great 
problem. Most cutaneous reactions are limited to localised dennatitis; however, generalised 
systemic effects may occur (Holdiness 1989). Investigators have reported skin-related side-
effects in up to 50% of patients using transdermal clonidine (Corazza et al., 1995); however, 
with other agents, this is demonstrated much less frequently (Holdiness 1989). Following 
sensitisation to the patch, reactivation of the de1matitis following oral medication is noted in 





1.5 Physical chemistry of transport 
Passive diffusion through the stratum comeum is well described by Fick's 1st and 2nd laws. 
Diffusion can be defined as the mass transfer of individual molecules of a substance as a 
result of the random molecular motion and the concentration gradient associated with the 
compound. Molecules may pass through a membrane in two main ways: molecular 
permeation; or by movement through pores and channels present in the membrane. In the first 
scenario, the permeation process involves the dissolution of permeating molecules in the bulk 
membrane. In the second case, passage through pores will be influenced by the relative sizes 
of the penetrating molecules and the diameter of the pores. 
1.5.1 Thermodynamics of Diffusion. 
Thermodynamics is the study of systems at equilibrium whilst mass transfer is the study of 
the rate of approach to equilibrium (Topp 1988). The thermodynamic basis of diffusion can be 
understood using the following system example. 




Figure 1.4. Schematic representation of two phases separated by a semi-permeable 
membrane. At equilibrium the three variables T, P, and ~L (temperature, pressure, and 
chemical potential respectively) are equal to their con-esponding variable in the 
adjoining compartment. 
If the chemical potential, µ1 was to increase so that it was greater than µ2, the system would 
then attempt to return to equilibrium by re-establishing chemical potential equality (variables 
T and P tmchanged). The reestablishment of the chemical potential equality is achieved by 
transport of component 1 from compartment 1 into compartment 2. Simplistically, this is the 
process of diffusion where the driving force is a gradient in the chemical potential (Topp 
1988). 
In the diffusion of a substance through the skin, the rate of mass transfer, flux, is proportional 





with the stratum comeum and the permeant in the relatively aqueous viable epidermis 
(Amsden and Goosen 1995). For simplicity in considering diffusion, the skin has been 
modelled as a trilaminate membrane for diffusion consisting of the stratum comeum, viable 
epidermis, and the dermis. Each layer can be considered to be homogenous and permeation 
through each Fickian in nature. For the purposes of this thesis, the stratum comeum will be 
considered as the dominant diffusional barrier given that the primary interest is with aqueous 





in which Dsc is the permeant diffusivity in the stratum comeum, dCsc is the gradient in 
permeant concentration across the stratum comeum, and dx is the thiclmess of the stratum 
comeum. The diffusivity in the stratum comeum represents an apparent diffusivity, including 
interaction and binding effects of the permeant with the stratum comeum. If sink conditions 
exist equation 1.1 becomes 
DC J: SC SC 
h 
(1.2) 
in which Csc is the permeant concentration in the stratum comeum in contact with the 
solution, and the thiclmess of the skin is represented by, h. This is often very difficult to 
determine so equation 1.2 is often expressed as 
J=P(~) (1.3) 
in which P is the specific permeability of the stratum comeum to the permeant, and C is the 
permeant concentration in the phase that is in contact with the stratum comeum. Often it is 
required to compare flux values, therefore they must be normalised, J ,defined by, 
where P is given by, 
- J p 
J=--C-h (1.4) 
P = DSC( c~c) = KSCDSC (1.5) 
where Ksc is the partition coefficient of the permeant between the contacting phase and the 
stratum comeum. The partition coefficient is the ratio of solubility of the permeant in each 
phase. At steady-state there is a direct relationship between the rate at which drng is delivered 
across the skin and properties of the fo1mulation which includes the partition coefficient, Ksc, 
and drng concentration in the formulation, C. Increasing C to a maximum, i.e. a drng 
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saturated formulation will enable J to be as large as possible under most conditions. However 
at these limits stability of the preparation may be an issue (Brain et al., 1993). It is a common 
misconception that increasing the concentration of a drug will result in an increase in drug 
flux (Hadgraft 1999). Such is the case with a drug applied as a suspension where the 
concentration will have no effect on flux. It is the chemical potential gradient that is the 
driving force. Altering the partition coefficient so that the drug has optimum affinity for the 
stratum comeum relative to the vehicle is less straightforward. Decreasing the solubility of the 
drug in the formulation so that the stratum comeum solubility is higher may mean the total 
amount of drug that can be loaded in the delivery system is low. This will affect the length of 
time a formulation will deliver the drug at appreciable rates. The ideal system has a balance 
between Ksc and C so that the leaving tendency of the drng from the formulation favours its 
efficient movement into the skin, but the saturation solubility of the drng in the vehicle is high 
enough that sustained delivery can be achieved over the intended time of application. 
1.5.2 Physicochemical Properties of the Drug 
The physicochemical properties of a permeant will influence the pathway of permeation and 
also the rate at which the drng will be transported through this pathway into the body. 
Lipophilicity, molecular size, ionisation state, and interactions with the skin are likely to be 
the dominant determinants through their effect on Kand D (Amsden and Goosen 1995, Potts 
and Guy 1992). 
Non-ionised drngs wili often permeate more readily than ionised drngs because the energy 
required to partition into a primarily non-polar stratum comeum will be lower (Xu and Chein 
1991). Current transdermally delivered drugs have log(octanol-water) partition coefficients in 
the range of 1 to 3 (Finnin and Morgan 1999). It is likely the water barrier function of the 
stratum comeum minimises the percutaneous penetration rates of very polar or charged 
substances thereby precluding useful passive delivery of these solutes. High levels of 
lipophilicity are also disadvantageous because the drng must not only permeate into the 
lipophilic stratum comeum but also the relative aqueous layers beneath (dermis) that lead to 
the capillary blood supply (Bucks et al., 1988). In general it is important for a drug to have at 
least some degree of aqueous solubility for transport to the systemic circulation to be 
achievable. 
The molecular size of the permeant will influence the diffusivity in the skin. Large molecules 







where 1J is the viscosity of the solvent, r is the solvated radius of the diffusing solute, R is the 
gas constant, T is the absolute temperature, and N is Avogadro's number. Clearly D is 
inversely proportional to the radius. This expression can also be written in tenns of molecular 
weight (Martin 1993), 





in which M is the molecular weight and v is the partial specific volume. From this D is 
inversely proportion to the cube root of molecular volume. These expressions relate to simple 
liquid systems. In the case of polymers and other organised strnctures ( and the stratum 
comeum), the dependence has been empirically suggested to follow an exponential 
relationship (Scheuplein and Blank 1971, Pugh et al., 1996). In practice, due to size 
influences on diffusivity, the maximum molecular weight of drugs used in passive 
transdermal systems has been around 350 Daltons. 
The size and partition coefficient of a molecule are not usually independent factors (Potts and 
Guy 1995). As M increases, it is quite usual that Ksc also increases. The effect of increasing M 
will therefore have a positive effect on permeability coefficient via an increase in 
lipophilicity, and a negative effect via a decrease in diffusivity. According to Potts and Guy 
(1992) a practical result of this observation is that small polar compounds often have better 
permeabilities than might be expected, based only on their lipophilicity, because of the 







1.6 Limitations of transdermal delivery systems 
Although many of drugs have been investigated as potential candidates for transdermal 
delivery, few have been commercialised in terms of dermal formulations. There are a number 
of reasons this, the pharmaceutics aspects of which are discussed here. The primary limitation 
to percutaneous delivery is the formidable barrier presented by the skin. The current 
limitations to transporting drugs through the skin of a patient is illustrated by searching for 
systems that have successfully reached the market. Those few successful passive transdermal 
systems that have been approved by the FDA contain drugs that share three common traits -
they are effective in low doses, have a molecular mass less than 400 Da, and a good lipid 
solubility (Prausnitz 1997). 
1.6.1 Dose and Potency 
It has been suggested that the potency of the drug candidate should be high enough that the 
total daily systemic dose is less than 20 mg (Finnin and Morgan 1999). This is likely to equate 
to drugs with low effective plasma concentrations i.e. quantities around ng/ml or less to be 
effective. Other factors are also likely to influence the total daily dose required such as 
metabolic susceptibility, plasma half-life, tolerance, and chronotherapeutic considerations. 
1.6.2 Appreciable percutaneous penetration rate. 
Permeation rates will depend on the physicochemical characteristics of the drug. This means 
the molecular weight of the drug should not exceed 500 Da; the drug should have adequate 
lipid and aqueous solubility (Log P in the range of 1-3, and melting point less than 200 
degrees C) (Finnin and Morgan 1999); and hydrogen bonding groups should number less than 
3 if significant interaction between the skin and drug are to be avoided (Fim1in and Morgan 
1999). 
1.6.3 Potential for local irritation. 
There is a potential for drugs and transdermal systems to cause cutaneous irritation. Rotation 
of the delivery site may alleviate the irritation but the irritation potential may still be 
significant, especially if the device is designed for prolonged application. Fonnulation factors, 
such as excipients and chemical enhancers also have the propensity to cause irritation (Bemer 





1.6.4 Systemic toxicity concerns. 
Although the drug adverse effect profile remains pharmacologically the same as by traditional 
routes, overdosage remains a possibility. Systemic toxicity may occur if the drug permeates at 
a greater rate than expected, due to skin barrier malformation, a delivery system device fault, 
or an incorrect use of the device. Toxicity is of particular concern in paediatrics where skin 
absorption characteristics may be different due to a premature skin barrier. Furthermore, the 
skin site that is selected for administration may show different absorption properties from 
other sites (see section 1.4.1 on skin variability). Systemic toxicity concerns are emphasised 
because drugs that are incorporated into transdermal delivery systems are generally potent 
compounds. 
1.6.5 Speed limitations. 
The considerable time required for drug penetration across the skin and the formation of a 
drug reservoir within the epidermis have been demonstrated (Wester & Maibach 1992). 
Therefore in some cases, such as in acute pain management with transdermal fentanyl, initial 
administration via alternative routes may be necessary to cover the time period during which a 
patch does not provide therapeutic levels of drug (Grond et al., 2000). Metabolism and 
degradation may also be influenced by the rate at which a drug permeates through the skin. A 
slowly permeating drug will have greater exposure to physical, microbiological, and 
enzymatic degradation to inactive or active metabolites than rapidly transported compounds 




1. 7 Candidates for transdermal delivery 
Transdermal delivery is more likely to be successful if the phaimacokinetic and 
pharmacodynamic characteristics of a drug are suited to this mode of delivery (Bemer and 
John 1994). Transdermal systems currently on the market were designed in order to meet the 
delivery profiles for existing drugs available in other traditional dosage forms. Because of 
this, the pharmacokinetics and pharmacodynamics of the drug were already well established. 
Table 1.2. Drugs for which transdermal systems are available 
Drug Indication Prior/Commonly Controlled Delivery Reference 
Administered (Transdermal) Advantages 
Dosage Form 
scopolamine Motion sickness Oral, parenteral Sustained release avoids bolus Bemer and 
associated side effects ( dry mouth, John 1994 
drowsiness, and hallucinations) 
nitroglycerin Angina Oral, transdermal Prolonged constant plasma drug Bemer and 
prevention ointment concentrations, greater than John 1994 
ointment preparation. 
estradiol Post Oral The low bioavailability due to Good et al., 
menopausal extensive 151 pass metabolism 1985 
symptoms avoided. 20 times reduction in dose 
could be facilitated. 
clonidine hypertension Oral Oral dose has comparatively high Amdts etal., 
incidence and severity of adverse 1984, Maibach 
reactions related to plasma 1985 
concentration. Transde1mal 
delive1y obtains a target plasma 
concentration for extended periods 
(up to one week) 
nicotine Smoking Gum, transmucosal Efficacy of smoking cessation Abelin et al., 
cessation therapy has been related to the 1989 
steady-state tr·ough plasma 
concentration. Transde1mal avoids 
the tr·ough via controlled release. 
fentanyl analgesic parenteral Prolonged duration of effect for Duthie et al., 
chronic pain treatment with little 1988 
potential for addiction 
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Drugs with short biological half-lives, subject to first pass metabolism, and thus requiring 
inconvenient and frequent oral or parenteral delivery are good candidates. Drugs with 
undesirable consequences resulting from poor compliance and fluctuating peak and trough 
plasma levels are also particularly suited for transdermal delivery. However, drugs that are 
given orally, that are effective once a day with reproducible bioavailability, and that are well 




1.8 Permeation enhancement. 
The aim of permeation enhancement is to improve permeation of drugs and other substances 
across the skin, either by increasing the rate of permeation to allow appreciable concentrations 
to be delivered, or by increasing the control over the rate of permeation. The range of 
transdermal drug delivery candidates is currently limited to a small number of compounds due 
to the restrictive nature of the stratum comeum barrier. Therefore, by employing permeation 
enhancement strategies, the range of possible drug candidates may be expanded. Permeation 
enhancement has been studied in most routes of drug delivery including via mucosal tissues, 
via cornea, across the blood brain barrier, and through the skin. It is a common goal to reduce 
the "threshold" of the barrier by altering the diffusibility parameters or the solubility 
parameters of drugs in the skin (Hsieh 1994). Evolving methods of skin permeation 
enhancement include chemical permeation enhancers (Hadgraft 1999) and iontophoresis 
(Banga et al., 1999) both of which have been under comprehensive investigation now for two 
decades. Newer and novel enhancement strategies are also part of the current focus of 
transdermal permeation investigations. These include colloidal systems such as liposomes, 
niosomes, and microemulsions (Cevc 1996); supersaturated systems (Hadgraft 1999); and 
physical enhancement methods that consist of electroporation (Prausnitz 1997); 
phonophoresis (Kassan et al., 1996); microfabricated needle technologies (Henry et al., 
1999); and iontophoresis (Banga et al., 1999). 











Minimally invasive technologies 
1.8.1 Chemical permeation enhancers 
Reference: 
Hadgraft 1999 
Xu and Chien 1991 
Cevc 1996 
Banga et al., 1999 
Prausnitz 1997 
Kassan et al., 1996 
Henry et al., 1999 
As yet, no overall theory of chemical enhancement has been devised. It is likely that the 
physical basis of enhancement will be multi-faceted, as demonstrated by the number of 
different mechanisms of action that have been proposed for ahnost all chemical enhancers that 
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have been widely studied. In general, it is assumed that chemical enhancers increase 
permeation by disrupting the highly organised structure of the stratum comeum, or by 
increasing the solubility of the penetrant in the stratum comeum. These effects can be 
assessed further by considering Fick's first law of diffusion. As discussed previously, Fick's 
first law of diffusion is generally accepted as a good description of the passive diffusion 
process across skin, 
J = DkscC 
h 
(1.8) 
where J, the amount of drug transported across the skin per unit time (flux), is the product of 
D, the diffusion coefficient, ksc, the skin-vehicle partition coefficient, and C, the concentration 
of the drug in the delivery system, divided by the thickness of the skin, h. Permeation 
enhancers theoretically modify the drug diffusivity, solubility, or both, in the skin, leading to 
an increase in transport. According to Ficks law, permeability can be enhanced by altering the 
structure of the skin (for example changing Dor h with the enhancer Azone), or by increasing 
the solubility of the drug in the skin (for example with the use of ethanol). Several reviews 
have been published over the last ten years that have considered chemical permeation 
enhancers (Walters 1989, Goodman and Barry 1989, Xu and Chien 1991, Williams and Barry 
1992, Singh and Singh 1993, Smith and Maibach 1995, Walker and Smith 1996, Hadgraft 
1999, Finnin and Morgan 1999). The characteristics of an ideal enhancer are listed in Table 
1.4. 
Table 1.4. Properties of an ideal enhancer. 
Not pharmacologically active 
Specific in action 
Rapid action of predictable duration 
Reversible 
Stable chemically and physically 
Compatible chemically and physically with drug and excipients 
Odourless and colourless 
Non-toxic, non-allergenic, and non-irritating 
A large number of different classes of compounds have been investigated as permeation 
enhancers. However it is unlikely that all the strict requirements outlined above will be found 
in any one enhancer (Hadgraft 1999). Water may represent a good enhancer, but even this 
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substance has the ability to induce unwanted effects in the skin (Wester and Maibach 1995). 
A brief summary of well studied enhancers in given here. 
1.8.1.1 Hydration as a Permeation Enhancer 
Water is an endogenous plasticizer of skin that is always present at a concentration gradient 
over the barrier (Wester and Maibach 1995, Cevc 1996). Water has the ability to alter the 
barrier properties of the skin to a number of substances by a range of possible mechanisms 
including impairing stratum comeum adhesiveness and solvent effects (Potts 1989). The 
degree of hydration of the stratum comeum has been shown to influence the permeability of 
water itself through the barrier (Blank et al., 1984). Vehicles that are used in many 
transdermal and topical formulations often make use of hydration influenced permeability 
increases (Wester and Maibach 1995). An example of this is the occlusive patch. These 
systems fully hydrate the skin and increase the penetration rate of the agents included in the 
patch (Scheuplein and Ross 1974). However it is also known that occlusion causes irritation 
and there is a potential for microbial contamination (Walters 1989). 
1.8.1.2 Sulfoxides 
Dimethylsufoxide (DMSO) probably acts by promoting drng partitioning from the dosage 
form or reducing skin resistance to drng substances (Barry 1987). However, there have been a 
number of other proposed modes of action for DMSO including: lipid and protein extraction 
(Embery and Dugrad 1971); increased lipid fluidity by disrnption of intercellular lipid chains 
(Barry 1987); and denaturation of protein substituents among others (Franz et al., 1995). 
DMSO displays concentration dependent activity suggesting that at least part of its action may 
be due to promotion of drng partitioning from the dosage fonn (Barry 1987). A major 
drawback with DMSO is the high concentration required for the enhancing effect (Walters 
1989). Despite a long history of investigation as an enhancer, commercial production of 
formulations containing DMSO has been insignificant (Finnin and Morgan 1999). 
1.8.1.3 Pyrrolidones 
No single mechanism of action has been clearly established for this class of enhancers. It is 
thought that the principal humectant in the stratum comeum is sodium pyrrolidone 
carboxylate, which increases the water binding capacity of the skin (Walters 1989). Since 
these compounds naturally occur, they were investigated in an attempt to find an enhancers 
with reduced toxicity potential. Reports have suggested that pyITolidones interact with keratin 
and lipids in the stratum comeum (Chattarag and Walker 1995). 
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1.8.1.4 Azone 
The three-dimensional structure of Azone is shown in Figure 1.4. Azone is a well studied 
chemical enhancer and has good overall enhancing properties. However general clinical 
acceptance has been limited because of the potential to irritate the skin (Finnin and Morgan 
1999). The enhancer has been shown to influence both hydrophilic and hydrophobic drugs 
(Walker and Smith 1996, Suhonen et al., 1999). Differential scanning calorimetry studies 
have shown that treatment with this enhancer results in decreases in the lipid thermal 
transitions of the stratum comeum (Barry 1986). It is expected that Azone acts by insertion 
into the lipid bilayers of the stratum comeum, where its seven membered head group is likely 
to lie in the plane oflipid polar head groups (Suhonen et al., 1999, Lewis and Hadgraft 1990). 
The presence of Azone within the bilayer may disrupt the efficient packing of the bilayers and 
thereby increase permeation by a structural alteration to the banier. A recent electron 
microscopy study using ruthenium tetroxide staining revealed that lamellar packing of the 
intercellular lipid bilayers disappeared, yet individual lamellae were still present after Azone 
treatment (Bouwstra et al., 1996). 
1.8.1.5 Fatty acids 
A common structural feature of many enhancers is a long hydrocarbon chain. In fatty acids, 
the length of the hydrocarbon chain has been found to influence the magnitude of 
enhancement across the stratum comeum (Golden et ai., 1987b, Suhonen et al., 1999). 
Furthermore, the presence of a double bond in the cis-conformation, as is found in oleic acid 
(OA) (C18:1), also enhances permeation (Aungst et al., 1986). The advantage of fatty acids 
and fatty acid esters is that many of these compounds are classified by regulatory bodies (i.e. 
the FDA) as Generally Recognised As Safe (GRAS) (Finnin and Morgan 1999). Several 
products commercially available use these compounds (Finnin and Morgan 1999). 
Oleic acid has been well studied in vitro (Goodman & Barry 1986, Gay et al., 1989). Using 
differential scanning calorimetry (DSC) and Fourier Transfonn infrared spectroscopy (FTIR) 
studies it has been demonstrated that these cis-octadecanoic acids increase the fluidity of the 
intercellular lipids. This increase in fluidity is con-elated with increases in the permeability of 
the stratum comeum barrier to such substances as salicylic acid (Golden et al., 1987b). In 
model membrane systems, the addition of cis-octadecanoic acids increases the rotational 
movement of the hydrocarbon chains observed by electron-spin resonance (ESR) (Gay et al., 






a result of fatty acid application. It is thought that reduction in the diffusional resistance of the 
skin is via an interaction with the intercellular lipid matrix (Suhonen et al., 1999). Bhatia et 
al. (1997a) described the effect whereby the highly compacted cells of the stratum corneum 
were transformed into a loose network of filaments accompanied with swelling of the cell 
layers. Investigations using FTIR have reported that QA exists in a separate liquid phase in 
the stratum corneum (Ongpipattanakul et al., 1991, Francoeur et al., 1990). Commonly, OA is 
used with a cosolvent such as ethanol or propylene glycol (PG) to improve the penetration of 
the molecule into the lipophilic regions of the human epidermal membrane (HEM). 
1.8.1.6 Polyols 
Propylene glycol (PG) is a familiar excipient in dermatological and topical preparations. It has 
been shown to increase the permeability of a number of drugs including estradiol, 
metronidazole, and trifluorothymidine (Chattaraj and Walker 1995). It is thought solvents like 
PG increase permeability of substances via a pure co-solvent effect (Bendas et al., 1995). 
Thus PG acts by increasing the thermodynamic activity of the drug in the formulation. 
However it is difficult to separate the effect of increased activity and effects on the stratum 
corneum barrier for enhancers (Hadgraft 1984). Bruzy and Bem1ett (1987) reported that PG 
may solvate a-keratin in the skin. This may cause occupation of hydrogen bonding sites 
reducing tissue binding and promoting permeation. 
1.8.1.7 Terpenes 
Terpenes have recently received much attention as permeation enhancers because they appear 
to have good penetration enhancing abilities, with low skin irritancy, and low systemic 
toxicity (Cornwell et al., 1996). Terpenes are compounds derived from essential oils. The 
mechanism of action of these compounds appears to differ depending on whether the drug is 
hydrophilic or lipophilic in nature. For hydrophilic drugs, such as 5-fluorouracil, the primary 
action of the enhancer is to increase drug diffusivity in the stratum corneum (Williams and 
Barry 1991a). Lipophilic drugs, for example estradiol, are accelerated not only through the 
reduction in the barrier function but also due to increased partitioning into the stratum 
corneum (Williams and Barry 1991b). It is assumed that the increase in partitioning is a result 




Surface active agents are often used in topical preparations to increase stability and 
appearance. These agents are characterised by the presence of both polar and non-polar 
groups on the same molecule. These compounds therefore adsorb at interfaces and reduce 
interfacial tension. Many of the publications relating to the effect of surfactants on biological 
membranes demonstrate the existence of a concentration dependent biphasic action with 
regard to membrane transport enhancement (Walters 1989). This enhancement of flux occurs 
at low concentrations of the surfactant, but decreases at higher concentrations, generally 
above the critical micelle concentration. The enhancement action of surfactants at low 
concentrations is often attributed to their ability to penetrate and disrupt the membrane 
structure (Walters 1989). Anionic surfactants may remove water soluble agents from the skin 
that act as plasticizers (Walker and Smith 1996). The hydrophobic interaction of the alkyl 
chains with the stratum comeum may leave the negative end group of the surfactant exposed, 
creating additional anionic sites in the membrane. This may lead to repulsive forces that 
separate the protein matrix in the stratum comeum, uncoiling the filaments, exposing more 
water binding sites, and possibly increasing the hydration level of the tissue (Walters 1989). 
Cationic surfactants have the reputation of being more initant to the skin than anionic or non-
ionic (Walker and Smith 1995). Non-ionic surfactants are recognised as the least likely to 
cause initation or tissue damage (Walters 1989). 
1.8.1.9 Miscellaneous 
There are a growing number of different classes of chemical enhancers reported in the 
literature, yet their clinical usefulness has not been established (Fi1min and Morgan 1999). 
One group of compounds which are cunently incorporated into some topical sunscreens, and 
which are classified as GRAS (Finnin and Morgan 1999), are padimate 0, octyl salicylate, 
and octyl methoxycinnamate. With considerable evidence showing minimal i1Titancy, these 
compounds have shown enhancement of permeability of several compounds (Finnin and 
Morgan 1999). An aerosol formulation of these compounds has also been shown to increase 
























Figure 1.5. Molecular Structure of Enhancers: (a) Azone, (b) Oleic acid, (c) DMSO, (d) 
Cineole. The structures of Azone and oleic acid are similar with both molecules 
having polar head groups and long alkyl chains. It has been predicted that the head 
groups of the enhancers (lactam in Azone and a carboxyl in oleic acid) will interact 
with the polar regions of the skin ceramides while the alkyl chains reside in the less 
polar lipid regions of the bilayers (Martin 1993). In contrast DMSO is a dipolar 
solvent that may enter the aqueous region of the lipid bilayers and interact with polar 





1.8.2 Liposomes and Transfersomes 
A comprehensive review by Cevc (1996) of the interaction of liposomes with the skin and 
their effect on permeation enhancement has recently been published. The use of such vehicles 
has gained considerable popularity especially in the cosmetic industry. However the location 
of penetration and whether or not they pass through the skin intact has not been clearly 
explained (Cevc 1996). Structurally a liposome is a spherical lipid bilayer that encapsulates an 
aqueous interior (Figure 1.6). It may be that liposomes assist in penetration by improving both 
partitioning and diffusion across the skin. The partitioning hypothesis is generally accepted 
(Schreier and Bouwstra 1994). Partitioning may be enhanced by liposomes by increasing the 
local drug concentration available at the stratum comeum surface. Also, incorporation of 
liposomes into the stratum comeum lipid bilayers could promote partitioning (Prausnitz 
1997). The diffusion enhancing component of liposome action is unclear. Some researchers 
have suggested that liposomes are able to penetrate the stratum comeum as intact vesicles 
(Cevc 1996), while others dispute this claim (Schreier and Bouwstra 1994). Transfersomes 
are defined as an supramacromolecular entity that can pass spontaneously through a 
permeability barrier and therefore transfer material. These aggregates therefore, resemble 
highly deformable lipid arrangements which have been suggested as possible vehicles which 
may be ideal to transfer drug more efficiently through the skin (Cevc 1996). 
Figure 1.6. Schematic diagram of a liposome in which phospholipid bilayers alternate with 





A brief introduction to the technology is outlined here while the principles and mechanisms of 
enhancement will be expanded upon in later chapters. Iontophoresis involves the application 
of an electric field, (usually less than 10 V or 0.5 mA/cm2) across the skin to enhance the 
delivery of charged and uncharged drugs. The possibility of using electrical current to deliver 
substances was illustrated in experiments performed in the early 20th century. Leduc, in these 
early experiments, demonstrated the potential usefulness of the technique (Singh & Maibach 
1994). Two rabbits were placed in series with a constant current applied, strychnine sulphate 
(positive strychnine ion) was introduced to the first rabbit via a positive electrode whilst 
potassium cyanide was delivered to the second rabbit via the cathode (negative cyanide ion). 
Both rabbits died due to their respective poisoning with strychnine and cyanide respectively. 
The experiment was performed again but with the electrodes reversed ( cathode for strychnine 
and anode for cyanide). In these experiments the rabbits survived 
The diagram below illustrates the system involved in iontophoresis. The stratum comeum is 
represented as the primary resistive barrier, whilst the epidermis and dermis are assumed to 
have negligible resistance due to the presence of mobile electrolytes in these zones. The 
potential difference which is present when a constant voltage is applied is the gradient which 





Figure 1.7 Schematic representation of an iontophoresis system placed on the surface of 
the skin. The anode compartment contains positively charged drug, D\ and is 




Iontophoresis has been reviewed extensively (Burnette 1989, Wong 1994, Liu and Sun 1994, 
Craane- Van Hinsberg et al., 1994a, Sage 1995, Delgado-Charro and Guy 1998, Banga et al., 
1999). The advantages of passive transdermal delivery have been introduced previously. 
Using iontophoresis, the scope of the transdermal delivery advantages is increased. 





Reduced frequency of administration 
Timing of administration not required 
Decreased discomfort 
Drug delivery rate can be manipulated using current 
Chronotherapy 
Patient controlled administration 
Individualisation of dose. 
Potential for closed-loop/ feedback from blood monitoring 
Increased permeation of drug across skin 
Increases the number of candidates for transdermal delivery (polar, 
charged, and larger molecules) 
Decreased loading of donor required and lowers cost of drug 
Minimises inter- and intra- patient variability 
Decreased onset time 
An electrical field has three main transport enhancing mechanisms for charged drugs. Direct 
electrophoresis (repulsion of like charges) is often considered the main mechanism, 
particularly for small charged solutes. The enhancement of a drug by this effect is dependent 
on the magnitude of the electric field and the mobility of the drug in the surrounding 
environment (formulation and skin). Proteins and peptides often have many sites of 
electrostatic potential and will have a net charge but their mobility may be reduced by the size 
of the molecule. Another mechanism of enhancement is electroosmosis (Pikal 1992). This is a 
force that arises when an electrical field is applied across a charged porous membrane. The 
negative charge of the skin at physiological pH favours the transport of positively charged 
ions across it. The result of this ion selectivity is a net flux of ions from the anode (positive 
electrode) to the cathode (negative electrode). The net force arising from this is called 
electroosmosis and can enhance the transport of positively charged and uncharged molecules 
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through the skin. The other main mechanism of iontophoretic enhancement is related to the 
effect of electrical fields and current flow through the stratum comeum. At voltages above 
one volt, the skin resistance falls (Burnette and Ongpipattanakul 1988, Scott et al., 1993) and 
structural changes that resemble new pore formation occur (Higuchi et al., 1999). Additional 
pathways or pathways with lower resistance to transport, enable greater rates of permeation. 
1.8.3.4 Electrorepulsion 
1.8.3.4.1 Faraday's Law 
Faraday's law describes flux in terms of the electric current flowing through the circuit. The 
law states that the quantity of material transported in aqueous solution is proportional to the 
electric current and the time the current is applied. The relationship can be written: 
JT = ( I = zauac: (-I-J = IUac: 
a ZaF ~ UCT· ZaF F~ UCT· 
L..Z; i l L_.Z; i I 
(1.9) 
i=l i=l 
where J:, the iontophoretic flux of compound 'a' at time T( J:) is related to the current 
applied (I), transport number (t: ), electromobility (Ua), charge (Za), concentration ( c;) and 
to these parameters of all other ions in the system (Delgado-Charro and Guy 1998). Thus it 
can be seen that current is directly proportional to flux if other factors remain constant. This 
relationship may enable iontophoresis systems to be modified easily in terms of delivery rate 
- potentially individualising patient therapy. In addition, modulation of current could facilitate 
different types of drug profiles. For instance, drug delivery may become more equivalent to 
naturally occurring blood levels of peptides. The maximum current flow through the skin is 
. . 2 
generally accepted to be less than or equal to 0.5 mA/cm (Delgado-Charro and Guy 1998). 
Faraday's law also highlights why clinically, iontophoretic devices should operate in constant 
current mode rather than constant voltage mode. According to Ohm's law, current is related to 
voltage (V = I x R). If resistance of the skin decreases while constant current is being 
delivered, the voltage of the system will also decrease. However in the case of constant 
voltage iontophoresis, a decrease in resistance would lead to an increase in current. Thus 
constant current delivery provides a safer way of iontophoretic electrical administration. 
However constant voltage mode enables iontophoresis investigations to be easily analysed 
mechanistically with regard to the Nemst-Planck equation. 
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1.8.3.4.2 Nernst-Planck Equation 
This relationship (Equation 1.10) describes mass transfer to an electrode in terms of three 
processes diffusion, migration, and convection that collectively contribute to overall flux. 
{ [
dC CzF d'J!] } 
J/}.lf/ =-& D -+---- ±vC 
dx RgasT dx 
(1.10) 
where J is the flux of the species in one dimension, & is the combine porosity and tortuosity 
factor of the membrane, D is the diffusion coefficient of the permeant, C is the concentration, 
xis the position in the membrane, z is the charge number, \If is the electrical potential in the 
membrane, Fis the Faraday constant, R is the gas constant, Tis the temperature, and vis the 
average velocity of the convective solvent flow. 
Flux of a species generally occurs to alleviate the differences in the electrochemical potential. 
In a system where a stirred solution containing species 'i', separated by a membrane that 
causes resistance to diffusion, the number of particles crossing the membrane over time will 
be: 
Ji =CiVi (1.11) 
where J is the steady state flux of the solute, v is the velocity of each particle and c is the 
concentration. At steady-state the velocities are constant and the total force acting on the 
particle is zero. Effectively, the frictional force balances the driving force. Force is the rate of 
energy change with distance, in this case being the gradient of electrochemical potential. It 
can be shown that under these conditions the velocity of the particles in the system are related 
to the driving force and a proportionality constant (velocity per unit force that is defined as 
mobility) to give: 
dµ,. 
Ji =-CiUi dx (1.12) 
where u is the proportionality constant (inversely related to frictional forces), and dµ/dx is the 
electrochemical gradient. This is the basic Nemst-Planck equation. The modified equation 
initially described above ( equation 1.10) is derived from this. Several additional assumptions 
and a factor to include the effect of solvent flow are required to reach the final equation 
(equation 1.10) (Srinivasan et al., 1990a). 
At steady state, constant temperature, and using the Einstein relationship D = RTu, 
J. = -n.[aci + ciziF dlfl;] 
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where a bar over a symbol represents variables referring to the membrane phase. Here, it is 
observed the electrochemical potential is divided into the individual chemical and electrical 
components. This is achieved by substituting into equation 1.12, the expression for the 
electrochemical potential of a species(= Jli+ zFljl) as described by Srinivasan et al. (1990a). 
In order to integrate equation 1.13 several assumptions must be made including the Goldman 
constant field assumption. This states that the dependence of 1/f on x is described by a linear 
function. Thus the equation becomes a linear first order differential relationship which is 
readily solved. However the Goldman equation is in terms of intramembrane properties which 
are much more difficult to measure than the properties of the external solution. Hodgkin and 
Katz assumed the partition coefficient, /3, across the membrane solution interfaces is 
concentration independent so that the external solution concentration of a species relates to 
the membrane concentration by this factor (Srinivasan et al., 1990a): 
Ci = /Jici,donor,receiver (1.14) 
Additionally, if the interfacial distribution is an equilibrium distribution (partitioning across 
the interface is rapid compared to movement through the membrane) then the potential 
difference across the membrane can be described simply by L1 lfl. From the Goldman-Hodgkin-
Katz (GHK) equation, a modified integral of Equation 1.13, is given in terms of the passive 
permeability coefficient, P, and K, a dimensionless constant. 
where, 
and 
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This expression does not account for convective flow however. The term± c1Jv(l-s) is added 
to modify the Nernst-Planck equation to account for this effect (or ±vC as seen in equation 1) 
(Sims et al., 1991a). If sink conditions are present the equation simplifies fmiher. 
.-- . -+---- ±c. -s J _ D [dci ciziF dlf/;] J (l ) 





Where c is the donor concentration, Iv is the convective flow rate, and s is the reflection 
coefficient (Roberts et al., 1998). 
Table 1.6. Assumptions of the modified GHK equation. 
Solution non-idealities 
- assumes solutions behave ideally, that is there are no interactions (solute-solute) 
- can be shown that the activity coefficient (which accounts for interactions) will vary by a few percent when a 
large concentration difference is investigated (O.OlM to O.lM). 
- in vitro iontophoresis situations involving identical donor and receiver solutions with drug present in trace 
amounts thus non-ideal situations are unlikely to result an any significant error. 
Solvent transport 
- assumed here that solvent flow effects are negligible. 
Constant Field assumption. 
- equations only apply when the electrical potential profile across the membrane is linear. 
- if the membrane has a high density of fixed charges then the net electric potential in the membrane is a function 
of both the applied electric field and the net charge component residing in the membrane. 
- however assume that the charge density of the membrane is low and thin, leading to a minimal curvature in the 
electrical profile. 
1.8.3.5 Electroosmosis 
The fundamentals of electroosmotic flow through the skin has been extensively reviewed by 
Pikal (1992). The permselectivity of the skin gives rise to this second mechanism of 
electrotransport. Electroosmosis results from immobile charges in the membrane that require 
mobile counterions (ions that are of opposite charge to the fixed charges in the membrane) to 
maintain electroneutrality in the membrane (Pikal 1992). This neutralisation of the charges of 
the pore wall results in a "double layer" of ions in solution distributed along the pore wall. 
The double layer carries a net charge equal but opposite to the net fixed charge present on the 
pore wall. When an electrical potential is applied across the pore an electrical volume force 
will act on the charged layer (Pikal 1992). The counterions are not confined to a small region 
adjacent the pore wall and a velocity distribution in the charged layer results. This is 
described by the Manning theory as a parabola shaped velocity profile for the fluid in the pore 
(Pikal 1990, Pikal 1992). Thus electroosmosis is quite distinct from the transport of hydration 
associated with ions that has been considered previously (Pikal 1992). In a recent 
investigation of the effect of increasing the net negative charge of the stratum corneum using 
permeation enhancers, researchers were able to demonstrate an corresponding increase in 
electroosmotic flow (Peck et al., 1998). Another important aspect of electroosmosis is the 
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importance of the relative increase in force as the molecular size increases (Pikal 1992, Peck 
et al., 1996). This has obvious implications for the transdermal iontophoretic delivery of large 
molecules such as proteins and peptides and must be considered in these investigations. These 
issues are described in greater detail in Chapter 5. 
A B C D 
Figure 1.8. Potential pathways of iontophoretic transport through the skin: A 
transcellular pathway, B - eccrine pathway, C - pilosebaceous pathway, D 
paracellular (intercellular) pathway. (Adapted from Cullander 1992) 
1.8.3.6 Pathways of ion transport. 
The predominant iontophoresis route of transport is believed to be through pre-existing 
pathways (Cullander 1992). Figure 1.8 shows the possible pathways iontophoresis may occur 
through. Traditionally it was thought these pathways were located at shunts in the skin surface 
such as the sweat ducts and hair follicles and other sites of lower resistance (Burnette 1989, 
Cullander 1992). Early studies showed that during iontophoresis there were regions of high 
current density across the skin (Grimes 1984, Burnette and Ongpipattanakul 1988). The 
iontophoretic use of pilocarpine to diagnose cystic fibrosis through the induction of sweating 
suggests that current travels down the sweat ducts (Bmnette 1989). In work from Burnette and 
Marrero (1986), in which charged dyes were delivered via iontophoresis, a dot like pattern on 
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human skin was observed. Grimnes (1984) used two types of electrodes in an in vivo 
experiment involving electrical current through the skin to demonstrate current flow does 
occur primarily through this shunt pathway. More recent work provided additional evidence. 
Cullander and Guy (1991) identified largest currents in the vicinity of hair follicles using a 
vibrating probe electrode. The use of SEM (scanning electron microscopy) has demonstrated 
the appendageal flux of mercuric chloride, ferric and ferrous ions (Monteiro-Riviere et al., 
1994, Cullander 1992). Visualisation of dye transport through pores has been observed in the 
work of Burnette and Ongpipattanakul (1988) with the use of fluorescein dye. Once the pores 
were localised by fluorescence a microelectrode was used to observe a maximum potential 
difference at the pore site. The potential difference was observed to decrease symmetrically as 
the microelectrode was moved away from the pore centre. 
Non-appendageal pathways have also been suggested as regions of iontophoresis permeation 
(Scott et al., 1993). The presence of such a pathway is likely in light of several recent studies 
that demonstrate the permeation of solutes in areas not associated with appendages (Lee et al., 
1996, Prausnitz et al., 1996a, Menon and Elias 1997, Turner and Guy 1997). The relative 
importance of either the appendage route or the intercellular route appears to be influenced by 
the structure of the drug, where ionic drugs may favour the appendage route (Turner and Guy 
1997). Recent investigations incorporating a chemical permeation enhancer with 
iontophoresis demonstrated that increases in fluidity in the stratum comeum induced by oleic 
acid coincided with increases in iontophoretic permeation (Bhatia and Singh 1997b ). 
1.8.4 Electroporation 
Another electrically-based physical permeation enhancement technique that has been 
investigated recently for transdermal delivery is electroporation. Electroporation involves the 
application of short, high voltage pulses to increase skin permeability via a mechanism that 
may involve the creation of transient pores in lipid lamella regions of the stratum comeum 
(Weaver 1993). Over the last ten to fifteen years electroporation has been used successfully to 
introduce large molecules into cells for transfection purposes (Weaver, 1995). More recently 
this technology has been used to introduce drugs through the skin (Edwards et al., 1995, 
Pliquett et al., 1995, Prausnitz et al., 1996b). During electroporation three stages of 
"electropermeabilization" are thought to occur: ( a) new aqueous pathways are created during 
a time period of microseconds or less, (b) molecules are transp01ied through these additional 
pathways predominantly by diffusion but also by electrophoresis and/or electroosmosis, (c) 
after the electrical pulse the pathways close at times ranging from milliseconds to homs 
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(Prausnitz 1997). Electroporation of the stratum corneum lipid bilayers is believed to occur 
during millisecond electrical field pulses of greater than 100 V (Prausnitz 1997). These values 
have been identified from theoretical analysis that has shown 1 V may electroporate 1 bilayer, 
therefore if the stratum corneum has approximately 100 multilamellar bilayers 100 V would 
be required (Weaver and Chizmadzhev 1996, Banga et al., 1999). There is significant indirect 
evidence that high voltage electroporation causes changes in the skin structure and these 
changes are considerably more important for permeability enhancement than any direct 
electromotive force the pulse exerts on the drug (Edwards et al., 1995, Prausnitz et al., 
1996b). Recently, the structural changes that occur during iontophoresis have been compared 
to electroporation phenomena (Inada et al., 1994, Chizmadzev et al., 1998). It has been 
suggested that even low voltage iontophoresis may electroporate the skin, but specifically at 
sites where there are fewer lipid bilayers such as the skin appendages (Chizmadzev et al., 
1998, Banga et al., 1999). 
1.8.5 Phonophoresis 
Ultrasound for physical therapy and chemotherapy (for which use of ultrasound is FDA-
approved) is performed at high frequencies ( - 1 MHz) and moderate intensities (- 1 W/cm2) 
(Prausnitz 1997). Transdermal permeation enhancement using ultrasound have also used these 
conditions ( often because of the regulatory acceptance) but recently large transport rates have 
been reported with low frequency ultrasound (20 kHz) (Mitragotri et al., 1996). The 
mechanism of enhancement is controversial and possibly includes increased convection 
(acoustic streaming) (Prausnitz 1997), cavitation related effects (Mitragotri et al., 1995), and 
perhaps thermal effects (Prausnitz 1997). 
1.8.6 Minimally invasive technologies 
These devices are designed to by-pass the stratum corneum barrier properties by mechanically 
providing openings in this structure. This is achieved generally by using a sharp needle-like 
structure which is placed in contact with the stratum corneum (Henry et al., 1998, Henry et 
al., 1999). These needles are usually small enough not to stimulate nerves that are fo1md 
deeper in the dermal tissues and do not provoke a pain sensation (Henry et al., 1998). 
Increased permeability has been shown to be up to 2.5 x 105 fold for calcein, a polar 
fluorescent probe molecule (Henry et al., 1998). ALZA corporation have also developed a 
similar technology (Daddona 2000). These teclmologies are invasive and may have to meet a 
different set ofregulatory requirements (such as sterility). 
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1.9 Transdermal delivery of peptide and protein drugs 
The biotechnology industry has produced, on a commercial scale, a generation of 
macromolecular compounds that have great therapeutic potential (Prausnitz 1997). Proteins 
and peptides are considered ideal drugs in many ways because they perform essentially all 
biological processes and reactions ( e.g. as enzymes, ligands for signalling, receptors, 
antibodies, and transcription factors) and are innately specific and potent (Amsden and 
Goosen 1995). Since the discovery of methods to clone and express the cDNAs encoding 
heterologous proteins, it has become possible to produce large quantities of virtually any 
protein for therapeutic purposes. The recent explosion of genomic information including the 
sequencing of the entire human genome will greatly increase the discovery of new proteins, as 
well as the understanding of their function. This will inevitably increase the number of 
potential protein drug candidates (Putney 1999). 
However, commercialisation of these compounds has been minimal (Table 1.7). One of 
primary reasons for this slow progress is the special drug delivery requirements of these 
compounds (Amsden and Goosen 1995). First, proteins are relatively large molecules with 
complex architecture. Unlike low molecular weight drugs, they possess secondary, tertiary, 
and, in some cases, quaternary structure with labile bonds and side chains with chemically 
reactive groups (Florence and Attwood 1998). Disruption of these structures (e.g., 
denaturation or aggregation) or the modification of side chains, which occurs readily with 
many proteins, can lead to loss of activity or immunogenicity groups (Florence and Attwood 
1998, Putney 1999). With this in mind, it is understandable that proteins and peptides 
generally have low bioavailability due to degradation in the GIT and extensive first pass 
metabolism. 
Secondly, stability of proteins and peptides in a pharmaceutical dosage form poses a different 
set of challenges than the evolved stability that a molecule would have inside the environment 
of a cell. In nature, proteins are synthesised in small amounts, generally act in a transient 
fashion, and are stabilised by the cellular and extracellular milieu (Putney 1999). In contrast, 
protein drugs must be highly purified and concentrated, and have a shelf life of at least two 
years. In this environment these compounds may have significant physical stability concerns 
involving denaturation, aggregation, and adsorption problems (Florence and Attwood 1998). 





in some cases proteins are of sufficient stability to allow them to be marketed as solution 
formulations (Physicians Desk Reference 2000 (PDR)). 
In addition proteins and peptides often have short biological half-lives and require time 
controlled or sustained plasma levels. Thus traditional routes have been problematic, delivery 
via the oral route exposes the compound to significant degradation and parenteral delivery 
requires frequent uncomfortable administration during treatment (Prausnitz 1997, Amsden 
and Goosen 1995). 
Delivery across the skin offers a number of potential advantages for protein and peptide 
compounds in accordance with the advantages introduced above. These include reduced 
degradation and metabolism due to stomach, intestine, and hepatic first-pass effect, improved 
patient compliance due to non-invasive delivery methods and prolonged duration of delivery, 
and the potential for steady or time varying controlled delivery (Guy and Hadgraft 1989, 
Cullander and Guy 1992, Amsden and Goosen 1995, Prausnitz 1997). Furthermore, as many 
of these compounds are endogenous, the allergenicity may be low. 
Table 1.7. Currently marketed protein and peptide drugs (PDR 2000). 
Alpha-1 antitrypsin 
Glucagon 
Interleukin -2 (IL-2) 






Tissue plasminogen activator 
Calcitonin 
Hepatitis B surface antigen (vaccine) 
Clotting factors (Factor VII, VIII, IX) 
Fertility glycohormones (FSH, hCG) 
Colony stimulating factors (GM-CSF, G-CSF) 
Luteinizing ho1mone releasing hormone (LHRH) antagonists 
Insulins 




1.9.1 Transdermal delivery of peptides - State of the art 
1.9.1.1 Passive 
Given that peptides and proteins have molecular weights in the range of 300 Da to greater 
than 1 x 106 Da and that they are predominantly hydrophilic, it is not surprising that skin 
delivery will be met with limited success. Passive delivery is difficult due to the generally 
macromolecular nature of these compounds, yet there are some reports of unassisted transport 
through the skin (Amsden and Goosen 1995). Recently there is a growing interest in using the 
skin as a site for the delivery of antigens and DNA (Fan et al., 1999, Baca-Estrada et al., 
2000). Topical immunisation has been observed after application of naked DNA to normal 
skin (Fan et al., 1999). Also after non-invasive application of model antigens (leukotoxin and 
hen egg lysozyme) appropriate immune responses were observed (Baca-Estrada et al., 2000). 
Delivery of vaccines and antigens pose a different set of problems to traditional drug delivery 
however. Only a fraction of a normal therapeutic dose for a peptide drug is usually required to 
elicit an immune response. For systemic drug therapy, unassisted delivery does not provide 
clinically relevant drug levels for peptides and proteins and so enhancement strategies are 
needed. A number of different approaches to permeation enhancement have been investigated, 
each an attempt to surmount the biological barriers to peptide delivery ( enzymatic and 
physical barriers). 
1.9.1.2 Chemical Permeation enhancers. 
A number of investigations have been reported using chemical enhancers for transdermal 
peptide delivery. Dimethylsulfoxide (DMSO) slightly increased the penneation of arginine 
vasopressin and corticotropin through rat skin (Kastin et al., 1966). A series of Azone 
derivatives were studied as permeation enhancers of desglycinamide arginine vasopressin 
(DGV AP) (Hoogstraate et al., 1991) A maximum increase in flux rate was reported to be 
around 3 .5 fold greater than the passive permeation rate. This is thought to be insufficient for 
clinically relevant blood levels to be achieved (Amsden and Goosen 1995). Choi et al. (1990) 
showed enhanced permeability of several bioactive peptides (amino acids, dipeptides, and 
leucine enkapalin) across hairless mouse skin using the non-ionic surfactant 
decylmethylsulfoxide. Although chemical permeation enhancers may significantly increase 
the h·ansdermal permeability of small molecules, the same effect is generally not seen in the 






Recent investigations have suggested that liposomes may be useful in the delivery of larger 
molecules across the skin. Macromolecules studied using this technology include cyclosporin 
(Egbaria et al., 1991, Niemiec et al., 1995), y-interferon (Du Plessis et al., 1992), a-interferon 
(Niemiec et al., 1995), melanin (Li et al., 1993), superoxide dismutase (Miyachi et al., 1987), 
monoclonal antibody (Balsari et al., 1994), and DNA (Li et al., 1993). From these studies 
there is an indication that liposomes are localised in the follicular strncture. It has not been 
conclusively shown that liposomes penetrate deep into the intact follicle, however liposome 
encapsulation may not be required for increased follicle penetration (Leib et al., 1992). The 
studies that have used liposomes as carriers for macromolecules have been performed in 
animal skin and further studies are required in human stratum corneum. Cevc et al. (2000) 
have recently described the delivery of a number of macromolecules across the skin in vitro 
and in vivo using Transfersomes©. These lipid carriers are reported to be highly defonnable 
and to move through the skin barrier via a hydrotaxis mechanism (Cevc et al. 2000). 
1.9.1.4 Physical Enhancement Techniques. 
An alternative to enhancing transport by modifying the stratum corneum chemically, is to use 
physical methods to either drive drngs across the barrier, or to increase the permeability of the 
barrier by supplying energy to the skin directly. It appears that transdermal delivery of 
peptides and proteins will have to incorporate physical enhancement strategies in order for 
such systems to be clinically viable. 
1.9.1.4.1 Electroporation of macromolecules 
In terms of macromolecular transport, electroporation has been demonstrated to enhance the 
delivery of a number of such molecules. Commercialisation of electroporation is likely to be 
less rapid than iontophoresis. The safety and tolerability issues are the initial concern and 
require further study (Prausnitz 1997). Also, miniaturisation of devices is not as advanced as 
iontophoresis due to the need for a capacitor (Banga et al., 1999). However electroporation 
may be quite suited to work in combination with an iontophoresis system and studies have 
shown delivery is substantially increased (Prausnitz 1997). The rationale behind the 
combination of the electrically assisted delivery techniques is that electroporation generally 
acts on the stratum corneum barrier to increase permeability, while iontophoresis action is 
predominantly on the drng itself. 
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1.9.1.4.2 Ultrasound 












Bonunannan et al. 1994 
Prausnitz 1995 
Zewe1t et al. 1995 
Regnier et al. 1996 
Tamada et al. 1993 
Tamada et al. 1993 
Prausnitz et al. 1996b 
Misra et al. 1999 
Wang et al. 1998 
Lombry et al. 2000 
Chang et al. 2000 
Use of ultrasound to transport drugs across the skin is known as phonophoresis or 
sonophoresis. Recent studies demonstrating the delivery of macromolecules at therapeutic 
rates has increased interest in this form of delivery (Mitragori et al., 1995). Low frequency 
ultrasound (20 kHz - 100 kHz) is different from conventional ultrasound in that it causes 
increased cavitation. When used for the delivery of macromolecules (Table 1.9), rates of 
delivery were sufficient for clinical applications (Prausnitz 1997). Preliminary structural 






Recent reports of transdermal delivery of macromolecules via ultrasound. 







Mitragotri et al. 1995 
1.9.1.4.3 Iontophoresis 
Iontophoresis was traditionally used to promote the delivery of small molecules. Large 
numbers of clinical studies using iontophoresis have been repo1ied. Roberts et al. (1998) 
provide an overview of these investigations and illustrate that most solutes used have a 
molecular weight below 500 Daltons. Several commercial products using iontophoresis are 
available including CF Indicator (Medtronic, Inc., Minneapolis, MN) used to deliver 
pilocarpine for cystic fibrosis screening, Drionic (General Medical Co., Los Angeles, CA) for 
water treatment ofhyperhidrosis, and Iontocaine/Phoresor (IOMED, Inc., Salt Lake City, UT) 
as a lidocaine and general purpose iontophoresis device (Prausnitz 1997). Macromolecular 
iontophoresis has been more challenging (Prausnitz 1997, Cullander and Guy 1992). 
Table 1.10. Recent reports of transdermal delivery of macromolecules using iontophoresis 
Peptide MW Charge Current Flux Range Skin Reference 
Range (µg/cm2h) Type 
(mA/cm2) 
threonine-lysine- 344 +1 0.18 - 0.36 0.038 - 0.093 HRS Green et al. 1992b 
praline 
thyrotropin releasing 362 +l 0.16-0.31 1.74-2.68 HMS Burnette & Marrero 
hormone (1RH) 0 0.16 - 0.47 3.62- 10.3 1986 
angiotensin 2 1046 + 0.28 0.236 HMS Clemessy et al. 1995 
vasopressin 1084 + 0.5 -1.0 0.116 - 1.56 HMS Lelawongs et al. 1989, 
Banga & Chien 1993 
CCK-8 analogue 1150 > -1 NIA 0 Human Srinivasan et al. 1990b 
LHRH 1182 +1 0.2 - 0.148 Porcine Heit et al. 1993, 
0.5 0.27 Human Potts et al. 1997 
leuprolide acetate 1269 +1 0.003 0 Human Srinivasan et al. 1990b 
calcitonin 3527 + 0.33 0.025 HRS Thysman et al. 1994 
growth hormone 3929 +l 0.098- 0.022 - 0.057 HGS Kumar et al. 1992 
releasing factor 0.23 
carboxy inulin 5200 -1 0.32 2.2 HMS Pikal & Shah 1990c 
insulin 5808 + 0.67 0.00-0.089 Human Srinivasan et al. 1989, 
HRS Banga & Chien 1993 
BSA 69 -0.35 0.32 0.52 HMS Pikal & Shah 1990 
kDa 
Abbreviations: BSA (bovine serine albumin), CCK-8 (cholecystokinin-8), HMS (hairless mouse skin), HRS 




It can be seen appreciable rates of flux have been observed for a number of peptides in the 
µg.cm-2.h-1 range. Amsden and Goosen (1995) looked at the feasibility of delivering several 
peptides based upon these studies. From a list including TRH, vasopressin, LHRH, LHRH 
analogue, calcitonin, and insulin, it appeared that only vasopressin would be able to be 
delivered clinically ( daily dose = 3 .9 µg vs. required daily dose = 2-4 µg). The predicted total 
daily amounts delivered of all other peptides were less than 50% of their required daily dose 
(Amsden and Goosen 1995). These estimates are rather crude given that a delivery time was 
assumed to be 40 min and the original studies were not performed in human skin. However, 





1.10 Aims of the study 
One of the primary concerns of delivering peptide and protein molecules across the skin is 
their large size. The large molecular dimensions are expected to significantly restrict the 
transport of these molecules across this barrier. Even with the use of physical enhancement 
techniques such as iontophoresis, the chances of successful delivery of peptides through the 
skin is uncertain. The aim of the research presented in this thesis was to gain a mechanistic 
understanding of the effect of electrically-induced changes on the transport of peptides across 
the skin and to further investigate strategies that may increase this transport. Specifically the 
objectives were to: 
a. Characterise excised human skin for use in permeability studies and determine 
selection criteria to minimise variations between samples. 
b. Select a model peptide and other solutes for comparison to be used in transport 
studies. 
c. Determine the effect of iontophoretic electrical field strength on the permeability 
enhancement of the model peptide across the skin. 
d. Determine the effect of electrically-induced membrane changes on electroosmosis. 
e. Evaluate possible synergistic action of chemical permeation enhancers when used in 
combination with iontophoresis. 
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2.1.1 Electrical nature of the skin 
Iontophoresis acts primarily on the drug rather than the barrier to enhance permeability 
through the skin. This is unlike other enhancement methods such as chemical permeation 
enhancers and electroporation which act on the membrane barrier. Consequently 
iontophoresis is particularly attractive because the toxicity to the membrane may be 
minimised and control over the delivery rates of the drug may be improved. However, it is 
reported that certain electrical field strengths change the resistance of the membrane (Inada et 
al., 1994). Recent reports by Li et al. (1998) and Higuchi et al. (1999) have suggested 
moderate voltage iontophoresis creates new pores in the stratum comeum membrane. 
Chizmadzhev et al. (1998) report a similar hypothesis in which moderate voltage 
iontophoresis electroporates the stratum comeum in the macropores (i.e. skin appendages). 
In vitro electrical characterisation of the human skin has been reported by several authors 
using several techniques (Dinh et al., 1993, Singh et al., 1998). Yamamoto and Yamamoto 
(1976) used tape stripping to identify the stratum comeum as the primary barrier of electrical 
current flow. Greater resistance was identified in the uppermost layers of the stratum comeum 
than underlying layers. The authors demonstrated that, after about 15 tape strippings, 
electrical resistance became constant and low. This indicates that beneath a certain layer, the 
barrier to electrical resistance becomes insignificant. 
Impedance spectroscopy has been used to investigate the resistance and capacitance behaviour 
of the skin (DeNuzzio and Bemer 1990, Burnette and DeNuzzio 1997). The resistance of 
fresh skin samples is between 5 to 100 kQ/cm (Singh et al., 1998). Capacitance measurements 
were less variable (1 - 20 x 10-9 F (Farad)). Decreases in resistance have been noted when 
voltage or current was increased (Kasting and Bowman 1990b, Dinh et al., 1993). When 
constant current was applied, resistance was observed to decrease over time (Foley et al., 
1991, Dinh et al., 1993). Skin impedance appears to be influenced significantly by the 
hydration state of the skin (Burnette and DeNuzzio 1997). Thus changes in skin impedance 
may be a reflection of factors that change skin hydration such as seasonal changes, day to day 
variation, and site differences (Burnette and DeNuzzio 1997). It is assumed as the stratum 
comeum becomes more hydrated, ions within the membrane become more mobile and 
therefore more responsive to an electrical field (Burnette and DeNuzzio 1997). 
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2.1.2 Electroporation during iontophoresis 
Recently Inada et al. (1994) investigated the effects of voltage on HEM. In accordance with 
previous reports, skin resistance decreased upon the application of voltage at a rate dependent 
on the magnitude of the electrical field. In addition, the reversibility of the changes was 
dependent on voltage strength, and also the duration of electrical field application. The 
authors demonstrated there were strong similarities between the electrical and permeability 
changes that occur during iontophoresis and changes that occur during electroporation. This 
suggests iontophoresis results in electrical pore formation. Chizmadzhev et al. (1998) recently 
proposed a bridging theory between electrical phenomena that occur during iontophoresis at 
moderate voltages and those events occurring during electroporation. Two parallel pathways 
were considered: the skin appendages and also through the intercellular lipid matrix. A model 
was developed that accounted for electroporation of the walls of the skin appendages and the 
intercellular lipid lamella. Experimental data was found to be well represented by the model. 
At relatively low voltages ( < 30 V) it was proposed that electroporation of the appendages 
occurs. The intercellular lipid matrix was electroporated at higher voltages. The first direct 
evidence for new pore induction during iontophoresis was reported recently by Li et al. 
(1999b). Low frequency alternating current (ac) iontophoresis was performed on neutral 
solutes at low to moderate voltages (2 - 4 V) across the human epidermis. This allowed the 
effect of the electrical field on transport to be examined without interfering contributions from 
electrorepulsion or electroosmosis. 
2.1.3 Aims 
Electrostatic repulsion is considered the main driving force during iontophoresis. However the 
application of an electrical field across the skin not only effects the compound to be delivered, 
but also the skin itself. In these initial electrical characterisation experiments it was our aim to 
1. establish an overview of how skin samples vary in terms of electrical resistance 
2. assess factors that influence electrical resistance in human skin 
3. determine what effects iontophoresis electrical fields have on skin resistance 
4. relate electrical changes observed during iontophoresis to possible si:luctural 
changes in the skin. 
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2.2 Experimental approach 
2.2.1 Materials 
Excised human skin samples were obtained from two main sources, the National Disease 
Research Interchange (NDRI) (Philadelphia, PA, USA) and the International Institute for the 
Advancement of Medicine (HAM) (Scranton, PA, USA). Skin was received as either full 
thickness or dermatomed and was stored until needed at - 60 °C. All samples were from 
female abdominal, breast, or lower back skin regions. Patient donor details ( age, brief medical 
history, and site of skin removal) were also obtained upon receipt of skin. Phosphate buffer 
saline (PBS) 0.1 M was obtained through Sigma Chemicals (St Louis, MO). This was used in 
all experiments as the buffer solution. 
2.2.2 Electrode preparation and power supply 
Electrodes were made from silver wire (0.25mm diameter, annealed, 99.9% purity) obtained 
from Alfa Aesar (Ward Hill, MA, USA). The electrode system was silver (anode) and silver 
chloride (cathode) (Ag/AgCl). The silver chloride electrode was prepared by electroplating a 
length of silver wire in 3 M potassium chloride. The electroplating was performed for a 
duration that ensured the layer of silver chloride was not depleted during iontophoresis 
experiments. Prior to electrical investigations and iontophoresis experiments, the silver 
electrodes were abraded to ensure a fresh silver surface was in contact with the buffer 
solution. Electrical fields were applied using Scepter®, a programmable and computer 
controlled power supply. 
2.2.3 Preparation of Skin 
Full thickness human skin was used as received unless a significant amount of underlying fat 
tissue was present. Removal of excess adipose layers was sectioned off using a scalpel. 
Dermatomed skin was also used as received. The dermatomed layer was 0.5 mm in thickness. 
Heat separated HEM was prepared from full thickness skin. The epidermis was separated 
from the underlying tissue using the method of Kligman and Christophers (1963). In 
summary, the full thickness tissue was placed in a 60°C water bath for a period of 60 seconds. 
The epidermal layer was then carefully teased from the dermis using blunt forceps to produce 
intact sheets ready for mounting on diffusion cells. After separation, the membranes were 
inspected by light microscopy for any gross damage or holes. The tissue was stored at -60°C 
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until required. Membranes to be used in diffusion experiments were allowed to thaw, placed 
in PBS, and hydrated at room temperature ( except for those membranes used in experiments 
investigating hydration effects). After overnight hydration, the sheets were mounted between 
the two side-by-side diffusion half-cells with the stratum corneum side facing the donor 
compartment. The diffusion cells were firmly clamped leaving an area exposed for diffusion 
of 0.64 cm2• The compartment volumes (3 ml) were each maintained at a constant 

















Figure 2.1 Schematic representation of side-by-side diffusion cell setup connected to a 
computer controlled power supply. 
2.2.4 Electrical studies 
2.2.4.1 Donor variability 
The resistivity of skin samples was measured after overnight hydration in PBS. Dermatomed 
human skin, full thickness human skin, and human epidermal membrane (HEM) were used. 
Comparisons of resistance between different tissues and also within each tissue type were 
made. Different donors were also investigated where possible. Resistance measurements were 
made by applying a small electrical potential across the electrodes (0.1 to 0.3 V) which were 
connected in series with the power supply and with a highly sensitive multimeter (Fluke, 




2.2.4.2 Hydration and Degradation Experiments 
The effect of hydration and time for hydration to reach equilibrium was investigated in HEM 
membranes. Thawed membranes were mounted to side-by-side diffusion cells and PBS buffer 
was added to both compartments. Electrical resistance of the membrane was immediately 
monitored. To avoid artifacts introduced by applying low electrical potentials continuously 
over the period of hydration (such as voltage induced resistance decreases), the electrical field 
was only applied transiently during the period of resistance measurement. Monitoring 
continued for several days to establish the length of time that electrical resistance remained 
stable and elevated. 
2.2.4.3 Voltage - Current profile of HEM. 
The conductance changes that occur in the HEM during electrical field application were 
investigated. A range of voltages were applied by using short constant voltage pulses ( < 1 
second) across the membrane. The conductance of the membrane was simultaneously 
recorded. After each pulse the baseline conductance was checked to ensure no significant 
changes in membrane resistance had occurred. Thus subsequent readings were assumed to be 
independent of prior pulses if the baseline did not change. A range of voltages that represent 
typical low to moderate iontophoresis electrical field strengths (0 to 5 V) were tested. 
2.2.4.4 Iontophoresis experiments 
A series of constant voltage iontophoresis experiments were performed across HEM. In this 
experiment and in all subsequent iontophoresis experiments constant voltage conditions were 
used rather than constant current iontophoresis so that the modified Nemst-Planck equation 
could be used in the interpretation of the flux data (Higuchi et al. 1999). The electrical 
protocol involved applying constant voltages over the membrane for a period of 5 hours. 
Membrane resistance was monitored at predetermined time points throughout the 
iontophoresis experiment. The voltages selected were 0.5, 1, 2, 3, and 4 V. During the 
iontophoresis experiments, a model ionic permeant, calcein, was used (Sigma Chemicals, St 
Louis, MO). This compound fluoresces (absorption maximum 494 run, emission maximum 
517 nm) and carries a charge of - 4. This makes it suitable for visualisation of possible 
permeation pathways that occur during iontophoresis (Burnette and Ongpipattanakul 1988). 
Once the iontophoresis period was completed, the HEM samples were removed from the side-
by-side diffusion cells and washed thoroughly to remove any surface fluorescent probe. 
Washing included using a constant stream of Milli-Q water (18 MQ.cm) for 1 minute. This 
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was followed by a rinse using cold acetone. This final rinse was included to remove any 
excess sebaceous oils that may bind calcein. Immediately following the washing of the 
membranes, they were placed on glass microscope slides and inspected using standard light 
microscopy and a stereoscope. The patterns of staining were recorded and representative 
photomicrographs were printed. Microscopy was performed using a Ziess Axiostop 
Microscope connected to a video monitor via a Sony 3CCD DXC-325 video camera. A 
stereoscope was also used (Nikon SMZ-U). High resolution images were printed using a Sony 





2.3.1 Donor Variability 
The overall variability of the skin tissues was high. For the full-thickness skin membranes 
after over night hydration, electrical resistance values ranged between 1 and 80 kQ. The 
resistance values of individual skin samples are graphed in Figure 2.2 to illustrate the wide 
distribution and variation within and between donor tissues. Each donor had a different mean 
resistance (Table 2.1) but no significant differences between the donors were detected because 
the intra-donor coefficient of variation (CV) was high (ranged from 70% to around 140%) 
(Table 2.1). 
Table 2.1. Variability of mean resistance observations for full-thiclmess human skin 


















Electrical resistance measurements for HEM skin samples is outlined in Table 2.2. These 
samples were all obtained from the same donors as the full thiclmess skin. The mean 
resistance of the prepared HEM samples was higher than other tissue types, averaging around 
146.7 kQ (Table 2.3). The coefficient of variation remained high at between 40 to 85 %. 
Table 2.2. Variability of mean resistance observations for human epidermal membrane 
obtained from 3 different donor sources. 
Donor n Mean Resistance SD %CV 
(kQ) 
2105 14 140 119.5 84.7 
2119 9 163 69.4 42.5 
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Figure 2.2. Observed electrical resistance values of human full-thickness skin mounted to 
side-by-side diffusion cells. Three donor skin sources tested (2105, 2119, 2796). 
Only one donor source was available for dennatomed skin so inter-donor variability could not 
be performed. The mean resistance of dermatomed skin was lower than other tissues tested 
(Table 2.3.). As with other tissues, the variability was also high between samples (CV = 
48.5%). 
Table 2.3. Variability of mean resistance observations of human skin (full-thickness, 

























2.3.2 Hydration and Degradation Experiments 
As HEM samples equilibrated with phosphate buffer, the observed skin resistance was 
monitored. There appeared to be two distinct groups of membrane resistance behaviour and 
are graphed accordingly: membranes with high initial electrical resistance (> 100 kQ/cm2) 
(Figure 2.3) and those with lower initial resistance (<50 kQ/cm2) (Figure 2.4). For those 
membranes with lower resistance, the effect of equilibration with the buffer appeared to be 
more significant. In these membranes most resistance changes occurred in the first four hours 
after the membranes were mounted to the diffusion cells. The electrical resistance changes for 
HEM samples with initial resistance less than 50 kQ/cm2, increased between 2 and 5 fold 
during this period. In contrast, membranes with high initial resistance (greater than 50 
kQ/cm2 ) generally did not increase in resistance immediately after mounting to the diffusion 
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Figure 2.3 and 2.4. Initial resistance of HEM samples immediately following placement to 
the side-by-side diffusional cells and equilibration with buffer. Figure 2.3 showing 
HEM samples with high initial resistance (> 100 kQ/cm2) and Figure 2.4 membranes 
with low initial resistance ( <50 kQ/cm2). 
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2.3.3 Degradation and membrane stability 
Following equilibration with PBS, all membranes had stable electrical resistance values. The 
skin samples were then monitored for possible degradation and decreases in resistance over 
time. The resistance behaviour of the membranes could be categorised according to their 
equilibrium resistance values. The membranes with high resistance at equilibrium (> 100 
kQ/cm2) underwent gradual decreases in membrane resistance after approximately 28 hours 
(Figure 2.5). After about 60 hours following placement on the diffusion cells, all high-
resistance membranes had electrical resistance values that were 50% or less than their initial 
values. The membranes with low resistance following equilibration with PBS, had stable 
membrane resistance values throughout the experiment. No decreases in resistance were 
observed (Figure 2.6). 
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Figure 2.5 Electrical resistance observations of HEM over time (37°C, 0.1 M PBS). 
Decreases in resistance of the membranes that had higher electrical resistance after 
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Figure 2.6. Electrical resistance observations of HEM over time (37°C, 0.1 M PBS). 
Constant resistance values were observed in membranes that had lower equilibrium 
resistance values. 
2.3.4 Voltage - Current Profile 
A typical voltage-current profile of the HEM at relevant iontophoresis voltages is shown in 
Figure 2.7. Voltage applied across the HEM influenced the membrane in two ways. Firstly, at 
low voltages, a linear relationship between voltage and current was demonstrated. Plots of the 
current observations in the region less than 1 V are shown in Figure 2.8. The second region 
identified in the voltage-current profiles was at higher voltages. Above 1 V, increases in 
electrical potential across the HEM caused disproportionately higher increases in current. In 
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Figure 2.7. Current profile of HEM as a function of applied voltage (a linear line 
indicating Ohm's law is included for comparison). 
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Figure 2.8. Linear regression analysis for several HEM samples for voltage - current 
profile at applied voltages of< 1 V. 
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2.3.5 Constant voltage iontophoresis experiments 
The electrical resistance values of HEM samples was monitored during the application of 
constant voltage iontophoresis. The change in membrane resistance is plotted as a percentage 
of the initial resistance of the HEM sample (Figure 2.9). The rate of decrease of HEM 
resistance was proportional to the magnitude of the voltage applied. The magnitude of the 
electrical field was also inversely proportional to the overall reduction in resistance of HEM 
samples. The greatest decreases in HEM resistance occurred in the initial stages of voltage 
application ( during the first hour). After the rapid decrease in membrane resistance, gradual 
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Figure 2.9. Mean percentage decreases observed in HEM samples during constant voltage 
iontophoresis for 5 hours (n ~ 4). 
Table 2.4 shows examples of the mean resistance changes of the HEM samples during 
constant voltage iontophoresis. The large standard deviations illustrate the high variability of 






Table 2.4. Mean resistance observations of HEM samples during constant voltage 
iontophoresis. 
Mean Resistance (kD/cm-)" 
Voltage n Ohour 1 hour 3 hours 5 hours 
0.5V 5 154 (64) 96 (5) 48 (28) 54 (2) 
lV 8 119 (96) 35 (32) 16 (10) 13 (9) 
2V 6 170 (150) 42 (44) 32 (44) 5 (0.6) 
3V 4 174 (84) 18 (16) 9 (8) 7 (5) 
4V 6 136 (55) 3 (0.2) 1.5 (0.7) 1.8 (0.1) 
mean (SD) 
In these iontophoresis experiments, calcein was also included in the donor compartment 
(cathode). Staining patterns of where calcein has passed through and/or bound to the skin, are 
shown in photomicrographs below (Figures 2.10 and 2.11 ). During low voltage iontophoresis 
(:Sl V) staining of the HEM continuous over the total area exposed to diffusion (Figures 2.1 Oa 
and 2.1 Ob). At low voltages, greater calcein staining was observed at the hair follicle structure 
(Figure 2.10c). At voltage levels of 2 to 4 V, small discrete and darkly stained regions were 
identified (2.1 lb and 2.1 lc). These regions were not associated with the pilosebaceous unit or 


























Figure 2.10. Typical low voltage iontophoresis ( <2 V) staining pattern of calcein as viewed 
by light microscopy. a) far left, magnification (x5) showing area exposed to 
iontophoresis after removal from diffusion cells and washing, b) (middle) 
magnfication x40, staining not localised, c) (x40) dark staining of hair follicle as 
viewed from stratum corneum side. 
Figure 2.11 . Typical iontophoresis staining pattern of calcein as viewed by light 
microscopy. a) far left, magnification (x40) hair foll icle (same as in Figure 2.10c) 
viewed from epidermal side (stratum corneum facing away) showing intact hair 
follicle sheath. Darkest staining regions near the top of the sheath. b) magnfication 
x40, high voltage iontophoresis staining pattern, darkly stained pilosebaceous unit in 
addition to other regions of staining (arrows) not associated with visible structures c) 




The electrical resistance of the skin was the focus of these investigations as it represents the 
resistance to flow of ions through the skin under an electrical field. Oh et al. (1993) have 
demonstrated that resistance changes during iontophoresis are related to changes to the 
current-conducting pathways in the skin. Resistance is influenced by temperature and ionic 
strength suggesting that conductance through the skin is primarily associated with aqueous 
pathways (Oh et al., 1993). Thus resistance and changes in resistance can indicate structural 
information about the iontophoresis pathway through the skin barrier (Inada et al., 1994, 
Chizmadzhev et al., 1998, Li et al., 1999a). Before resistance measurements can be used with 
confidence in iontophoresis permeability studies (as in following chapters) it is necessary to 
identify the nature of the observed resistance values. Thus skin electrical variability was 
investigated. 
2.4.1 Skin Variability 
The resistance of a membrane indicates the permeability of the membrane to small mobile 
ions that carry current (Craane-van Hinsberg et al., 1994a). Factors such as ionic strength, 
temperature, tissue type, and membrane hydration may influence the resistance of human 
skin. When these variables are well controlled, differences in resistance between skin samples 
reflect differences in the structure of the aqueous pathway across the skin. A disrupted barrier 
will allow ions to be transported more freely and therefore will have lower resistance. Thus 
measuring the resistance of a number of tissue types can give information on the integrity of 
the barrier. Our measurements demonstrated that the resistance of human skin was highly 
variable. This is consistent with recent reports of inter- and intra-individual differences in 
stratum comeum electrical impedance (Konturri et al., 1993, Norlen et al., 1999). 
Measurements performed after overnight hydration indicate the full-thiclmess skin was the 
most variable (CV::::; 90%), followed by HEM and then dermatomed skin. Dermatomed skin 
had lowest variability (CV - 50%) but also had an overall lower resistance than other tissues. 
This implies that the preparation method for the dermatomed skin may have damaged the 
membrane in some way (mechanical stress from dermatome blade, removal of hair follicles 
during dermatoming, pre- and post-surgical cleaning procedures). The presence of defects or 
"holes" in the membrane barrier will provide conducting ions with low resistance pathways 




small pores already present. Therefore the variation in electrical resistance that originates 
from site to site and genetic differences in skin tissues will be overshadowed by a substantial 
drop in resistance caused by the defects in the membrane. Thus the variability of dermatomed 
skin is essentially a reflection of the low resistance pathways. Typically a resistance of greater 
than 10 kQ cm2 (Inada et al., 1994) or greater than 35 kQ cm2 (Kasting and Bowman 1990a) 
have been used as criteria for acceptance of a membrane as undamaged. Dermatomed skin 
obtained from our external source demonstrated low resistance and therefore was not used in 
further studies. Furthermore history of skin prior to delivery was not available. Such 
information can identify possible agents or procedures that may damage the skin. 
Variability was also different depending on the origin of the skin (i.e. skin from different 
donors may have different barrier characteristics). Skin samples from the same donor were 
less variable (Table 2.5). This may be because these membranes are biologically similar, have 
the same preparation methods, and have had identical storage conditions. 
The skin samples were stored at -60°C. In general, storage at this temperature resulted in 
similar electrical resistance observations and permeability data to other literature reports 
(Section 4.5.1). In addition, any effects of different storage conditions on membrane 
permeability is minimised by using a selection criteria for the HEM samples (>20k0hm/cm2) 
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High variability and moderate . 
resistance result due to damage 
occuning to only some membranes. 
Low variability and low resistance 
result due to consistent damage to all 
membranes tested. 
Moderately high variability and high 
resistance result from only a small 
number of membranes being damaged 
however the resistance of these is very 
different from intact membranes. 
avariability is generally high regarcfiess of damage i:6 membranes. Many studies have demonstrated equally large 
variability in skin resistance (Burnette and DeNuzzio 1998). 
67 
Full-thickness skin demonstrated a higher average resistance (arom1d 30 kQ cm2) than 
dermatomed skin. However relative to HEM (prepared from full-thiclmess) the resistance 
values were substantially lower (HEM resistance= 147 kQ cm\ Given that HEM samples 
were prepared from full-thiclmess this observation appears· contradictory. However, during 
mounting to the side-by-side diffusion cells considerable pressure is applied to both sides of 
the membrane around the area of diffusion. Full-thiclmess skin is substantially thicker than 
epidermal membrane because of the underlying fat tissues. Because of the thiclmess of 
unseparated skin, there is likely to be greater mechanical force exerted on the edges of the 
stratum comeum. This possibly results in minor disruptions of the membrane and causes 
decreases in resistance (Figure 2.12) 
Subcutaneous fat tissue of full thickness skin 
~ 0 0 ~ 
Side view illustrating the positioning of tissue in 
side-by-side diffusion cells 
Clamped diffusion cells 
with underlying fat tissue 
intact can result in regions 
of high pressure around the 
area of diffusion causing 
mechanical damage to the 
barrier. 
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Clamped diffusion cells with 
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HEM samples were much easier to work with, have easy preparation, and generally 
demonstrated higher electrical resistance. In addition removing the underlying fat tissue from 
the skin is beneficial during permeation studies. In the in vivo situation this layer is normally 
supplied by the microvasculature and therefore acts as sink for permeating substances. 
However, in in vitro studies, the fat tissue may represent an additional barrier to drug 
transport. For these reasons HEM was selected as the membrane for all subsequent studies. 
2.4.2 Skin hydration 
Previous studies employing impedance measurements of the skin have shown that hydration 
has a significant effect on skin resistance properties (Burnette and DeNuzzio 1998). Our 
studies also demonstrated that el.ectrical resistance could fluctuate markedly during the initial 
period after the membrane was placed in the buffer solution. The changes in resistance could 
be to higher or lower values depending on the skin sample. Membranes with lower initial 
electrical resistance generally increased in resistance. This could result from swelling of the 
skin membrane during hydration resulting in the occlusion of holes in the barrier (Kasting and 
Bowmari 1990a). During hydration the skin can absorb three to five times its own weight in 
water (Wester and Maibach 1995) and is lmown to swell in all 3 dimensions (x,y,z) upon 
contact with water (Norlen et al., 1997). In those membranes with higher electrical resistance, 
hydration did not result in any characteristic change in electrical resistance. The initial 
fluctuations could be related to temperature equilibration with the buffer medium and changes 
in the ion concentration in the membrane. Our observations do not support the theory that 
hydration of the skin results in increases in the mobility of ions in the stratum comeum. This 
has been suggested to result in decreases in electrical resistance (increases in conductance) of 
the skin because more conducting ions are present to carry current flow (Burnette and 
DeNuzzio 1998). X-ray diffraction observations also indicate that water is not present in large 
amounts in the intercellular lipid bilayers (Bouwstra et al., 1998). Accordingly, hydration 
increases of the stratum comeum may predominantly occur in the comeocytes. However, 
freeze-fracture microscopy has shown that water may be present in the intercellular regions in 
separate domains (van Hal et al., 1996). Our studies seem to suggest that hydration is 
particularly important for skin samples with low resistance. It may be the case that hydration 
does not influence electrical current passage through lipid bilayers to the extent that cmTent 
through large pores or holes is affected. 
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2.4.3 Skin degradation 
The electrical resistance of the skin may be used as an indicator of the integrity of HEM 
samples (OECD Draft therapeutic guidelines 1999). Decreases in electrical resistance of a 
membrane indicate ions permeate with greater ease through the barrier and may imply 
structural changes have occurred. Thus, using electrical resistance, the integrity of the HEM 
samples placed on side-by-side diffusion cells, was monitored over time. Membranes with 
high equilibrium resistance ( assumed to have no defects or holes) gradually degraded after 
about 24 hours. This is similar to observations made by Peck et al. (1993) using electrical 
resistance measurements in conjunction with mannitol permeability changes. The decreases in 
barrier properties appeared to be related to mechanical stress imposed on the membrane by 
washing and/or stirring. By supporting the HEM sample between a permeable membrane 
electrical integrity and permeability remained constant for several days (Peck et al., 1993). 
Low resistance membranes do not display these decreases in resistance. It is assumed that 
resistance decreases due to degradation in the side-by-side diffusion cells (as observed in high 
resistance membranes) is insignificant compared to the decrease in resistance that results from 
pre-existing defects or holes in the barrier. 
2.4.4 Current - Voltage Profile 
The central law that describes the resistance of a membrane in response to an electric field is 
Ohm's law: 
V=iR (2.1) 
where Vis voltage, i is current and R is resistance. A material obeying Ohm's law will have 
linear increases in current with corresponding linear increases in applied voltage (because 
there is constant resistance in the membrane). This was characteristic of HEM samples at low 
voltages. Therefore it is expected that there are no significant structural changes occurring in 
the HEM at these electrical potentials. At higher electric fields however, marked increases in 
current flow above the linear Ohmic relationship were observed. Kasting and Bowman 
(1990b) showed similar results using impedance spectroscopy. They suggested a number of 
possible explanations for this trend, the most likely being a dielectric breakdown of epithelial 
cell membranes lining the skin appendages. Recent studies by Chizmadzhev et al (1998) and 
Weaver et al., (1999) indicate that moderate iontophoresis voltages causes electroporation of 
the lining of the skin appendages while higher voltages can cause pore formation through the 
stratum comeum lipid matrix. 
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2.4.5 Constant voltage iontophoresis 
Electrical changes during constant voltage iontophoresis are strongly dependent on the 
magnitude of the electrical field applied across the membrane. Inada et al. (1994) also showed 
that iontophoresis results in electrical resistance decreases that are dependent on voltage 
levels. In Inada's study, the rate and extent of resistance decreases were found to closely 
parallel those obtained for electroporation studies. Electroporation is the formation of pores 
and modification of pre-existing pores in lipid bilayers (Inada et al., 1994). This is of interest 
in transdermal delivery because the. utilisation of such a phenomenon may possibly lead to 
increased permeation of solutes. Specifically, if iontophoresis induced electroporation yields 
an mcrease in pore size for the skin, the delivery of larger peptide molecules may be 
facilitated. 
Our investigations showed there is a marked variability in the electrical changes that occur 
during iontophoresis (Table 2.4). These variations were present in tissues obtained from the 
same donor and same site on that donor. This indicates the skin's barrier to resistance is quite 
heterogeneous. The variability of the electrical changes in the skin may prevent accurate 
predictions of expected porosity changes. 
Calcein was used to indicate the primary pathway during iontophoresis at a series of low to 
moderate voltages. These experiments indicated that calcein, an ionic compound with a 
molecular weight of 622.5, was mainly transported through regions located in the hair follicle. 
At higher voltages (3 and 4 V) other discrete staining regions not associated with the hair 
follicles appeared. Although these staining patterns were not in the region of hair follicles, 
they may be related to sweat ducts orlocalised transport regions (Chizmadzhev et al., 1998, 
Scott et al., 1993). The usefulness of staining and dye residue experiments is limited. This is 
because the location of dye deposits may be related to binding affinity of the compound with 
certain structures of the stratum comeum. Therefore stained regions may not be solely 
representative of regions of high iontophoresis transport. 
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2.5 Chapter summary 
Simple electrical characterisation of human skin was performed. This was achieved by 
monitoring electrical resistance of the membrane which serves as a direct measure of ion 
mobility in the barrier. Wide variations were observed from all skin samples including those 
derived from the same site and donor prepared using identical methods. Imperfections that 
may have been present in dermatomed skin due to surgical preparation caused a reduced skin 
resistance. This skin source was not used in future studies. Full-thiclmess skin also had 
reduced resistance relative to HEM indicating its unsuitability for use in clamped side-by-side 
diffusion cells. HEM samples were observed to have a wide range of electrical resistance 
values but commonly greater than 35 k.Q cm2• The effectiveness of the heat separation 
procedure was confirmed also by the microscopy studies that showed the pilosebaceous units 
were intact. Effects of hydration in intact membranes was unpredictable and therefore a time 
period of around 4 hours was identified as a minimum equilibration time for HEM samples 
placed in the side-by-side diffusion apparatus. The integrity of the membranes once they were 
placed on the diffusion cells appeared to decrease after about a day, as determined by 
electrical resistance measurements. Evidence from previous studies suggested that this is due 
to mechanical stress to the membrane and must be taken into account if HEM studies are to be 
performed over extended time periods. Electrical resistance measurements at elevated 
electrical fields (> 1 V) and also during constant voltage iontophoresis display decreases that 
are proportional to the magnitude of the voltage applied. Our observations mirror other work 
that indicates iontophoresis at these voltages can lead to electroporation of certain structures 
in the stratum comeum (Inada et al., 1994). The increases in porosity in the membrane may 
represent a potential strategy to increase iontophoresis transport. Studies performed using 
calcein during iontophoresis, indicated this molecule is transported primarily through the hair 
follicles. At elevated voltages the possible presence of other pathways was also identified. 
Discrete staining of areas not associated with hair follicles may demonstrate transport through 
sweat ducts or even localised transport regions induced by higher electrical fields. These 
simple investigations were necessary to help gain a better understanding of the nature of the 
HEM and its response to electrical field prior to performing quantitative permeation studies. 
Selection criteria and preparation methods have been resolved. Importantly, the variable 
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Prior to conducting iontophoresis investigations, careful selection of a model peptide was 
needed. The desired characteristics of a model peptide include: a defined size relative to skin 
pathways; good physical and chemical stability; lmown and predictable charge characteristics; 
commercial availability; and previous literature reports. Because a major constraint to 
developing transdermal peptide delivery systems is the size of these molecules (Yoshida and 
Roberts 1993), the size of the model peptide was a focus of this chapter. Other important 
characteristics that were deemed necessary for the model peptide included good physical and 
chemical stability to ensure accurate and reproducible permeation studies could be performed. 
The charge characteristics of the peptide need to be lmown so that iontophoresis is performed 
in the right direction (electrorepulsion), and at the correct pH (peptides are zwitterions). We 
found luteinizing hormone releasing hormone, LHRH, was optimal in size and stability and 
was also found to have a number of prior reports detailing attempts to delivery it through the 
skin. A short description on the rationale for selecting this peptide and other molecules used 
in this work is outlined here. 
3.2 Physicochemical characteristics for transdermal iontophoresis 
3.2.1 Size considerations 
Early studies of Scheuplein indicated that the pathway by which substances diffuse across the 
skin is lipophilic (Scheuplein and Blank 1971). Since these studies, many investigations have 
further characterised the nature of the lipoidal pathway (Guy and Hadgraft 1988, Morimoto et 
al., 1992, Potts and Guy 1992). An alternative and/or coexisting pathway has also been 
proposed to account for the transport of polar molecules through the skin (Flynn 1985, 
Kasting et al., 1992). Flynn (1985) examined data from the literature and included a porous 
pathway in parallel with the lipoidal pathway to account for the positive deviation of polar 
molecules from model predictions made assuming a single lipoidal pathway (polar molecules 
have greater permeability than expected). In contrast, recent reports have suggested 
significant permeation of ionised drugs may occur through the lipophilic pathway due to an 
ion-pairing mechanism (Valenta et al., 2000, Hadgraft and Valenta 2000). This suggests 
against the presence of a aqueous pathway. Studies performed by Peck and co-workers (Peck 
et al., 1993, Peck et al., 1994, Peck et al., 1995) have provided additional evidence for the 
pore pathway across the stratum comeum for polar solutes. These studies used small neutral 
polar solutes as model permeants through the human epidennal membrane. The permeation 
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investigations, under varying temperatures, different ionic strengths, and in combination with 
electrical resistance measurements, indicate pores are likely to be present somewhere across 
the stratum comeum barrier (Peck and Higuchi 1998). The dimensions of the pore pathway 
has also been widely investigated (Table 3 .1 ). The pores have not been visualised directly but 
are estimated to have dimensions in the same order of magnitude as large molecules (Table 
3.1). The estimates of pore size for skin reported in the literature are either average values of 
the pathway size, or have been obtained from models that assume a single pore size. 
Table 3.1 Summary of pore size estimates for skin reported in the literature. 
Pore Size Method of Size Tissue Reference 
A Determination 
6.75 to 27 Electrical resistance Hairless Pikal 1992 
mouse 
18 Hindered pore theory Hairless rat Ruddy and Hadzija 1992 
skin 
30 'free volume' model human skin Yoshida and Roberts 1992 
8 Pore-restriction model Dermatomed Yoshida and Roberts 1993 
human skin 
25 Electrical resistance Dermatomed Dinh et al.. 1993 
human skin 
22 to 54 Hindered pore theory HEM Inamori et al .. 1994 
15 to 25 Hindered pore theory HEM Peck et al.. 1994 
2.00 Streaming potential HEM Aguilella et al .. 1994 
6.8 to 17 Ionic mobility-pore model Literature Lai and Roberts 1999 
data 
6 to 12 Iontophoresis and HEM Li et al. 1998 
Hindered pore theory 
10 to 14 AC iontophoresis and HEM Li et al. 1999a 
Hindered pore theory 
10 to 20 Hindered pore theory HEM Higuchi et al.. 1999 
Structural evidence for the pore pathway and its anatomical location has also been the focus 
of several studies. There is evidence that iontophoretic current flow through the skin is 
associated with hair follicles and sweat ducts (Cullander and Guy 1991, Burnette and 
Ongpipattanakul 1988, Jadoul et al., 1995, Scott et al., 1993, Turner and Nonato 1998). 
However other non-appendage related pores have also been shown possible (Cullander and 
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Guy 1991, Monteiro-Riviere et al., 1994, Roberts et al., 1998, Turner and Nonato 1998). It 
seems likely iontophoresis transport involves both pathways and the relative significance of 
each is dependent on the nature of the penetrant. Regardless of the microscopic location of the 
pores, the pore size estimates are useful for predicting restricted diffusion of solutes across the 
skin. According to the hindered pore theory, when a large molecule is transported in a liquid 
filled pore of similar size dimensions, solute transport is restricted due to frictional forces, 
steric interactions and long-range intennolecular forces (Anderson and Quinn 1974, Bremier 
and Gaydos 1977, Deen 1987). This theory has been used on a number of occasions to model 
drug transport through the skin (Ruddy and Hadzija 1992, Yoshida and Roberts 1993, Li et 
al., 1998). Details of the hindered pore theory are elaborated upon in Chapter 6. Briefly, the 
hindrance to diffusion is determined by a series of well established equations (Deen 1987, 
Roberts et al., 1998, Higuchi et al., 1999). Hindered transport equations relate the size of a 
solute to the extent of hindered transport encountered within a pore using the ratio of the pore 
radius and the solute radius (Deen 1987). These functions result in two types of hindrance 
terms, Hand W, representing the diffusional hindrance factor and convective hindrance factor 
respectively (Peck et al., 1996). These hindrance factors effectively reduce the free diffusion 
coefficient of a solute to a diffusion coefficient expected within a restrictive pore. If there is 
no hindrance to transport, H and W will be equal to one. However, as the solute size increases 
relative to the pore radius, hindrance increases and H and W approach zero. The effect of 
different pore sizes and solute radii on the factors H and W are illustrated in Figure 3 .1 and 
Figure 3.2. By using the hindered pore model in combination with the Nemst-Planck 
equation, the influence of pore size on iontophoresis transport can be studied. Thus, selecting 
a model solute of appropriate size, i.e. so the dimensions of the molecule are close to the 
estimates of skin pore dimensions, any modifications to the pathway structure (by 
iontophoresis or other enhancement strategies) will be highlighted by corresponding changes 
in permeability of the molecule. The size of the solute will be optimal when small changes in 
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Figure 3.1 and 3.2. The effect of solute radius (plots of four different solute radii: 2.7 
Angstrom to 7.4 Angstrom) and pore radius (x axis) on the hindrance factors H (upper 
graph) and W (lower graph). As pore radius increases the hindrance factors approach 
one (no hindrance to tranpsort). However as the pore radius approaches the size of the 
solute the value of H and W decrease dramatically. At these small pore radii the 
differences of H and W for each solute are also large and will influence diffusion 
through the pore accordingly. 
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3.2.2 Stability considerations 
In order for diffusion and skin permeability studies to be perfonned with confidence, the 
stability of the model peptide should be such that little or no degradation occurs during the 
course of the experiments. This is particularly important in permeability studies that result in 
very low rates of flux across the barrier membrane. These studies often require the use of 
highly sensitive analytical procedures in order to detect small drug quantities resulting in the 
receptor side of the diffusion cells. In such cases isotope detection often affords the best 
sensitivity and ease of analysis. However the drawback of using radiolabeled molecules in 
diffusion studies is the potential for measuring an isotope not attached to the parent molecule. 
In the case of radiolabeled peptides, it is conceivable that instability and degradation could 
give rise to erroneous permeability data from peptide fragments. Thus data on the stability of 
the model peptide must be obtained to validate the use of radio labeled solutes. These studies 
are summarised in Chapter 7 of this thesis. 
3.2.3 Electrorepulsion and electroosmosis 
A particularly important characteristic of solutes during iontophoresis is the molecular charge. 
Since iontophoresis largely operates by a charge related mechanism ( electro-repulsion) and 
due to the perm.selectivity of the skin ( electroosmosis ), this characteristic should be 
considered in the selection of a model solute. In human skin electroosmosis occurs under the 
anode in the direction of the stratum comeum (Pikal 1992). This transport mechanism assists 
the transport of neutral and positively charged molecules (Pikal and Shah 1990a). Thus 
negatively charged ions will be expected to have lower permeability as electroosmotic flow 
increases (Srinivasan and Higuchi 1990). Furthermore, electroosmosis has been shown to be 
higher during anodal iontophoresis than cathodal iontophoresis over a range of pH levels 
(Pikal and Shah 1990a). Electroosmosis is also thought to become a dominant transport force 
when ionic mobility is negligible (Roberts et al., 1998). Therefore, as the size of the molecule 
increases, the importance of electroosmosis increases (for ions of similar charge). As a 
consequence, during peptide iontophoresis, electroosmosis is likely to be a significant 
mechanism of transport (Delgado-Charro and Guy 1998). 
Another factor that may be important in iontophoretic delivery of peptides is highlighted by 
work performed by Delgado-Charro and co-workers (Delgado-Charro and Guy 1994, 
Delgado-Charro and Guy 1995, Delgado-Charro et al., 1995). Investigations using lipophilic 
analogues of LHRH demonstrated that these molecules have the capacity to decrease the 
electroosmotic flux of mannitol. During these investigations it was also demonstrated that 
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these LHRH analogues could inhibit their own transport in a concentration dependent manner. 
The mechanism for this was due to a modification of the surface charge of the skin. The 
solutes reversed the surface charge of the skin (from negative to positive) and thereby reduced 
their own iontophoretic permeability by inhibiting typical anodal electroosmosis. The 
structural features of solutes that could induce such a response have been investigated 
(Hirvonen et al., 1996, Hirvonen and Guy 1997, 1998). These workers found that positively 
charged and lipophilic molecules (i.e. tripeptides and propranolol) could induce the same 
effect. It appears molecules may have potential for reversing skin surface charge if they are 
significantly lipophilic with an adjacent positively charge group. Thus the lipophilicity of the 
model drug should be determined to bring to light any possible drug-skin interactions likely to 
influence electrotransport through the skin. The influence of lipophilicity on the 
electrotransport of uncharged species has also been investigated (Green et al., 1991a, 1991b, 
1992a, 1992b). Electrotransport via electroosmosis of these species was independent of 
lipophilicity over 5 orders of magnitude of the partition coefficient. Thus it appears 
interactions with the membrane and pore walls requires additional attractive forces, such as 
combined lipophilic-ionic interactions, to evoke changes in iontophoretic permeability. 
3.2.4 Partition coefficient 
Partially ionised drugs may interact with both the aqueous regions in pores and the lipid 
protein region surrounding the pores (Roberts et al., 1998). The partitioning of a solute into 
the stratum corneum is important for modelling passive permeation of solutes across the skin. 
In terms of iontophoretic transport partitioning may also have an important role. Most 
previous studies have not accounted for interactions between the solute and the pore wall 
except in the case of solute size restriction (Inada et al., 1994). Uptake to the pore wall has 
been suggested to be a significant effect and is related to the fraction of unionised solute 
(Roberts et al., 1998). These authors demonstrate a curvilinear relationship between the total 
permeability of a solute and the fraction unionised. This suggests an increasing interaction of 
the solute with the lipophilic regions of the pore as the fraction unionised increases, and 
effectively decreases the observed flux of the solute. Thus, unionised components of a 
partially ionised solute will partition to lipid regions of the aqueous pore and decrease the 
effective mobility of the solute. This type of interaction will negatively influence flux of a 
solute. Reduction in permeability will result from possible interactions and partitioning of the 
solute to regions in the stratum corneum removed the from the conducting pathway of 






which ionised lipophilic solutes interact with the skin by two concurrent mechanisms. 
Significant interaction with the pore wall is likely to occur by "anchoring" the lipophilic 
moiety of the solute to the membrane via van der Waals forces, and electrostatic interaction 
between the charge of the solute and the surface of the skin. It is probable the charged 
interaction will have greater effect for cationic solutes due to the net negative charge of the 
membrane. Octanol is the best common solvent for modelling partitioning of a penetrant into 
the stratum comeum (Pugh et al., 1996). However the interactions between the solute and the 
pore will not be completely explained or predicted using partitioning data. Instead this simple 
parameter functions as a useful indication of a solutes tendency to leave the iontophoretic 
pathway (assumed to be aqueous) and result in lower than expected transport rates. 
3.2.5 Surface adsorption of LHRH 
Protein and peptide adsorption to surfaces is a widely reported phenomena and has been 
mechanistically investigated recently (Burns et al., 1996, Malmsten and Veide 1996, Luthi et 
al., 1998). Insulin adsorption is a primary example of macromolecule adsorption to surfaces 
(Florence and Attwood 1998). Adsorption of the model peptide during iontophoresis may 
have several effects depending on the site of adsorption. Binding to glass surfaces of the 
diffusion cell apparatus may potentially decrease the available amount of peptide for 
permeability. This will decrease the apparent permeability of the peptide. In addition, binding 
to the surface of the skin may occur. As mentioned above this may alter the electrical 
characteristics of the membrane and alter transport processes in this way. 
3.2.6 Aims 
These investigations were performed to ascertain the suitability of LHRH as a model peptide 
for transdermal iontophoresis studies. Experimentally the size of the molecule, its partition 
coefficient, and surface binding tendency were determined. These observations were 
compared to literature reports and computer molecular modelling estimates. The 
characteristics of the molecule determined from these sources were then assessed in view of 
the transport models developed for iontophoresis of large molecules. In addition to LHRH, a 
smaller molecule, tetraethylammonium bromide (TEAB), was also characterised. TEAB was 





3.3 Experimental approach 
3.3.1 Materials 
[3H]LHRH (specific activity 50 Ci/mmol), [14C]Tetraethylammonium bromide (TEAB) 
(specific activity 2.4 mCi/mmol) and 14C-sucrose (specific activity 1.2 mCi/mmol) were 
obtained from NEN Research Products (Wilmington, DE). Phosphate Buffered Saline (PBS) 
(pH 7.4) was obtained from Sigma Chemical Co. (St Louis, MO). Deionised water (resistivity 
>18 MQ cm) was used to prepare all solutions. All other chemicals (Sigma) were of at least 
reagent grade and used as supplied, unless indicated. 
3.3.2 Determination of Stokes-Einstein radii 
The Stokes-Einstein equation states that the diffusion coefficient of a molecules is related to 




where D is the diffusion coefficient of the solute in bulk solution, R is the gas constant, T is 
the absolute temperature, 'T/ is the solvent viscosity, N is Avogadro's constant, and r is the 
Stokes-Einstein radius. This equation was used to calculate the radii of LHRH and 
tetraethylammonium bromide (TEAB) using the apparatus shown in Figure 3.3. 
Determination of the diffusion coefficient was performed in a similar method as described by 
Peck et al., (1994) using diffusion cells fitted with a porous glass disc (Fritted glass disc 
porosity E, ACE Glass, New Jersey). Both chambers were stirred and the donor port was 
stopcocked to prevent solvent flow to the receiver side. The fritted glass disc contributes no 
hindrance to diffusion because the pore sizes (between 4-8 microns) are much larger than 
hydrodynamic radii of the compounds in solution (Peck et al., 1994). Thus the permeability 
coefficients are related directly to the diffusion coefficients via a proportionality constant for 
the system. This constant is easily calculated by calibrating the set-up using a compound with 
a lmown diffusion coefficient. Sucrose has a widely reported diffusion coefficient and was 
used as a calibration molecule for the diffusion cell set-up. The permeability of sucrose, P, 
obtained from the fritted glass cell is related to the diffusion coefficient, D, through a 
proportionality constant for the experimental set-up, C. 
~ucrose = ccalibration X Ds11crose (3.2) 
Using the proportionality constant (obtained from sucrose expe1iments), the penneability data 




these molecules using similar expressions to Equation 3.2. All detenninations were perfonned 
at 37°C. 
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Schematic diagram of the diffusion cells fitted with a fritted glass disc used to 
determine the Stoke-Einstein radii ofLHRH and TEAB. 
3.3.2 Adsorption of LHRH to glass 
The effect of LHRH adsorption to glass surfaces was investigated for aqueous solutions due 
to unexpected results obtained during the diffusion coefficient determination experiments. 
Investigating surface adsorption was also pertinent given the reasons detailed in section 3.2.5 
(alterations to LHRH concentrations and binding to skin surfaces). The extent to which 
LHRH was adsorbed to the fritted glass disc was studied. The fritted glass disc represents a 
particularly severe environment with respect to adsorption. The glass disc has many potential 
sites of adsorption (highly charged surface) and a very high surface area. The effect of LHRH 
concentration was investigated using the experimental set-up shown in Figure 3.4. Loss of 
LHRH to the glass surfaces of the fritted disc was detennined by analysing solutions of 
LHRH at different concentrations before and after passage through the disc. The effect of 














Figure 3.4. Schematic diagram of the simple set-up used to investigate LHRH adsorption 
to glass surfaces. 
3.3.3 Partition coefficient 
Following similar methods of Tsai et al. (1996) the octanol/water partition coefficient of 
LHRH was determined. A 1 % solution of LHRH in water containing 0.2 µCi of 3H-labeled 
drug was equilibrated with an equal volume of octanol on a shaking water bath at 37 °C for 
16-18 hours. Aliquots were removed from each phase and measured using liquid scintillation 
counting after the addition of a scintillation cocktail. The ratio of LHRH concentrations in 
organic and aqueous phases enables the calculation of the apparent partition coefficient. 
3.3.3 Molecular modelling and computer estimates of solute physical characteristics 
The diffusion coefficient and Stokes-Einstein radius of LHRH has not been reported in the 
literature to date. Results reported by Nikiforovich and Marshall (1993) and Nikiforovich 
(Personal Communication 1999) of several low energy LHRH conformers were modelled 
using Weblab Viewer Lite® (Molecular Simulations Inc.). Manipulation of these 3D 
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structures allowed measurements of distances within the structure and were compared to our 
Stokes radius results. 
Chemsketch© (Advanced Chemistry Development Inc, Toronto, Canada) Pallas© 
(CompuDrug International, Inc., San Francisco, USA), and ClogP© (BioByte Corp., 
Claremont, USA) software was used to calculate other predicted parameters of LHRH and 







3.4.1. Diffusion coefficient of model permeants 
The estimates of the diffusion coefficients for TEAB and LHRH are shown below in Table 
3 .2 alongside several molecules that have been reported in previous diffusion studies. 
Table 3.2 Diffusion coefficients and Stokes-Einstein radii determined for LHRH and 
TEAB relative to observed data for other solutes 
Compound Molecular Weight Diffusion Coefficient Radius 
(x 10-5 cm.2/sec) (A) 
TEAB 131 8.7 3.75 
LHRHb 1182.5 1.4 23.7 
Urea• 60 17.5 2.73 
Mannitol" 182 9.03 4.44 
Sucrose• 342 6.98 5.55 
PolyStyrene Sulfonate 1515 4.4 7.5 
1800" 
PolyStyrene Sulfonate 5370 2.4 13.6 
4600" 
aDetermined elsewhere by fritted glass experiment (Peck et al., 1994, Inamori et al., 1994). 
bExperimentally determined in this study. 
3.4.2 Surface adsorption of LHRH 
The effect of LHRH concentration on the adsorption of the peptide to the glass fritt is 
summarised in Table 3 .3. It was also noticed during these studies adsorption appeared to be 
less if the fritt has been washed prior to the experiment. 
Table 3.3 
(n=3) 
Average losses of LHRH to glass fritt as a function of LHRH concentration 















3.4.3 Apparent partition coefficient determination 
All solutes were hydrophilic. LHRH partitioned to the greatest extent into the octanol layer 
(approximately 3%). TEAB being ionised in aqueous solution partitions the least into octanol. 
The ratios of concentration in octanol to concentration in PBS are shown in Table 3.4. 
Table 3.4. Summary of LHRH, TEAB and sucrose partitioning into the octanol phase 
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Images in Figure 3.5 are examples of proposed low energy conformational structures of 
LHRH. Data for these was obtained from Nikiforovich (1999) and subsequently transferred 
into a molecular modelling software package that allows simple calculation of molecular 
distances (WebLab Viewer©). The seven conformations proposed by Nikiforovich and 
Marshall (1993) were typically folded into a U-shape giving the structures an approximate 
spherical appearance (Figure 3.5a- d). Molecular diameter distances ranged from 14.8 to 20.5 
























a. CPKmode b. Van der Waals surface 
c. Ball and Stick with distance monitor d. Solvent surface superimposed 
Figure 3.5 Examples of low energy structures of LHRH constructed using data from 
Nikiforovich (1999) and WebLab Viewer©. Image (a) is displayed in CPK mode, (b) 
displayed in surface mode (Van der Waals forces) demonstrating the approximate spherical 
arrangement of the molecule. Image ( c) is a ball and stick representation illustrating the 
folded nature of LHRH, and illustrates a backbone distance measurement (Angstrom), ( d) 
shows another conformation with solvent surface superimposed on the line structure. 
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3.4.5 Physicochemical parameters obtained from predictive software 
Parameters estimated from Pallas and Chemsketch are summarised below in Table 3.5. The 
basic structures ofLHRH, TEAB and sucrose are also included in Figure 3.6. 
Table 3.5. Molar volume and LogP estimates obtained from predictive software for the 
model solutes. 
Molecule Calculated LogP Molar Volume Molar Volume Radius of equivalent sphere 
a b (cm3/mole) (A3/molecule)° (Ai 
LHRH -6.27 -4.77 783° 1300.0 6.77 
TEAB -0.93 NIA 85.6d 142.1 3.24 
sucrose -5.63 -3.09 166.7° 276.8 4.04 
11cfetermi.iiedfrom Pallas©. Calculated for unionized structures. 
b determined using ClogP (Biobyte Corp) Calculated for unionized structures. (NIA - could not calculate for 
disconnected structures) 
0determined from Chemsketch© 
dcalculated using partial molal volumes as per Yalkowsky and Zografi (1972) 
0converted from cm3/mole by dividing by 0.6023 (Yalkowsky and Zografi 1972) 
fcalculated from molar volume assuming the molecules is a sphere 
HO OH CH3 













Figure 3.6 Optimised structures of TEAB (a), sucrose (b), and LHRH (c) from which 




The appropriateness of LHRH as a model peptide for iontophoresis studies, based on size and 
other physicochemical parameters, appears well founded. The Stokes-Einstein measurements 
demonstrated that LHRH has an approximate radius of 23 A and therefore is in the same order 
of magnitude of pore size estimates. The desired dimensions of a model peptide in this study 
are considered to be approximately 20-30 A - close to the estimates of the skin pores for 
iontophoretic transport (see pore size estimates given in Table 3.1). This range is regarded to 
be most useful when considering large molecule transport through the skin because molecules 
of this size will be significantly influenced by subtle changes in pore strncture. The LHRH 
hydrodynamic radius determined by diffusion studies is higher than estimated using computer 
modelling software. The estimates from Lab Viewer© indicate the LHRH radius is 
approximately 10 A (Figure 3.5). The molecular volume estimates from ChemSketch© 
predict a smaller radius of around 7 A (Table 3.5). The modelling estimations it appear to be 
at least half that of our experimentally determined radius. This underestimation is likely to be 
due to several factors. Firstly the experimental radii relate to hydrodynamic radii that include 
solvent molecules surrounding the molecule. This hydration effect is not accounted for using 
the computer algorithm. Also the effective radius determined by diffusion studies is likely to 
be influenced by the dynamic nature of LHRH. Gupta et al., (1993) suggest the LHRH 
peptide backbone is very flexible and therefore the molecule does not have a well defined 
three dimensional strncture. Therefore the computational predictions will be limited in this 
respect. Lastly, the apparent diffusion coefficient ( experimental) will be influenced by 
interactions between the molecule and the diffusional barrier (glass fritt). Calibration of the 
diffusion setup with sucrose does not eliminate this effect because LHRH is likely to interact 
with the glass fritt in a different manner than sucrose ( as illustrated by the adsorption of 
LHRH to the glass). Therefore the experimentally determined diffusion coefficient is likely to 
be an underestimation. These comparisons of experimental observations with mathematical 
predictions highlights limitations of both sets of data. 
The molecular modeling strnctures indicate that LHRH is globular rather than porous. This is 
important when modeling transport using Stokes-Einstein radii because this theory assumes 
molecules are solid spheres (Deen 1987). 
Adsorption is considered detrimental to iontophoresis investigations due to the loss expected 
with binding to glassware and also interferring with skin surface charges. LHRH was found to 
bind appreciably to glass (approximately 3% loss at low concentrations). These conditions 
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(glass fritt) are particularly harsh however, and in vitro investigations in side-by-side glass 
diffusion cells are not expected to show equal losses due to a significantly less surface area. 
The potential for this type of interference exists and therefore careful monitoring of the donor 
concentration for losses is required. In addition it appears washing the glass surface may 
reduce this adsorption. A similar finding was also reported by Luthi et al. (1998). 
For the general purposes of this work, that being investigation of large molecule transport 
during iontophoresis, electroosmosis is considered an integral force for delivering 
macromolecules (Pikal 1992). Hirvonen and co-workers (1996, 1997, 1998) described how 
interactions between the solute and charges on the pore wall can diminish this transport 
mechanism via the skin surface neutralisation. Although LHRH is positively charged (Heit et 
al., 1994) and its lipophilic analogues cause inhibition of electroosmosis, it has been shown 
that LHRH does not exhibit this phenomenon (Delgado-Charro and Guy, 1994). However the 
tendency of LHRH to partition into the lipophilic regions of the stratum comeum was thought 
to be important for analysis of the iontophoresis permeability studies. Our studies showed the 
lipophilicity of LHRH was higher than the small ionic solute, TEAB and also the uncharged 
polar solute, sucrose. Similar partitioning characteristics were reported by Sasaki et al .. 
(1997). The partition coefficient derived from computer predictions via fragmental methods 
(Mannhold et al., 1995) was an order of magnitude different from our experimental apparent 
partition coefficient. This is likely to be a result of the limitations of such methods to predict 
for large molecules (Leo 1993). It must be noted however that the computer estimates 
calculate parameters on the basis that the compound is unionized. LHRH is zwitterionic in an 
aqueous solution (the isoelectric point ofLHRH is around 9.6 with a net positive charge at pH 
7.4) (Heit et al. 1994b). Therefore the computer calculated partition coefficient for LHRH 
must be viewed with caution because it relates to· the unionized fonn only. However, it 
appears that these partitioning characteristics may be sufficient to result in a depot of LHRH 
to remain in the skin following iontophoresis (Heit et al., 1994b). The effect of LHRH 
partitioning into the lipophilic regions of the pore wall may influence transport appreciably 
more than a corresponding hydrophilic ion such as TEAB. 
TEAB was included in these studies to provide a comparison for LHRH. TEAB is small ionic 
solute (radius approx 4 A, cationic) and has previously been used in iontophoresis studies 
(Sims et al., 1992, Higuchi et al., 1999). TEAB itself can provide important infom1ation 
regarding the pore pathway during iontophoresis because it is similar in size to the conducting 
ions. Sucrose was also selected as the electroosmosis flow marker for iontophoretic 





because it is uncharged. However sucrose is polar and therefore can be transported via 
electroosmosis. Various reports detailing sucrose iontophoresis are in the current literature 
(Higuchi et al., 1999). 
3.6 Summary 
Using LHRH as a model peptide, permeability studies can be designed to investigate the 
mechanisms of large molecule iontophoresis. In particular, changes in the nature of the pore 
pathway may be uncovered by observing changes in permeability of LHRH. According to the 
hinder pore theory and previous pore size estimates, LHRH is a good example for peptide 
iontophoresis. Other important characteristics of the model solutes were also determined and 
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There are three main mechanisms that promote drug delivery during iontophoresis. Firstly, 
charged species, contained within an electrolyte solution, will be transported as they move 
down their electromotive gradient across the stratum corneum. Secondly, an electroosmotic 
solvent flow occurs across the skin and thus assists in the delivery of some solutes during 
electrical field application (Pikal 1992). Thirdly, iontophoresis facilitates permeation by 
inducing structural changes in the skin during the application of moderate electrical potential 
gradients (greater than 1 V) (Inada et al., 1994) .. These structural alterations appear to 
resemble the formation of new pathways similar to those created during electroporation 
(Inada et al., 1994, Li et al., 1999a, Higuchi et al., 1999). Electroporation of the stratum 
corneum requires much larger voltages (>50 V) in order to create new pores in the lipid 
bilayers of the intercellular matrix (Singh et al., 1998, Prausnitz 1997, Chizmadzhev et al., 
1998). However the presence of shunt pathways with much less lipid bilayer resistance have 
given rise to the idea of pores forming in the lining of appendages termed "macropores" 
(Prausnitz 1997, Chizmadzhev et al., 1998). Recent thermodynamic investigations into the 
nature of induced pores have reported the size of these pathways is smaller than the pre-
existing pores (~ 10 A versus 20 A, respectively) (Li et al., 1998, Higuchi et al., 1999). The 
similarity in size between the voltage induced pathways in the skin and peptide molecules 
may mean that iontophoretic permeation enhancement will be significantly restricted through 
these new pathways. No investigations designed to address this issue using large solutes have 
been reported to date. 
This study investigated the hypothesis that increases in the porosity of the HEM will not 
significantly increase the transport of peptides due to the small size of elect1ically-induced 
pores. Specifically, we compared the permeability enhancement of a model peptide, LHRH, 





4.2 Model Development 
4.2.1 The modified Nernst-Planck model 
Constant voltage iontophoresis can be represented by the Nemst-Planck equation for 
electrochemical transport phenomena. The modified Nemst-Planck equation (Equation 4.1) 
provides a general framework for mechanistic iontophoresis transport studies (Sims et al., 
1992, Li et al., 1998, Roberts et al., 1999, Higuchi et al., 1999). The applied model expresses 
iontophoretic transport in terms of the passive diffusion, migration driven by electric field, 
and electroosmotic flow contributions (Higuchi et al., 1999). 
{ [
dC CzF dlf/l } 
J1::,lf' =-s HD-+---- ±WvC 
dx RgasT dx 
(4.1) 
where J is the flux of the species in one dimension, sis the combined porosity and tortuosity 
factor of the membrane, D is the diffusion coefficient of the permeant, C is the concentration, 
xis the position in the membrane, z is the charge number, Fis the Faraday constant, Rgas is the 
gas constant, T is the temperature, If/ is the electrical potential across the membrane, v is the 
average velocity of the convective solvent flow, and Hand Ware hindered transport factors. 
Certain limitations arise when attempting to use this equation for the experimental protocols 
used here. Firstly, LHRH molecular size is close to that of the pore size estimates therefore it 
is necessary to account for steric and frictional interactions between the solute and the 
membrane using the hindered pore theory (Ruddy and Hadzija 1992, Roberts et al., 1998, Li 
et al., 1999a). Secondly, electrical fields may result in structural changes in the skin ands, the 
combined porosity and tortuosity factor of the membrane, will be altered. These alterations 
need to be accounted for in order to calculate solute iontophoresis permeability using this 
equation. Thirdly, the average velocity of the convective solvent flow during an iontophoresis 
experiment will be significantly influenced by the nature of the skin surface and pores. 
Therefore accurate estimation of electroosmotic flow can be achieved by incorporating an 
electroosmotic flow marker into permeability experiments. 
4.2.2 Hindered pore theory 
Hindered transport factors are used to explain reduction in transport due to the effect of the 
size of the model solutes relative to the pore dimensions. The hindrance factors reduce the 
free diffusion coefficient of a solute to the diffusion coefficient of the molecule in a 
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cylindrical pore. An extensive review of the hindered pore theory (HPT) can be found in the 
literature (Deen 1987). 
Steric and :frictional interactions between the diffusing molecules and the pores of a 
membrane may be accounted for by using the hindered transport theory. To incorporate these 
hindrance terms into modelling of the transport processes across the skin the model assumes 
that the aqueous pores in the HEM are cylindrical and of uniform size. The calculation of the 
hindrance factors are based upon the relative sizes of the pore and molecule, defined by "A. 
A=~ (4.2) 
RP 
where rs is the solute radius and Rp is the pore radius. 
The theory accounts for restriction of Brownian diffusion and electromotive migration using 
hindrance factor H(A). Also effects of hindrance on convective solvent flow are calculated by 
the use of the factor W(A). These terms are calculated using Equations 4.3 and 4.4 below 
(where O ~ 11, < 1) (Lai and Roberts 1999, Roberts et al., 1998a, Deen 1987). 
H(;L) = 6Jr(l-11,)2 
3.18,r' (l-Afm[1 + t,a .. (1-A)" J + t,a.,,,(A)" 
(4.3) 
where the coefficients are a1=-l.22, a2=1.53, a3=-22.51, 34=-5.61, as=-0.34, a6=-l.22 and 
a1=1.65. Also, 
c1-;L)2(2 -c1- ;i,)2)(3.187Z'2 c1-;i,)-512 [1 + f b"c1-;ir] + IA,+3 c;i, rJ 
W(;L) = 11=1 11=0 ( 4.4) 
2( 3.181r'(l -Ar"'[1 + t,a .. (1- A)" J + t,a,,.,(A)" J 
where b1=0.12, b2=-0.04, b3=4.02, b4=-3.97, b5=-l.92, b6=4.39 and a7=5.0l. 
The subtleties of these equations however can often be masked by the variability of the skin 
and therefore must be considered in interpretation of such data. 
4.2.2.1 Assumptions of the hindered pore theory 





Table 4.1 Main assumptions of the hindered pore theory for transdermal drug delivery 
applications (Deen 1987). 
1. The skin is considered as a porous membrane made up of a series of parallel cylindrical channels of uniform 
length and width. 
2. The radius of the solute molecule and that of the pore are of the same magnitude but significantly larger tl1an 
the solvent (a continuum). 
3. Pore length is assumed to greatly exceed the pore radius. 
4. The donor phase is in dilute amounts so that solute-solute interactions are neglected. 
5. Electrostatic interactions between the solute and the pore wall are sufficiently screened, preventing high 
concentrations of the solute near the pore wall. 
6. The solute is spherical, compact and solid. 
4.2.2.1.1 Porous membrane consisting of uniform cylindrical pores 
Recent reports provide good evidence for the existence of a porous route during iontophoresis 
(Cullander 1992, Scott et al., 1993, Peck et al., 1993, 1994, 1995, Peck and Higuchi 1998). 
Therefore it is reasonable to consider the skin as a porous membrane. Anatomically the pores 
are considered to reside either in the substructure of the skin appendages, or in the 
intercellular lipid matrix of the stratum comeum, or in both (Chizmadzhev et al., 1998, Scott 
et al., 1993). Given that the skin is highly tortuous with respect to water permeation (Elias 
1990, Bunge et al., 1999), it is unlikely that the pores are cylindrical. In addition, the pores 
present in the skin are unlikely to be uniform in size. The assumption that pores are 
cylindrical arises because the complexity of the calculations is great when the hindrance to 
transport is not constant down the length of the pore (Anderson and Quinn 1974). Since there 
is no way of determining the exact nature of the pores at this time it seems reasonable to 
simplify the conditions so that pores are represented by cylinders of uniform size. Thus, the 
tortuous, irregular pores in the skin are averaged by the calculations of this theory to 
equivalent cylinders. 
4.2.2.1.2 Solute and pore radii 
The second requirement is that the radius of the solute molecule and that of the pore are of the 
same magnitude but significantly larger than the solvent (a continuum). Based upon results of 
several different workers, the effective pore size of the HEM is likely to be in the 10 to 30 A 
range (Chapter 3, Table 3.1). LHRH is estimated to be in the same order of magnitude as this 
(-23 A) while TEAB is smaller (-3.75 A), yet still appreciably larger than water (-1.9 A if 1 




4.2.2.1.3 Pore length 
The pore length must greatly exceed the pore radius in order to neglect mass transfer 
resistances associated with pore entrances and exits so that fully developed velocities profiles 
can be used (Deen 1987). In the HEM case it is safe to assume pore lengths are much larger 
than the radii of these channels. 
4.2.2.1.4 Solute-solute interactions 
Using radiolabeled compounds trace amounts of the solute can be used in the donor solution 
without loss of sensitivity of analysis. Thus solute-solute interactions can be assumed to be 
negligible. Generally, a dilute polymer solution is considered to have less than 1 % w/v 
polymer (Ruddy & Hadzija 1992). 
4.2.2.1.5 Solute-pore interactions 
Electrostatic interactions between the solute and the pore wall also need to be considered. 
Ionic interactions, or lipophilic interactions, or both, could induce solute-wall effects that are 
not accounted for by the hindered pore theory. Sufficient screening of the charges on the pore 
wall may prevent significant ionic interactions. It is well known the stratum comeum is 
negatively charged at physiological pH (Burnette 1989) and therefore LHRH and TEAB, both 
cations, may interact with these charges. In addition, LHRH may have small partitioning 
interactions with the lipophilic regions of the HEM. The electrical double layer that forms at 
interfaces can be used to estimate the shielding of surface charges (Martin 1993). The Debye 
length ([) is an indicator of the thiclmess of the electrical double layer adjacent to a charged 
surface. The more effective the shielding, the smaller the electrical double layer will be. In a 
pore, sufficient screening of the charged surface will be obtained when the Debye length is 
small relative to the radius of the pore. 
1 
1-[(;~ )Lkc,lJ' (4.s) 
where F is Faraday's constant, s is the dielectric constant of the solvent, Rand T are the gas 
constant and absolute temperature respectively, and z and C are the valence and concentration 






,c = 3.29 x 107 zC2 (4.6) 
where K is the inverse Debye length given in cm-1, with concentration, C, given in mol/L 
(Kemery et al., 1998). The Debye length is altered by changing the ionic strength of the 
solution, in particular, increasing the ionic strength will increase screening. Ruddy & Hadzija 
(1992) reported a Debye length of 4.54 A using a 0.45M solution of PBS. In our experiments 
a phosphate buffered saline solution was used with an ionic strength of 0.1 M, which indicates 
the Debye length will be around the 9 A region. Therefore if the pore radius is approximately 
30 A, the double layer will occupy a large proportion of the pore radius and the surface 
charges will be incompletely shielded for a molecule such as LHRH, which has a 
hydrodynamic radius of approximately 20 A. Thus, possible interactions with the pore wall 










Dimension estimates of pore, solute, and electrical double layer. 
Solute shape 
The final requirement is that the solute is spherical, compact and solid (as depicted in Figure 
4.1). Many peptides are linear and flexible polymers and therefore this condition is not 
satisfied. Davidson and Deen (1988) modified the standard hydrodynamic theory such that 
polymers were treated as structures consisting primarily of solvent. These molecules undergo 
less overall hydrodynamic resistance relative to spherical molecules of equivalent Stokes 
radius. Another influence is that partitioning of a sphere is more favourable between the pore 
and bulk solution resulting in greater rates of transport. LHRH structural information is sparse 
in the literature. Our modelling efforts from data obtained from Nikiforovich and Marshall 
(1993) indicated the peptide is relatively globular (Chapter 3). Another group of researchers 
found the folded structure of LHRH was energetically prefened instead of a linear chain 
98 
(Gupta et al., 1993). From the limited data available LHRH appears to fit the criteria of being 
spherical, compact and solid. 
4.2.3 Enhancement Ratios 
The Nemst-Planck equation (Equation 4.1) can be integrated to yield permeability 
enhancement ratios (E) for a particular solute. These are useful because they allow easy 
comparison between two different types of molecules. In effect they are simply the ratio of 
iontophoresis flux and passive flux (Equation 4. 7). 
E 
J. = 1011!0 
J . passive 
(4.7) 
For cation enhancement ratios, the Nemst-Planck model becomes, 
£cations= Jiontopho:esis =( -K[l-(Pe/K)] J (4.S) 
J passive 1- exp[K(l - (Pe/ K))] cations 
and for anions, 
E . = Jiontophoresis -( - K[l +(Pe/ K)] J 
muons -









The Peclet number (Pe) characterises the effect of convective solvent flow on the flux of the 
permeant while K describes the direct field effects (Sims et al., 1991b). 
Schematically, the enhancement ratio calculated from the Nemst-Planck model can be 
separated out into the following components contributing to overall enhancement (Equation 
4.12), 
E = Eionto + Eelectroosmosis (4.12) 
Thus the primary transport effects predicted by the model are the direct electrical field effect 
and electroosmosis forces (Higuchi et al., 1999). 
4.2.4 Estimation of porosity changes 
One of the assumptions made in the modified Nemst Planck equation is that the diffusional 

















assumption may be incorrect. Under an applied potential of around 1 V or greater, the 
porosity of the HEM increases (Inada et al., 1994). At these voltage levels the observed 
enhancement ratios can also be schematically represented by the contributing components of 
permeability enhancement (Equation 4.13), 
E observed = ( Eionto + E electroosmosis ) X E Aft (4.13) 
where EM is the increase in porosity of the membrane due to the electrical field. E /',R 
represents the change in s, the porosity-tortuosity factor, from the Nemst-Planck equation 
(Equation 4.1 ). The observed E ratio obtained from iontophoretic flux studies (Equation 4.13) 
and the E ratio derived from the Nemst-Planck model (Equation 4.12) can not be quantifiably 
compared to each other due to this additional porosity tenn. To facilitate comparisons the 
membrane permeability changes that occur during iontophoresis experiments must be taken 
into account. At prese:t;1t there is no way of precisely predicting the porosity change in the 
HEM as electrical field strength increases, but electrical conductance changes provide a good 
estimate (Inada et al., 1994, Higuchi et al., 1999, Chizmadzhev et al., 1998, Li et al., 1998). 
Therefore increases in porosity, Et.R, can be estimated by changes in HEM electrical 
conductance (G), 
Gionta E ;:::! -
Aft G passive 
(4.14) 
g1vmg, 
E model X E /',R = E expected (4.15) 
therefore, 
E expected ;:::i E observed (4.16) 
This relationship (Equation 4.16) will hold true if the porosity increases provide additional 
transport pathways for the solute under investigation. Conductance, being a measure of the 
electromobility of the background electrolyte in the HEM, is more likely to indicate the 
porosity changes for ions that are similar in size to sodium and chloride ions (the conducting 
ions) (Higuchi et al., 1999). Therefore, if the voltage induced pores, as indicated by 
conductance changes, are smaller than the permeant dimensions, correcting for porosity will 
fail to fit the Eexpectect predictions to the observed enhancement ratios. This approach allows the 
effect of the porosity changes on the transport of different sized ions to be analysed at 











4.3 Experimental approach 
4.3.1 Materials 
[3H]LHRH (specific activity 50 Ci/mmol) and [14C]Tetraethylammonium bromide (TEAB) 
(specific activity 2.4 mCi/mmol) were obtained from NEN Research Products, Wilmington, 
DE. Phosphate Buffered Saline (PBS) (pH 7.4) was obtained from Sigma Chemical Co., St 
Louis, MO. Silver wire (99.9% purity) was also obtained from Sigma Chemical Co. Lengths 
of silver wire (15 cm) were coiled and used as electrodes. In order to obtain a silver chloride 
electrode the coiled silver wire was electroplated in 3 M KCL. All other chemicals used were 
analytical grade. Deionised water (resistivity> 18 MQ cm) was used to prepare all solutions. 
4.3.2 Preparation of epidermis 
Full thickness female abdominal, breast, or lower back skin was obtained and prepared as 
described in Chapter 2 (2.2.2) to yield sheets of HEM. HEM samples were selected for their 
integrity using electrical resistance measurements (made at low potential difference (0.3V) 
applied over short instances) in addition to visual inspection. Only samples with baseline 
resistance of greater than 20 k0hms/cm2 were accepted. 
4.3.3 In vitro HEM studies 
The general procedure for performing in vitro permeability experiments has been well 
described in the literature (Guy and Hadgraft 1989, Williams and Barry 1992). In our study, 
sheets of HEM were mounted between the two side-by-side diffusion half-cells, stratum 
comeum side facing the donor compartment. The diffusion cells were firmly clamped leaving 
an area exposed for diffusion of 0.64 cm2• The circulating water bath supplying the jacketed 
donor and receptor compartments was maintained at 37°C. The diffusion cells each had a 3 ml 
volume and were stirred using small Teflon coated magnetic bars. 
All permeability measurements were performed in 0.1 M PBS solutions at pH 7.4. 
Iontophoresis treatments involved applying a constant DC voltage across the membrane at 
pre-selected levels (1, 2, 3, and 4V) using Scepter© a computer controlled power supply. 
Regular sampling from the receptor allowed the calculation of flux for each permeant. These 
samples were mixed thoroughly with 5 ml of liquid scintillation fluid (Ultima Flo M™, 
Packard, Meriden, CT) and analysed in a Beckman LS5801 scintillation counter for 10 
























radiolabeled permeants to be present in the donor solution whilst ensuring that there were no 
osmotic pressure contributions and that solute-solute interactions were negligible. 
During the course of all experiments, including those without iontophoretic currents, electrical 
conductance measurements of the membranes were monitored using a Fluke 89 IV true RMS 
multimeter (Fluke, Everett, WA USA). These conductance measurements were utilised in the 
estimation of membrane porosity changes that occur at moderate iontophoretic voltages as 
outlined in the model development section. 
4.3.4 Data analysis 
Disintegrations per minute (DPM) counts measured for each receptor sample were converted 
to amounts of compound using the specific activity, dilution and sampling corrections. Plots 
of cumulative amount, Q, over time, t, were subsequently constructed. From these, 
permeability coefficients (normalised flux), P, for each solute was determined using the 




where A is the diffusional area, !lC is the concentration difference across the membrane, and 
dQ/dt is the steady-state slope of the above-mentioned plots. The permeability coefficients 
were then used to calculate enhancement ratios for each treatment group. Enhancement ratios 
were calculated by dividing the permeability coefficient of the solute resulting from 
iontophoresis by the permeability observed during passive conditions . 
E ·= Fiontophoresis 
?Passive 
(4.20) 
The experimental enhancement ratios, Eobserved, were compared to enhancement ratios 
calculated using the modified Nemst-Planck equation (Equation 4.1), Emodel· In the model, the 
contribution of electroosmosis to a solute flux enhancement is represented by the Peclet 
number, Pe (Higuchi et al., 1999). The Pe contributions were estimated by incorporating a 
non-ionic solute into the iontophoresis experiments since convective solvent flow velocity is 
particularly troublesome to calculate in complex systems such as the HEM (Pikal 1992, Peck 
et al., 1996). Non-ionic solutes will not be influenced by direct repulsion forces from the 
electrical field and therefore are representative of electroosmosis effects only (Higuchi et al., 
1999). The E ratio for a non-ionic molecule during iontophoresis is equivalent to its Peclet 























of Pe numbers for LHRH and TEAB using the equation derived by Li et al.,.(1997) (Equation 
4.21). 
W H Dsucrose) Pe LHRH sucrose • sucrose 



















4.4.1 Observed Flux Profiles and Enhancement Ratios 
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Figure 4.2. Representative plot of the cumulative amount of LHRH (ng) transported across 
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Figure 4.3. Representative plot of the cumulative amount of TEAB (mcg) transported across 

















' ,\ I 
-< 
The straight line portion of the flux profile implies a steady-state has been attained. The flux 
is calculated from the slope of the linear regression of points in this region (between 2 and 5 
hours). This flux is normalised for concentration to yield a permeability coefficient from 
which the E ratio is determined from. 
The E ratios from iontophoresis experiments for both LHRH and TE.AB are summarised in 
Table 4.2. The experimental LHRH permeation enhancement ratios, Eobserved, increased as the 
electrical field strength was increased, from 2.5 fold enhancement at 1 V to 13 .5 fold 
enhancement at 4 V (Table 4.2 and Figure 4.4). Variability was high between all samples in 
each experimental group. Similarly, TE.AB enhancement ratios were observed to increase as 
the electrical field strength increased (Figure 4.5). However the magnitude of TE.AB 
enhancement ratios was three orders of magnitude greater than the LHRH observed 
enhancement ratios. Identical sucrose iontophoresis experiments were also performed to assist 
in the estimation of the convective solvent flow component of iontophoretic permeation 
enhancement. In accordance with TE.AB and LHRH observations, sucrose permeation 
enhancement also increased with electrical field strength (Figure 4.6). 
Table 4.2 Permeation enhancement ratios from iontophoresis flux experiments performed 
across HEM. 
Permeant Voltage Observed Porosity Model Expected Enhancement 
(Volts) Enhancement Increases: Enhancement Ratio (Emodel X E,..R): 




TEAB 1 181 ± 140 5.3 ± 1.6 40 209.9 ± 63.4 
2 1732 ± 469 22.5 ± 4.1 79 1770.8 ± 322. 7 
3 6938± 1718 66.9 ± 20.5 118 7874.1 ± 2412.8 
4 7212 ± 1091 69.0 ± 38.9 157 10812.3 ± 6095.6 
LHRH 1 2.5 ± 0.4 5.2 ± 1.3 231 2233 ± 1638 
2 4.0± 3.0 9.4 ± 4.5 408 3816± 1827 
3 11.0 ± 1.6 25.9 ± 9.2 584 15133 ± 5358 
4 13.5 ± 5.1 98.8 ± 72.6 761 75145 ± 55243 
a Mean± SD, n ~ 4. 
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Figure 4.4. Observed enhancement ratios for LHRH, Eobserved. 
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Figure 4.5. Observed enhancement ratios for TEAB, Eobserved, (grey bars) and expected 
enhancement ratios, Eexpected, as calculated from equation 4.15 combining the Nemst-
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Figure 4.6 Observed enhancement ratios for sucrose, the electroosmotic flow marker. 
4.4.2 Electrical Conductance Measurements 
Electrical conductance changes, Et-.R, were also measured to assist in predicting the porosity 
changes that occur in the membrane. These are summarised in Table 4.2. Like the E ratios, 
electrical conductance of the membrane increased as electrical field strength was increased in 
both the LHRH and TEAB experiments. A maximum increase in Et-.R was detected at 4 V for 
both experiment groups although the standard_ deviation was large. To investigate this 
variability, Et-.R for all individual experiments were plotted against the voltage applied across 
the membrane (Figure 4. 7). The range and variability of the porosity changes increased as the 
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Figure 4.7. Variation of the porosity increases, E~R, observed during each iontophoresis 
permeation experiment. 
4.4.3 Nernst-Planck enhancement ratios 
The Nemst-Planck model enhancement ratios, Emodel, were calculated assuming a 30 A pore 
radius for each solute as described in the model development section. These are shown in 
Table 4.2. The model enhancement ratios were transformed using Equation 4.15 to obtain 
Eexpected, an enhancement ratio that can be compared to the experimental enhancement ratios. 
The expected LHRH enhancement ratios could not be effectively plotted as a comparison for 
Eobserved due to the differences between these numbers. A summary of Eexpected values for 
LHRH are shown in Figure 4.8. These Eexpected ratios are several orders of magnitude greater 
than the observed permeation enhancement ratios (Figure 4.4). The expected enhancement 
ratios, Eexpected for TEAB are plotted in Figure 4.5. Unlike observations for LHRH, the Eexpected 




























(.) " a ! 10000 
..i:: >< 









Voltage applied (Volts) 
4 
Figure 4.8. Expected enhancement ratios for LHRH (Eexpected) as calculated from equation 
4.15 combining the Nernst-Planck model and porosity changes. 
Figure 4.9 a and bare plots ofEexpected versus Eobserved for LHRH and TEAB respectively. This 
representation facilitates a comparison of the observed values with the expected model 
predictions for each solute. An identical match between the model and observations would be 
represented by a slope of 1 between the data sets. For LHRH the slope is 0.001, demonstrating 
a large discrepancy between the observed permeation enhancement and that predicted by the 
model. Conversely, TEAB results show a slope of approximately 1.4, representative of a 
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Figure 4.9a & b. Eexpected ratios for LHRH and TEAB (top and bottom graphs 























4.5.1 Solute permeability 
Our observed LHRH permeability during iontophoresis ranged from around 6 x 10-4 cm/h to 
6.4 x 10-3 cm/h. The permeability coefficients of LHRH appear to fit well with those 
previously reported (Sims et al., 1992, Bhatia et al., 1997b, Bhatia and Singh 1997). In vitro 
LHRH iontophoresis permeability results has recently been described by Bhatia et al. 
(1997b). These studies were performed across skin from various species under several 
different experimental treatments. Iontophoresis permeability coefficients reported were in the 
range of 1 x 10-3 to 1 x 10-4 cm/h and therefore in agreement with our observations. In 
previous investigations, LHRH permeability across human skin was below the limits of 
HPLC detection (Lu et al., 1992, Srinivasan et al., 1990b) whilst in animal studies, LHRH 
permeability appeared to be measurable (Bhatia et al., 1997b, Bommannan et al., 1994). Our 
laboratory used intact human tissue that is generally reported to have lower permeability 
relative to animal skin for many solutes (Cevc 1996, Siddiqui 1989) and therefore 
necessitated the use of radiolabeled LHRH and liquid scintillation counting as an analytical 
method. Reports of TEAB permeability coefficients in HEM are also in the literature (passive 
permeability from around 5 x 10-5 cm/h to about 8 x 10-4 cm/h) (Sims et al., 1992). These are 
similar to the passive permeability coefficients observed for TEAB in the current study (5.9 x 
10-5 cm/h to 1.2 x 10-4 cm/h). 
4.5.2 Calculation of Emodel 
Simple calculation of the Pe number from equation 11 is complicated by the structural 
changes that occur in the membrane at voltages above 1 V. At these electrical field strengths 
the porosity changes in the HEM also contribute to the E ratio of the non-ionic solute. 
Consequently the enhancement factors of neutral molecules above 1 V are no longer solely 
composed of electroosmotic flow and should not be used to estimate Pe numbers for other 
molecules using equation 11. However, Pe estimates can be obtained from the voltage region 
where the membrane remains constant (below 1 V). In this voltage region, Pe is directly 
proportional to electrical field strength (Figure 4.6) (Pikal 1992, Peck et al., 1996, Peck et al., 
1998). Thus the relationship between electroosmosis and voltage below 1 V provides a 
predictive estimate for electroosmosis at higher voltages. Once Pe values are lmown, the 
theoretical enhancement ratio is easily calculated and can then be compared to observed E 


















4.5.3 Porosity effects on solute enhancement 
The hypothesis that voltage-induced pores during moderate voltage iontophoresis are too 
small to provide additional pathways for macromolecule transport was the focus of our 
studies. By combining porosity change measurements with permeability enhancement data for 
a small and a large solute we were able to provide experimental support for this proposal. 
TEAB permeability, Eobserved, increased dramatically as the porosity of the membrane, EL'.R, 
increased during iontophoresis (Table 4.2). However porosity increases observed during 
LHRH iontophoresis had a much smaller effect on LHRH permeability enhancement. 
In order to calculate the proportion of TEAB permeability enhancement resulting from 
electrically-induced changes in the membrane, the observed permeability data were compared 
to the theoretical model (Table 4.2). It was apparent that the observed permeability 
enhancement ratios were an order of magnitude greater than Emodel predictions. This 
discrepancy was largely explained by changes occurring in the membrane during electrical 
field application. By incorporating the porosity changes (ELiR) into the Nemst-Planck model 
predictions the enhancement ratio expected if voltage-induced porosity changes give rise to 
new pathways for solute transport, Eexpected was derived. For TEAB, good agreement of 
Eexpected with Eobserved indicates that the differences between the observed enhancement ratio 
and the Nemst-Planck derived predictions (Emodel) are for the most part explained by porosity 
increases. The slope of the relationship illustrated in Figure 4.9 (approximately 1.4) implies 
that the Eexpected ratios are slightly higher than the Eobserved ratios. This observed variation from 
the model predictions is likely to be the result of a number of possible events including large 
biological variation between samples, the differences in electromobility of TEAB compared 
to other conducting ions, physicochemical interactions between TEAB and the pore walls, and 
possible joule heating effects at higher electrical field strengths. The variable nature of the 
HEM is well known (Cullander and Guy 1992) and is illustrated in our study by the large 
standard deviation observed in the conductance measurements during iontophoresis (Figure 
4.7). 
Examination of the LHRH permeability data shows a large disagreement between the Eobservect 
ratios and the model enhancement ratios, Emodel· Furthermore, incorporating the porosity 
correction created an even greater discrepancy between Eobserved and the Nemst-Planck model. 
From these comparisons and in light of TEAB results, it appears that the electrically induced 
changes in the membrane did not influence LHRH enhancement to the extent observed with 
TEAB. We cannot infer from our data that there were any increase in permeability 





















enhanced by voltage induced pathways, the magnitude of enhancement is considerably 
smaller than that observed for TEAB. 
An interesting observation during TEAB permeation experiments was the leveling off of 
Eobserved as voltage levels were increased from 3 to 4 V. At these elevated electrical field 
strengths porosity changes only increased slightly (from 67 fold to 69 fold at 3 and 4 V 
respectively). It seems likely that in the TEAB experiments through HEM, a maximum 
magnitude of porosity was induced at approximately 3 to 4 V. However, further experiments 
are needed to confirm the possibility of a maximum limit to porosity induction. Examining the 
corresponding LHRH porosity changes this behaviour is not observed and at 4 V there was a 
disproportionate increase (26 fold and 99 fold increases at 3 V and 4 V respectively). This 
difference observed between TEAB and LHRH experiments demonstrates the electrical 
nature of HEM samples is highly variable and emphasises the need to incorporate porosity 
corrections for mechanistic evaluations of iontophoresis at voltages greater than 1 V. 
Our observations provide experimental support to studies that have looked at the nature of 
these voltage induced pores (Li et al., 1998). These researchers predicted the induced 
pathways to be around 10 A in radius, much smaller than the radius of the existing pores (20 
A). Pores of this size are unlikely to be of significant benefit in promoting the transport of 























4.6 Chapter summary 
During moderate voltage iontophoresis the skin porosity increased, as indicated by increases 
in the electrical conductance of the membrane. The porosity increases promoted the 
permeability of TEAB, a small ionic solute. By applying a correction for porosity changes it 
was possible to compare observed permeation enhancement ratios for TEAB to the modified 
Nernst-Planck model predictions. Given the use of innately variable biological membranes, 
good agreement for TEAB was achieved. Enhancement of LHRH during moderate voltages 
was much less than that observed for TEAB. Porosity increases appeared to have little effect 
on LHRH permeability. Applying the porosity correction did not provide agreement between 
observed enhancement data and the modified Nernst-Planck equation. Overall, iontophoretic 

























The influence of voltage on electroosmotic flow during iontophoresis across 
human epidermal membrane 
Introduction 




























5.1.1 Electroosmosis of peptides 
Electroosmotic volume flow is thought to be a significant driving force for the iontophoretic 
flux of macromolecules (Pikal 1992, Hirvonen and Guy 1998). As introduced in Section 1, the 
permselective nature of the skin gives rise to a convective solvent flow under an electrical 
field. The Manning theory, which describes the effect of electroosmosis on iontophoresis, 
predicts the importance of electroosmotic flow increases as the size of the drug ion increases 
(Manning 1967, Pikal 1992). For peptides, the relative contributions of electroosmosis and 
electrorepulsion have been inferred, but have not yet been quantitatively determined 
(Delgado-Charro and Guy 1998). It is generally accepted that electroosmosis has greater 
importance in iontophoresis of larger molecules such as peptides and proteins, since larger 
molecules will carry a much smaller fraction of the total current compared to the fraction 
carried by smaller more mobile buffer ions. In effect, this makes the flux contribution of 
electroosmosis during iontophoresis more important as the molecular size of the solute 
increases. Also, the importance of electroosmotic transport for larger molecules has been 
demonstrated in experiments that have delivered peptides via "wrong-way" iontophoresis 
(Pikal and Shah 1990b, Burnette and Marrero 1992). In wrong-way iontophoresis a large 
negative solute can be delivered across the skin by placing it in the anode. This illustrates the 
dominating mechanism of electroosmosis over electrorepulsion for certain solutes. 
The influence of electroosmosis on peptide delivery has been investigated. As mentioned in 
Chapter 3 the structure of the solute may sometimes detrimentally influence electroosm.otic 
transport. This was observed with the LHRH analogues nafarelin and leuprolide (Himoven et 
al. 1996). Cationic peptides with bulky lipophilic residues adjacent to a positively charged 
residue appear to decrease their own transport by neutralising skin charges in a concentration 
dependent manner. The concept of altering skin charge to manipulate electroosmosis has also 
been investigated by Peck et al. (1998). An anionic surfactant (sodium dodecyl sulfate) was 
shown to augment the electroosmotic flux or' small neutral polar solutes . The mechanism 
appeared to be by adsorption of the surfactant to the skin, thus increasing the net negative 
charge of the pore wall and thereby increasing electroosmosis. 
Alterations of pH, inducing changes in the net charge of a peptide, may yield important 
information on the significance of electroosmosis for particular molecules. The amino acids 
lysine and histidine were iontophoresed under a range of different pH conditions (Green et 
















ionised state. In addition pH effects on the skin charges were also observed. At low pH, 
electroosmosis was reduced presumably through neutralisation of the negative skin charges. 
The tripeptide thyrotropin releasing hormone (TRH) however had greater flux in the neutral 
state (pH 8) than when charged (pH 4) indicating the significance of electroosmosis as a 
transport mechanism for this molecule. Recently, similar methodology has been adopted in a 
study that elegantly illustrated how pH changes can be used to manipulate the contribution of 
electroosmosis between O to 100% of the total iontophoretic transport (Lopez et al., 1999). 
These workers observed that the influence of electroosmosis on the transport of 5-fluorouracil 
(5-FU) could be dominant or absent depending on the experimental conditions. The flux rates 
of the peptides angiotensin (Clemessy et al., 1995) and desglycinamide arginine vasopressin 
(DGA VP) (Craane Van Hinsberg et al., 1994b) have also been shown to be significantly 
influenced by changes in electroosmosis. 
5.1.2 Theoretical Background 
5.1.2.1 Electroosmosis 
The Poisson-Boltzmann equation and equations of fluid motion can provide the theoretical 
basis of electroosmosis investigations (Sims et al., 1993, Peck et al., 1998). In the theoretical 
development described by Sims et al. (1993) these equations are considered in the presence of 
an electrical potential gradient. This equation gives a velocity profile of electroosmosis via the 
radial potential profile of a pore, \Jf(r). 
l d (dv) X 2neX . -- - = --p(r) =--smh{e\J'(r)/(kT)] 
r dr dr 17 17 
(5.1) 
where v is the solvent flow velocity, r is the distance from the charged surface of the pore, 
p(r) is the is the excess charge density, 17 is the coefficient of viscosity, X is the applied 
electrical field, n is the bulk concentration, e is the electronic charge, lJ,l(r) is the elect1ical 
potential at r, k is the Boltzmann constant, and T is the absolute temperature. This model 
predicts electroosmosis in terms of an idealised cylindrical pore. Once the electrical potential 
profile inside the pore is determined, the electroosmotic solvent velocity may be calculated. 
According to this model, increasing the electrical field strength (X) should result in increases 
in electroosmotic flow velocity. This may be particularly important for large solutes that are 

























5.1.2.2 Porosity changes 
A common observation in iontophoresis is that the permeability of the skin is altered during 
and after the application of moderate electrical fields. This phenomenon is consistent with 
pore formation in the membrane (electroporation) (Inada et al., 1994, Chizmadzhev et al., 
1998). Characterisation of these electrically-induced pathways has recently been performed 
using the hindered pore theory (Li et al., 1998). These researchers found that, in spite of , 
large increases in porosity, the new pathways were significantly smaller than the pre-existing 
pores (radii approx. 6-12A compared to around 20A). These small pathways are clearly of 
limited value in the delivery of peptide and protein molecules with molecular dimensions in 
the same order of magnitude as the pore. Consequently it would be interesting to know the 
influence of these small voltage induced pathways on electroosmotic flow. 
If significant electroosmosis occurs in the electrically-induced pores, it will be of limited 
value for large molecule permeability because they are significantly smaller than pre-existing 
pores. On the other hand, if electroosmosis occurs predominately through pre-existing pores, a 
greater proportion of electroosmotic flow may be available to facilitate large molecule 
transport. These voltage-induced pores may also have different charge characteristics 
compared with pre-existing pores. If voltage-induced pores have low surface charge densities 
(uncharged pores) then it is expected that increases in porosity will have little influence on 
electroosmosis (Figure 5 .1 ). However, if the voltage induced pores are negatively charged, 
electroosmosis may be augmented, and convective solvent flow will be in the same direction 
as the net electroosmotic flow in the pre-existing pores (into the skin). If the voltage-induced 


























Electrically induced pores (radius - 10 A): 
A= Neutral - no electroosmosis. 
B = Negatively charged favouring electroosmosis 
into the skin. 
C = Positively charged favouring electroosmosis in 
reverse direction. 
Pre-existing pore (radius - 20 A), 
negatively charged favouring 
electroosmosis into the skin 
Figure 5.1 Schematic diagram showing the possible influences of electrically induced 
pores on electroosmotic flow transport through the human skin at moderate voltages. 
Electrically induced pores are smaller the pre-existing pores and have an undetermined 
charge therefore they may influence transport in the indicated directions. 
5.1.3. Aims 
This study investigated the influence of voltage-induced pore creation on electroosmosis by 
measuring the flux of sucrose, an electroosmotic flow marker, during moderate voltage 
iontophoresis. These observations were viewed in the light of the porosity changes that occur 
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5.2 Experimental approach 
5.2.1 Materials 
14C-sucrose was obtained from NEN Research Products (Wilmington, DE.), and phosphate 
buffered saline pH 7.4 (PBS) from Sigma (St Louis, MO.). Silver electrode wire and all other 
chemicals (Sigma) were of at least reagent grade and used as supplied, unless indicated . 
Human skin was obtained from the International Institute for the Advancement of Medicine 
(IIAM) and stored frozen until required. Water was purified by a Milli-Q system (Millipore) 
which yielded a product of resistivity of 18.2 MQ cm. Iontophoretic voltages were applied 
across the skin using Scepter®, a computer controlled power supply device. A Fluke 
multimeter was also used to monitor accurately current flow during experiments. 
5.2.2 Permeation Studies 
The sucrose iontophoresis and passive permeability studies were performed using almost 
identical methods to those described in Chapter 4. Side-by-side diffusion cells with a 
diffusional surface area of -0.64 cm2, and a receptor volume of -3 ml were used. HEM 
samples were mounted between the cell compartments , which were subsequently filled with 
PBS pH 7.4. The samples were then allowed to fully hydrate overnight. The flux studies 
involved filling the donor compartments with the test solutions , which contained trace 
amounts of 14C-labeled sucrose. Prior to the iontophoresis flux stage, a passive flux 
determination was performed to allow enhancement ratios to be calculated for each individual 
HEM sample. This substantially reduced the intra-sample variability and maximised the 
quantity of data that could be obtained from each HEM sample. Constant voltage 
iontophoresis was perfo~ed at 0.3, 0.5, 1, 2, 3, and 4 V (n=3). During the permeation 
studies, at pre-determined time points, 1 ml samples were removed from the receptor phase 
and replaced with an equal volume of PBS. The samples were assayed for radioactivity for 
10 minutes in a liquid scintillation counter (Beckman LS5608) after mixing with 5 ml of 
liquid scintillation cocktail (UltimaFloM, Packard). 
Disintegrations per minute (DPM) obtained from analysis of the receptor sample solutions 
were converted to amounts of compound using the specific activity, dilution and sampling 
corrections. Plots of cumulative amount, Q, over time, t, were constructed and from these, 



























where A represents the diffusional area, and e is the concentration of permeant in the donor 
phase. The permeability coefficients were then used to calculate enhancement ratios for each 
HEM sample. The enhancement ratio is the permeability coefficient of sucrose resulting from 
the iontophoresis flux stage divided by the permeability coefficient resulting from the passive 
flux stage. 
E = flontophoresis 
Ppassive 
(5.3) 
HEM conductance values were measured throughout the iontophoretic experiments. The 
change in conductance, or E(R), represents the ratio of HEM conductance during 
iontophoresis, Giontophoresis, to the initial conductance of the membrane before the electrical 
field application, Ginitial· 
G. E(R) = 1ontophoresis 
Ginitial 
(5.4) 
A recent report by Li et al. (1998) described the incorporation of a porosity-tortuosity 
correction factor into calculations when iontophoresis results in membrane changes· These 
conductance changes have been found to be not entirely quantitative in the correction of 
membrane porosity (Li et al., 1998). In these experiments, conductance is primarily a measure 
of the ease of transport of the buffer ions (Na+ and en. Therefore the measured increases in 
conductance relate to the formation of new pores that facilitate small ion transport rather than 
the transport of all species. These conductance changes are useful in the prediction of porosity 
changes with sucrose transport because the molecular dimensions of sucrose are sufficiently 
close to those of Na+ and er ions. In effect this means that these solutes will be transported 




























5.3.1 Permeation Studies 
A representative plot of the cumulative amount of sucrose penneated into the receptor 
chamber during iontophoresis is shown in Figure 5.2. 
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Figure 5.2. Representative flux profile for sucrose iontophoresis (2V) 
Permeability coefficients for sucrose ranged from 2.1 x 1 o-8 cm/s under passive diffusion 
conditions to 348 x 10-8 cm/s during 4V iontophoresis (Table 5.1). For each HEM sample, 
two permeability coefficients were determined. A passive diffusion stage was followed by an 
iontophoresis stage allowing the two permeability coefficients obtained to be used in 
calculating individual enhancement ratios. The average enhancement ratios are plotted in 
Figures 5.3 and 5.4. 
The enhancement ratios for sucrose increased linearly at voltages below 1 V (Figure 5.3). 
However, as depicted in Figure 5.4, disproportionate (non-linear) increases in enhancement 
ratios were observed as the potential difference increased above 1 V. A quadratic equation is 
fitted to the data in Figure 5.4 as an illustration of the dramatic increase in the enhancement 
ratios of sucrose relative to the linear increase observed Figure 5 .3 (the fitted line is not meant 






















Table 5.1 Permeability coefficients of sucrose across HEM as a function of the electrical 
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Figure. 5.3 Sucrose Enhancement ratios across the HEM as a function of increasing 
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Figure 5.4 Sucrose Enhancement ratios across the HEM as a function of increasing 
voltage(> 1 V) (mean± SD, n = 4) 
5.3.2 Porosity changes 
A good estimate of the porosity changes that occur in the HEM during iontophoresis can be 
obtained by monitoring electrical conductance of the membrane. Increases in the conductance 
of the HEM were mirrored by increases observed in sucrose permeability enhancement 
(Figures 5.5 and 5.6). At 1 V, porosity increases were significantly higher than sucrose 
permeability enhancement (Figure 5.5). At all voltage levels (except 1 V) sucrose 
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increasing iontophoresis voltage strengths (V<l) (mean± SD, n = 4). 
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Figure 5.6 Sucrose enhancement ratios with accompanying porosity increases for 





















A number of neutral polar solutes, including sucrose, have been utilised in iontophoresis 
studies because they can indicate the nature of electroosmotic flow in a membrane (Pikal 
1992, Higuchi et al., 1999). This is because, being uncharged, these molecules are not 
affected by direct electrical field repulsive or attractive forces. Therefore the permeability of 
sucrose represents, in the absence of membrane permeability changes, the convective solvent 
flow during iontophoresis. However, as the electrical field strength increases, certain changes 
in the membrane occur (Inada et al., 1994, Chizmadzhev et al., 1998). A typical voltage-
current profile obtained for HEM samples was shown in Chapter 2 (Figure 2.7 and Figure 
2.8). Ohms law states the ratio of potential difference to current remains constant for a 
conductor provided the temperature remains the same. This is obeyed in the HEM at voltages 
less than 1 V. Above this potential difference, conduction occurs more easily and the current 
across the membrane increases non-linearly. This dramatic decrease in the resistance is related 
to the flow of conducting ions in the system and has been recently reported to be the result of 
electrically induced poration of the membrane (Chizrnadzhev et al., 1998). At these electrical 
field strengths, sucrose permeability enhancement will be due to two effects, electroosmosis 
and membrane permeability increases (porosity). 
In Figure 5.3 the linear increase in sucrose enhancement, and therefore electroosmosis, with 
increasing voltages below 1 V is consistent with the Poisson-Boltzmann model. The linear 
increase in current as voltage increased (Figure 5.5) is also expected in terms of Ohm's law, 
and indicates there were no significant increases in porosity. 
Conductance is a useful comparison for electroosmotic flow during iontophoresis studies. 
This is because conductance is determined by small ionic species that are insignificantly 
affected by convective flow due to their small mass to charge ratio. Therefore in Figure 5.6 
the large increases in conductance of the membrane at voltages greater than 1 V will be 
essentially independent of any electroosmotic flow increases. At these voltages, 
electroosmotic flow was markedly increased. The positive deviation of electroosmotic flow 
enhancement as voltages increased above 1 V could be due to either a). an increase m 
convective solvent flow velocity through existing pathways, or to b) an increase m 
electroosmosis resulting from an increase in the number of pathways present in the HEM, or 
to c ). a combination of these effects. The parallel nature of the electroosmosis and 















sucrose permeability as voltages increase above voltages greater than 1 V (Figure 5.4) is 
largely due to electrically induced pore formation. Thus, at higher electric fields, 
electroosmosis increases can be explained almost wholly by the porosity increases. Increases 
in solvent velocity, if it occurs, appear to play only a minor role in the non-linear 
enhancement of sucrose permeability. 
Another noteworthy observation was the difference of electroosmosis and conductance ratios 
at the 1 V level. 1 V appears to be the threshold electrical field strength at which electrically 
induced pores begin to appear (Chapter 2). Therefore a possible explanation for increases in 
porosity even though significantly smaller increases occur in electroosmosis, could be 
because the pores do not form completely (relative to higher voltages). It is possible that pores 
at this threshold are transient or smaller than sucrose dimensions and therefore prevent 
sucrose transport from being equivalent to conductance ion transport. However, no direct 
evidence for this exists and further investigations using smaller electroosmotic flow probes 
may elucidate this. 
It was also noted at all other voltage levels that sucrose permeability enhancement was greater 
than porosity increases in the HEM. This indicates that despite the significant increases in 
electroosmosis, due to electrically induced pores, solvent flow through pre-existing pores still 
occurs. 
It is not possible, from this study, to draw unequivocal conclusions regarding the surface 
charge nature of electrically-induced pores (as schematically proposed in Figure 5.1). Direct 
measurement of electroosmotic flow through individual pores has not been measured so only 
general inferences can be made. With this in mind, it appears from the combination of 
conductance measurements and sucrose enhancement that electrically induced pores provide 
substantial pathways for electroosmosis. Thus, it may be assumed that they are predominantly 
negatively charged. No observations suggest that significant neutral or positively charged 






















5.5 Chapter summary 
Increasing the voltage across the HEM results in increases in electroosmosis, as measured 
using sucrose permeability. Electroosmotic flow dramatically increases at voltages above 1 V. 
Simultaneously, the membrane conductance, indicating porosity, mirrors these increases. 
Because the positive deviation of electroosmosis at voltages above 1 V is directly proportional 
to porosity increases, it appears that there is significant electroosmotic flow through voltage 
induced pores. The effect of increased electrical field strength on solvent flow velocity was 
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6.1.1 Size limitations of iontophoresis 
The stratum comeum is widely recognised as a formidable barrier preventing the 
percutaneous penetration of exogenous substances. This difficulty in delivering substances 
across the barrier is particularly evident with transdermal peptides. The large size of these 
macromolecules, relative to the transport pathway dimensions, greatly limits the movement of 
such substances across the stratum comeum. Even when an external driving force is used 
such as in iontophoresis, peptide delivery is still low (Chapter 4). Iontophoresis uses an 
electric field across the skin barrier to drive drug delivery and increases compound 
permeability via several mechanisms including electrorepulsion (for charged molecules), 
electroosmotic flow (for charged and neutral molecules), and electrically induced changes in 
the stratum comeum structure. Iontophoresis has been shown to increase the rate of delivery 
of a multitude of compounds (Amsden and Goosen 1995). However, iontophoresis has 
limitations in the delivery of large molecules. As the size of the permeant molecule increases 
and approaches the "pore" size dimensions, transport of solutes, whether iontophoretic or 
passive, becomes insignificant (Deen 1987). Furthermore, it has recently been reported that 
iontophoretically induced pathways in the HEM are not expanded by increasing the electric 
field strength (Li et al., 1998). An apparent strategy that has the potential to circumvent these 
limitations is the incorporation of a chemical permeation enhancer into the iontophoretic 
delivery system. 
6.1.2 Synergy between iontophoresis and chemical enhancers 
An extensive review of the literature from 1989 to the present revealed only 26 reports on, 
iontophoresis in combination with some type of chemical enhancer system. A summary of 
these studies is outlined in Table 6.1. Several of these studies have demonstrated a synergistic 
permeability enhancement between iontophoresis and the chemical enhancer. We define 
synergy as the permeation enhancement of a drug resulting from iontophoresis and enhancer 
treatment together, Ecombination, which is greater than the permeability enhancements of the 
individual treatments when used separately, Erontophoresis and EPermeation enhancer• 
i.e. Ecombination > Erontophoresis + EPermeation enhancer 
In the studies where there was no synergy, the incorporation of the enhancer into the 





















an extent that is expected when the enhancement methods are used separately ( an additive 
effect). Therefore, synergy was considered the scenario where the enhancement methods co-
enhanced each other. Simplistically, observations of synergy indicate that the two 
enhancement methods have the same site of action in the stratum comeum. 
6.1.3 Mechanisms of Synergy 
Although the concept of combining iontophoresis and other enhancement strategies has been 
studied for at least ten years, investigations have been sporadic. Firstly, the site of action must 
be considered. Synergism is more likely to occur between iontophoresis and chemical 
enhancers if they share the same site of action. The pathway of iontophoretic transport has not 
yet been fully elucidated (Banga et al., 1999). Visualisation studies have suggested the 
primary route through the stratum comeum is located in or near the skin appendages 
(Cullander and Guy 1991, Cullander 1992, Monteiro-Riviere et al., 1994) while other 
biophysical investigations indicate that ion and water transport occurs, at least in part, through 
the polar region of the intercellular lipid lamellae (Prausnitz et al 1996a, Lee et al., 1996, 
Menon and Elias 1997, Turner and Guy 1997). Therefore those enhancers that exert an effect 










Table 6.1. Iontophoresis and permeation enhancers: Overview of studies performed 
Electrical Field 
Drug Enhancer Skin Type 
(mNcm2) 
Synergya Reference 
Insulin EtOH FTH 0.125-0.5V Possible Srinivasan et al.1989 
leuprolide /CCK-8 EtOH FTH 0.5V Yes Srinivasan et al. l 990b 
AZT DMSO HRS/FTH 0.1 /IV No Wearly et al.1990 
piroxicam OA, EtOH HMS 0.07- 0.5 Yes Gay et al.1992 
Sotalol, salicylate DDAA, Azone. HEM, snake 0.5V No Hirvonen et al.1993 
TEA- multi-component In vivo HMS 122 Yes Su et al. 1993 
CQA 206-291 EtOH HGPS 0.3 Possible Hager et al.1993 
Acyclovir cetrimide or SLS HMS Possible Lashmar & Manger I 994 
metoprolol Azone HEM 0.53 Yes Ganga et al. 1996 
XRD SLS and HDTMAB HEM 0.17. Possible Chesnoy, Set al.1996 
Impedance Azone®IPG, SLS, OA, In vivo human 0.1. Possible Kalia and Guy 1997 
spectroscopy stearic / linoleic acids 
Na Nonivamide BAC, CPC, SLS, IPM Rat 0.3 - 0.5 No Fang et al.1997 
Acetate 
LHRH EtOH, 10% OA/EtOH, Porcine Yes Bhatia et al. 1997b 
10%0AIPG 
CCK-8 EtOH, I 0% OA / EtOH Porcine Yes Bhatia et al.1997a 
LHRH DMAC and 2-P Porcine Yes Bhatia and Singh 1997 
LHRH EtOH ± 10% fatty acids Porcine 0.2 Yes Bhatia and Singh 1998 
cyclosporin A EtOH pulsed No Wang et al.1998 
Urea, sucrose SDS,DTMAB HEM 0.25 V Yes Peck et al.1998 
AZT OAIPG HMS Yes Oh et al.1998 
LHRH 5% linolenic acid or HEM 0.2 Yes Bhatia and Singh 1999 
limonene in EtOH 
Insulin, TEWL Possible Choi et al.1999 
Insulin (bovine 10% OA, 1 % menthol in Rat 0.44 Possible Kanikkannan et al.1999 
and human). EtOH, Depilatmy er. 
Enoxacin liposome encapsulation Rat Possible Fang et al.1998 
TEWLandEM OAIPG HMS 500 pulsed Possible Jiang et al.2000 
mannitol lipids (EPC, DSPC, SA) HEM 0.53 Possible Kirajavainen et al.2000 
"Synergy definitions: Yes - synergy between Iontophoresis and enhancers that is greater than the individual enhancement ratios of the 
Iontophoresis and enhancer added together, No - retardation of permeability, no augmentation of permeability, or simple additive effect of 
individual enhancement values, Possible - suggestion of synergy although not confirmed, mechanism defined that outlines possible 
synergism. 
Abbreviations: 2-P (2-pynolidone), AZT (azidothymidine), BAC (benzalkonium chloride, CCK-8 (cholecystokinin-8), CPC (cetyl 
pyridinium chloride), CQA 206-291 (dopamine agonist), DDAA n,n-dimethylaminoacetate), DMAC (dimethylacetamide), DSPC 
(distearoylphosphatidylcholine), DTMAB (dodecyltrimethylammonium bromide), EM (electron microscopy), EPC (L-a-
phosphatidylcholine, egg lecithin), EtOH (ethanol), HDTMAB (hexadecyl trimethylammonium bromide), HEM (human epidermal 
membrane), HGPS (hairless guinea pig skin), HMS (hairless mouse skin), HPC (hydroxypropylcellulose), HRS (hairless rat skin), IPM 
(isopropyl myristate), LHRH (luteinizing hormone releasing hormone), OA (oleic acid), PG (propylene glycol), PVP (polyvinylpyrrolidone), 
SA (stearylamine), SDS (sodium dodecyl sulfate), SLS (sodium lauryl sulfate), TEA- (tetraethylammonium ion), TEWL (transepidermal 


















On a molecular level, synergistic enhancement may be due to several mechanisms. A number 
of investigations have shown the importance of surface charge and iontophoresis (Peck et al., 
1998, Delgado-Charro and Guy 1994, Delgado-Charro et al., 1995). In these studies 
modifications to surface charge were related to changes in iontophoretic permeability due to 
increases or decreases in electroosmosis. Peck et al., (1998) used surfactants sodium dodecyl 
sulfate (SDS) and dodecyltrimethylammonium bromide (DT AB) to alter skin surface charges. 
The anionic surfactant (SDS) increased the net negative charge on the skin pore wall, thus 
enhancing the iontophoretic flux of sucrose and urea due to increased convective solvent 
flow. The cationic surfactant on the other hand reduced the net negative charge and retarded 
the iontophoretic flux of sucrose and urea. Fang et al. (1997) also used surfactants in 
combination with iontophoresis in rat skin. Iontophoresis following SDS treatment was found 
to result in lowered iontophoretic permeability of an anionic solute (sodium nonivamide 
acetate). However cationic surfactants (benzalkonium chloride and cetylpyridinium chloride) 
resulted in moderate increases in iontophoretic permeability. The mechanism was considered 
to be structural ( effects on tight junctions and water permeability) rather than charge related. 
SDS was thought to increase the hindrance to transport by restricting solute entry into the 
pores of the skin. Recently Kalia and Guy (1997) investigated the effect of SDS on the 
electrical properties of the skin. Skin impedance measurements indicated SDS significantly 
increased current passage through the skin. The reduction in skin resistance was considered to 
be due to structural reorganisation of the lipid matrix of the stratum comeum. Lipid disorder 
may increase ion transport via interactions located in the appendageal structures (the pathway 
considered of greatest importance in iontophoresis) or via the creation of transient transport 
pathways (Kalia and Guy 1997). 
Hager et al. reported that ethanol has an indirect synergistic effect on the delivery of a 
dopamine agonist (CQA 206-291). It was suggested that ethanol increases the drug solubility 
and therefore increases the conductivity of the donor solution. An increased conductivity 
corresponds to increased drug flux. 
Hirvonen et al. (1993) found no synergistic increase in transport of sotalol (cationic) or 
salicylate (anionic) when Azone or n,n-dimethyl amino acetate (DDAA) are combined with 
iontophoresis. They suggested that disordering of lipids in the stratum comeum, caused by the 
enhancers, may have closed the pathways of iontophoresis. These observations were 
consistent with the findings of impedance spectroscopy work performed by Kontturi et al. 
(1993) who demonstrated an increase in skin resistance following enhancer application to the 
















the aqueous pathways. In the case of Azone this may be due to an isolating layer on the skin 
surface (Kontturi et al., 1993). Kontturi et al. (1993) have proposed that the enhancers open 
new channels in the lipid matrix ( as determined by fractal dimension measurements) that are 
too small for ionic transport. Ganga et al. (1996) also used Azone and iontophoresis. In 
contrast to the findings of Kontturi et al. (1993), metoprolol tartrate (cationic) was 
synergistically increased by the concurrent use of Azone and iontophoresis. Both studies used 
human skin but the enhancer application method was different. The fo1mer study pre-treated 
the epidermis with Azone for three hours while the later study incorporated the enhancer into 
the donor compartment (5% w/v). The electrical field used by Ganga et al. (1996) was also 
significantly higher than that used by Kontturi et al. (1993). The experimental conditions, 
such as enhancer treatment and electrical field strength, in addition to the nature of the drug, 
appear to influence the likelihood of synergy. 
The influence of iontophoresis in combination with enhancers has also been investigated 
using peptide molecules (Srinivasan et al., 1989, 1990b, Bhatia et al., 1997a, 1997b, Bhatia 
and Singh 1997, 1998, 1999). Insulin was delivered across hairless mouse skin using 
iontophoresis after treatment of the membrane with ethanol (Srinivasan et al., 1989). Without 
ethanol pre-treatment no insulin flux was detectable. Leuprolide and a cholecystokinin-8 
(CCK-8) analogue were also enhanced by ethanol in combination with iontophoresis. Like 
insulin, these peptides had no measurable flux prior to pre-treatment with ethanol. Bhatia et 
al. (1997a) investigated CCK-8. Synergistic effects were observed when using ethanol and 
oleic acid in ethanol in combination with iontophoresis. The enhancement of transdermal 
permeation, using iontophoresis and an enhancer, was essentially the product of the individual 
treatment enhancement ratios, indicating the effect was much greater than additive between 
the techniques. 2-pyrrolidone (2P) and dimethylacetamide (DMAC) also co-enhanced 
iontophoresis of the peptide LHRH in combination with iontophoresis (Bhatia and Singh 
1997). The enhancement of the combination was less than the product of the individual 
techniques but still significantly greater than the sum. Fatty acids have been extensively 
investigated in combination with iontophoresis for LHRH permeability across porcine skin 
(Bhatia et al., 1997b, Bhatia and Singh 1998). Synergy between the chemical enhancers and 
iontophoresis was observed alongside increases in lipid fluidity of the stratum comeum as 
indicated by FTIR spectroscopy (Bhatia et al., 1997b). This led the authors to propose that the 
fluidisation of the stratum comeum lipids was structurally related to the synergistic behaviour. 
The structure of the fatty acid enhancer molecule was also observed to have some influence 



















were more effective than saturated fatty acids. These authors have recently reported the effect 
of linolenic acid/ethanol and limonene/ethanol enhancers on LHRH transport through human 
epidermis (Bhatia and Singh 1999). Linoleic acid in ethanol showed substantial synergy with 
iontophoresis when compared to the individual enhancements of iontophoresis and enhancer 
individually. Transition electron microscopy indicated that combining the enhancers with 
iontophoresis disrupts the stratum comeum into a loose network of disordered keratin and 
swollen stratum comeum cell layers. The authors suggest that the decreased diffusional 
resistance was related to an increased free volume within the stratum comeum as a result of 
















Figure 6.1 Schematic diagram of the basis for synergy between iontophoresis and the 






















In summary, there appears to be at least three models for the mechanisms that may influence 
synergy between iontophoresis and chemical permeation enhancers. These are summarised in 
Table 6.1. Synergy appears to be related to the solute structure, type of skin, method of 
enhancer application, type of enhancer, electrical field strength, and possibly. a number of 
other experimental conditions. 
Table 6.2 Proposed mechanisms of synergy between iontophoresis and chemical 
permeation enhancers. 
Mechanism 
Pathway and/or pore related 
Charge and/or surface related 
Solubility and/or conductivity related 
6.1.4 Oleic acid as a model enhancer 
Effect 
Permeation enhancer assists iontophoresis by increasing 
the free volume of the aqueous pores, creation of new 
pathways, increasing size of existing pores. Enhancers 
may also retard permeability by occluding the pore, 
disrupting pore structure, or increasing the viscosity in the 
pore. 
Permeation enhancers may increase iontophoretic transport 
via an effect on the skin surface charge, promoting 
electroosmosis, or by decreasing reflection from pore 
opening by like-charge repulsion. Neutralisation of charge, 
or adsorption of charged species to the pore wall may also 
decrease electroosmotic-regulated permeability. 
Permeation enhancer may increase the solubility of solute 
ions increasing the fraction of Clment the drug carries . 
Also enhancers may decrease transport by contributing 
ions into the system that compete with drug ions. 
The role of fatty acids as chemical enhancers has been well studied. In particular, oleic acid 
has been shown to decrease the phase transition temperatures of skin lipids resulting in an 
increase in motional freedom of these structures (Francoeur et al., 1990, Ongpipattanakul et 
al., 1991). Therefore it is conceivable that an increase in the fluidity of this region may result 
in an expansion of the aqueous pathway and therefore an increase in the pore size of the 
iontophoretic transport pathway. The effect of pore size increases are likely to increase the 
permeability of all species that are restricted by the pore dimension, particularly large 
molecules such as peptides. Pore size modifications can be predicted using the hindered pore 











transport through porous membranes because apparent diffusion coefficients are frequently 
much less than those observed in bulk solution. The interaction between the pore wall and the 
solute are responsible for the reduction of the apparent diffusion coefficient and can be taken 
into account by incorporating so-called hindrance factors into transport models (Deen 1987, 
Li et al., 1998, Higuchi et al., 1999). 
6.1.5 Aims 
The purpose of this research was to investigate the effect of permeation enhancer pre-
treatment on the iontophoresis of LHRH, a model peptide with dimensions similar to that of 
the "pores" of the stratum comeum. These investigations were also performed using a small 
ionic solute for comparison with LHRH data. The effect of enhancer pre-treatment on 
electroosmosis was also determined, because it is considered to have a major effect on 
permeation enhancement of large molecules during iontophoresis (Chapter 5). In addition to 
permeation experiments, thermal analysis ( differential scanning calorimetry) and 
spectroscopic studies (infrared spectroscopy) were used to characterise the effects of 
iontophoresis and permeation enhancers on the stratum comeum. These investigations 
enabled observations of the structural changes that occur in the stratum comeum to be related 














6.2 Experimental Approach 
6.2.1 Materials 
Radiolabeled [3H]LHRH (specific activity 51 Ci/mmol), [14C]tetraethylammonium bromide 
(TEAB), and [14C]sucrose were obtained from New England Nuclear (Boston, MA). 
Phosphate Buffered Saline (PBS) (pH 7.4), oleic acid (OA) and propylene glycol (PG) were 
obtained from Sigma. All other chemicals were reagent grade. Deionized water (resistivity > 
18 MQ) was used to prepare all solutions. 
6.2.2 Preparation of Epidermis 
HEM samples were prepared from full thickness female abdominal, breast, or lower back skin 
as described in Chapter 2 . 
6.2.3 In vitro HEM studies 
The general procedure for performing in vitro permeability experiments has been described in 
Chapters 4 and 5. After overnight hydration, the sheets of HEM were mounted between the 
two side-by-side diffusion half-cells, stratum comeum side facing the donor compartment. 
The diffusion cells were firmly clamped leaving an exposed area for diffusion of 0.64 cm2. 
The compartment volumes (3 ml) were maintained at a constant temperature (water bath 
thermostat set at 37°C) and stirred using small Teflon coated magnetic bars. During the course 
of all experiments, including those without iontophoretic currents, electrical conductance 
measurements of the membranes were monitored. All permeability measurements were 
performed in O.lM PBS solutions at pH 7.4. The protocol for the permeability experiments 
involved two stages (Figure 6.2). Stage 1 was a passive flux determination to establish a 
baseline permeability of the radiolabeled solutes. Following a wash out period, stage 2 was 
performed. This was to determine the permeation enhancer related flux, the iontophoretic 
flux, or the permeation enhancer in combination with iontophoresis flux. Control samples 
were also incorporated into the design to ensure no permeability changes occurred between 
stages 1 and 2. Iontophoresis treatments involved applying a constant voltage across the 
membrane (2V) using Scepter© a computer controlled power supply. Constant voltage 
iontophoresis allows easy application of the Nemst-Planck equation that describes 
electrochemical transport phenomena. The chemical enhancer effects were investigated by 

















compartment for a 2-hour period. Regular sampling from the receptor allowed the calculation 
of flux for each permeant after sample analysis. Samples were mixed thoroughly with 5 ml of 
liquid scintillation fluid (Ultima Flo M™, Packard, Meriden, CT) and analysed in a Beckman 
LS5801 scintillation counter for 10 minutes. The sensitivity of liquid scintillation counting 
was such that the radiolabeled permeants were only needed in trace amounts in the donor 
solution, ensuring that there were no osmotic pressure contributions and minimising the 
likelihood of solute-solute interactions. 
Stage I. Flux Enhancer Stage II. Flux Treatment Group 
Determination Treatment Stage Determination (n ~ 5 for each group) 
Passive Flux I > Enhancer 
~ Enhancer 
Pre-treatment~ Iontophoresis :>Enhancer plus 
I 
~ Flux Iontophoresis 
Passive Flux 
~ 
No Enhancer Pr~ 
Passive Flux I > Passive 
treatment ~ Iontophoresis I :>1ontophoresis 
Flux 
Figure 6.2. Outline of experimental protocol for in vitro permeation experiments to 
generate groups for each treatment combination. Each HEM sample had two flux 
determinations performed allowing individual enhancement ratios to be calculated for 
each membrane. This facilitated direct comparisons between treatment groups, 
decreased variability, and allowed greater amotmts of data to be generated for each 
membra.rie. 
6.2.4 Data analysis 
The analysis of DPM counts of the samples obtained from the permeability experiments was 
performed as described in Chapter 4. Permeability coefficients were calculated and used to 
calculate enhancement ratios for each treatment group. Enhancement ratios were calculated 





















enhancer pre-treatment, iontophoresis, or combination of pre-treatment and iontophoresis) by 
the permeability observed during passive conditions: 
E = ?Treatment 
?Passive 
6.2.5 Electrical investigations 
(6.1) 
The conductance changes in the HEM samples during enhancer and iontophoresis treatment 
were monitored throughout the experimental procedure as outlined in Figure 6.2. The 
electrical conductance and resistance measurements were made using a highly sensitive 
multimeter connected in series with the power supply and the side-by-side diffusion cells 
(Fluke, Everett, Washington, USA). These measurements provide information on the porosity 
of the membrane as detailed in Chapters 2 and 4. 
6.2.6 Effect of chemical enhancer on partitioning of solutes 
The effect of the chemical enhancer OA/PG on the octanol and water partition coefficient was 
determined, using the procedure described in Chapter 3. In this partition coefficient 
determination 5% oleic acid was added to the octanol phase. The effect of propylene glycol 
on partitioning was also investigated by placing propylene glycol and oleic acid/propylene 
glycol in the octanol-water system (also 5% w/w concentrations). One percent solutions of 
LHRH, TEAB, and sucrose in water containing 0.2 µCi of 3H-, or 14C-labeled drug were 
separately equilibrated with an equal volume of the organic phase on a shaking water bath at 
3 7 °C for 16-18 hours. Aliquots were removed from each phase and measured using liquid 
scintillation counting after the addition of a scintillation cocktail. The ratio of solute 
concentration in the organic and the aqueous phase were used in the calculation of the 
apparent partition coefficient. 
6.2. 7 Physical Investigations 
6.2.7.1 Skin preparations for DSC and IR spectroscopy 
Human epidermal membrane was separated from full thickness human skin as described in 
Chapter 2. The sheets of HEM were incubated at room temperature for 1 to 2 hours, 
epidermal side down, on filter paper soaked in 0.2 % (w/v) trypsin in PBS at pH 7.4 (Chesney 
et al., 1999). The epidermis was then removed by placing under a stream of distilled water. 



















The IR experiments and treatment of epidermis with enhancer were performed on stratum 
comeum samples derived from the same donor and donor sites so that direct comparisons of 
enhancer effect could be made. The dry weight of the stratum comeum was obtained before 
hydrating to between 15 to 40 % with water. 
6.2.7.2 Differential scanning calorimetry (DSC) 
The investigations focused on the effects of enhancer pre-treatment and iontophoresis on the 
lipid phase transitions. DSC studies on human stratum comeum were performed using either a 
Perkin Elmer DSC7 or Perkin Elmer Pyris (Perkin Elmer Instruments, Norwalk, Connecticut). 
All samples were hermetically sealed in aluminium sample pans to prevent fluctuations of the 
level of hydration of the membrane. A heating rate of 10°C / min was selected so that 
endothermic peak resolution and temperature lag effects were optimised (Cornwell et al 
1996). The heating range was generally between 20°C and 140°C. The DSC was calibrated 
with an indium reference and Milli-Q water. Baseline measurements were obtained then the 
stratum comeum samples were analysed. The sample pan was placed in the sample holder and 
measured against an empty sample pan in the reference cell. The normal sample size chosen 
for stratum comeum samples was around 10 to 20mg (Leopold & Lippold 1994, Golden et al 
1987a, 1986, Gay et al 1994). These samples were hydrated to levels between 4% and 70%. 
In preliminary studies it was found that when the water content of the stratum comeum was 
between 30% to 40 % (percentage dry weight) the four transitions were consistently observed. 
All subsequent determinations were performed at this hydration level. Lipid phase transitions 
temperatures have been found to be constant above this water content by other authors (Potts 
1989). The specific hydration levels were well controlled to ensure reproducibility of thermal 
events. Hydration was typically attained by obtaining the dry weight of the stratum comeum 
membrane after storage over desiccant, followed by hydration in a saturated copper sulfate 
solution hydration chamber until the membrane weight increased to the desired levels. The 
transition midpoint was considered to be the transition temperature measurement. 
The enhancer to be investigated in this study was 5% oleic acid in propylene glycol. Tissue 
samples were treated with the enhancer solutions by soaking for 2 hours. The samples were 
pre-hydrated before treatment. After treatment the stratum comeum samples were removed, 
and briefly rinsed with cold acetone (to remove excess enhancer). The samples were then 




















6.2.7.3 Fourier transform infrared spectroscopy 
The main effects that were studied were pre-treatment with enhancer, enhancer effect over 
time, and the effect of iontophoresis on the IR absorption spectra of enhancer pre-treated 
human stratum comeum. The effects enhancer pre-treatment was studied using transmission 
FTIR, attenuated total reflectance FTIR (ATR-FTIR) and diffuse reflectance FTIR. The effect 
of iontophoresis was studied in situ, using ATR-FTIR. Additionally the enhancer effect was 
followed over a period of time after initial application of the chemical to the stratum comeum 
surface using ATR-FTIR. Infrared spectra were obtained on a Biorad FTS-175C FT-IR 
(Fourier Transform Infrared) spectrophotometer (Biorad, Cambridge MA, USA), interfaced 
with a PC equipped with Biorad WIN-IR 3.04 software. All spectra were obtained in the 
frequency range 4000 - 800 cm-1. Each sample was scanned 16 times and collected at a 
resolution of 4 cm-1• Peak positions were determined using Biorad WIN-IR 3.04. In general 
peak height could not be used quantitatively because sample volume and total contact area 
(for ATR) were not accurately obtained. 
6.2.7.3.1 Transmission IR 
Simple transmission FTIR was performed after mounting the stratum comeum membranes in 
the instrument sample holder. The stratum comeum membranes were positioned across the 
incident beam, pulled straight, and secured using a magnetic holder. This technique was used 
to support the data obtained from Attenuated total reflectance FTIR that was used to 
investigate possible changes due to iontophoresis in situ. 
6.2.7.3.2 Attenuated total reflectance 
Attenuated total reflectance FTIR (ATR-FTIR) spectra were also obtained using a Horizontal-
ATR accessory (Pike Technologies, Madison, WI, USA). Two internal reflection elements 
(IRE) were used, one for use ofliquid samples and the other for membranes. Both IRE's were 
made of ZnSe (80 mm x 10 mm x 4 mm, trapezoid shape, angle of incidence 45 degrees) and 
had a total number of 10 reflections of the incident beam. The samples of HEM membrane 
were mounted onto the ATR accessory, stratum comeum side down, and positioned so that a 
uniform and good contact between the IRE and stratum comeum was maintained. In 
experiments where the stratum comeum was treated with enhancer after mounting on the 
crystal, the liquid sample accessory IRE was used. At pre-selected time points spectra were 





















using an electrical field in situ the stratum corneum was arranged on the ATR accessory as 
shown in Figure 6.3. 
Electrode 
Electrode 
Internal Reflectance Element 
Figure 6.3. Schematic diagram of the ATR-FTIR set-up that was arranged to measure, in 
situ, the effect of electrical fields on the spectra of the stratum corneum. 
6.2.7.3.3 Diffuse reflectance FTIR 
The other technique used was diffuse reflectance IR spectroscopy. Sectioned stratum corneum 
samples were placed in a sample cup containing KBr powder and placed in the diffuse 
reflectance accessory (EasiDiff, Pike Technologies, Madison, WI, USA). The spectra 

























6.3.1 In vitro HEM flux studies 
Enhancement ratios for each HEM sample, solute, and treatment group are summarized in 
Table 6.3. LHRH permeability was increased by enhancer pretreatment (a 3.5 fold increase 
over passive permeability), iontophoresis (over 14 fold), and also by the combination of the 
two together (29 times). Thus when the two treatments were used together they synergistically 
caused the permeability coefficient ofLHRH to increase. 
Table 6.3 Solute permeation enhancement ratios from HEM flux studies combining 







HEM sample# LHRH TEAB sucrose 
1 0.5 0.5 1.3 
2 0.5 1 1 
3 2.1 2.4 1 
·-"------·----·-·--·"-·---·---"--·-·----.. ·-·-·-·-·--------·-.. -·-·---·"""'"'"'"""""""'""-""'-'""'""-'"'"" .. "" .... _, __ ,, ___ , .. .. .. ,.... .. 
rnean 
SD 0.9 1 0.2 
1 3.1 15 2.1 
2 3 9.5 1.3 
3 3.1 16.2 1.8 
4 4.6 18.7 1.6 
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permeability investigations of LHRH through HEM under different treatment 
conditions. (Passive = passive permeability, E = passive permeability through 
enhancer pretreated HEM, I = iontophoresis permeability, I+E = Iontophoresis 









Passive I E I I l+E 




1.3 I 14.9 1442 1346 
I 
Figure 6.5. Summary of the mean enhancement ratios (n ~ 3) obtained from 2-stage 
















TEAB had much greater permeability enhancement with iontophoresis than that observed 
with LHRH (enhancement ratio was greater than 1400) (Figures 6.4 and 6.5). However, for 
TEAB, when enhancer pretreatment was used in combination with iontophoresis no further 
increases were detected. A 15 fold increase in passive permeability is observed due to 













sucrose E ratios I 1.1 I 1.7 45.6 29.5 
-·-·---
Figure 6.6. Summary of the mean enhancement ratios (n ~ 3) obtained from 2-stage 
permeability investigations of sucrose through HEM under different treatment 
conditions. 
Pretreating the HEM with enhancer reduced the permeability of sucrose during iontophoresis 
(around 30 fold enhancement with combination of chemical enhancer and iontophoresis 
versus around 45 fold enhancement with iontophoresis alone) (Figure 6.6). However, due to 
variability this difference was not statistically significant. Decreased sucrose iontophoresis 
indicates a decrease in electroosmotic flow following the addition of OA/PG to the system. 
6.3.2 Effect of permation enhancer and iontophoresis on skin conductance 
The conductance ratio is a measure of the extent by which the electrical conductance of the 
HEM is increased due to treatment with the enhancer, iontophoresis, or both. Figure shows 
enhancer treatment resulted in a substantial increase in HEM conductance (12.5 times initial 
conductance). Iontophoresis also induced conductance increases (18.8 fold increase). The 
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Figure 6.7. Summary of the mean conductance enhan~ement ratios (n 2:: 6) obtained from 
2-stage permeability investigations of LHRH and TEAB through HEM under different 
treatment conditions. 
Table 6.4 Overall conductance increases observed during permeation experiments 
Passive Enhancer 
( GTreatmen/Ginitiai) 1.1 ± 0.1 12.5 ±4.0 
lontophoresis 
18.8 ± 8.3 
Enhancer plus 
Iontophoresis 
36.1 ± 13.3 
6.4.2 Effect of permeation enhancers on the partition coefficent of solutes 
The addition of oleic acid and propylene glycol to the octanol water system had no significant 
effect on the distribution of LHRH or TEAB into the octanol phase from the water phase. 
6.4.3 Differential scanning calorimetry 
A typical thermogram obtained from the DSC of human stratum comeum samples is shown in 
Figure. The four transitions of interest are found at around 40°C (Tl), 75°C (T2), 85°C (T3), 
and 100°C (T4). Table 6.5 summarises the effect of enhancer treatment on these transitions 
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Figure 6.8.. Typical DSC thermograms of human stratum corneum heated from 25 °C to 
100°C at 10°C / minute. Stratum comeum samples were hydrated to 40% water content 
(w/w) and placed in sealed sample pans so that the sample size was approximately 5 mg. 
Four transition temperatures were typically identified, Tl at around 40°C, T2 at 70°C, T3 
at 85°C, and T4 at around 95 to 100°C. The lower trace is an example of a oleic acid 
treated stratum comeum. 
Table 6.5. Temperatures of identified transitions occurring in untreated and treated human 
stratum comeum during DSC . 
n Tl T2 T3 T4 
Untreated stratum 5 40.2 ± 1.6 70.2 ± 1.0 83.2 ± 2.8 97.4 ± 2.6 
corneum 
Treated stratum 5 39.6 ± 1.1 64.7 ± 1.1 84.9 ± 1.1 100.3 ± 3.9 
comeum 
Treated plus 5 40.1±1.8 63.8 ± 2.1 83.7 ± 1.9 98.7 ± 2.6 
Iontophoresis 
Statistical analysis of these transition temperatures (Student's t-test, P<0.05) indicated that the 


















not result in anyother shift in other transition temperatures. In addition iontophoresis had no 
additional effect on the shift of transition temperatures. 
6.3.5 FTIR spectroscopy 
Typical FTIR spectra from transmitance and ATR-FTIR are shown in Figures 6.10a and b 
respectively. Strong absorbances due to amide groups (1500-1700 cm-1) and water (3000-
3600 cm-1) are common for biological samples. The absorbance regions of interest in this 
study were the peaks representing C-H symmetrical stretching (2850 cm-1) and the 
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Figure 6.9 a & b. Typical examples of a transmitance FTIR spectrum (upper trace) and 
ATR-FTIR spectrum (lower trace) of human stratum corneum (water content 70% 




























6.3.5.1 Transmitance spectra 
Overall, the variability of absorbance readings was low. The absorbance peaks were very 
reproducible in control samples (without treatment) (Figure 6.10). Treatment of the stratum 
corneum with OA/PG enhancer shifted the absorbance peaks to a higher frequency. This shift 
was significant after the 2 hour treatment period (Figure 6.11). 
Table 6.6. Changes in frequency of symmetric and asymmetric C-H stretching vibration 
relating to enhancer treatment, hydration, and iontophoresis as detected by FTIR 
spectroscopy 

















2940 2s·20 29'00 
Asymmetric stretching 
(- 2920 cm·') 
2917.77 ± 0.04 




(- 2850 cm·') 
2850.01 ± 0.07 
2851.62 ± 0.66 
2840 28·20 
Figure 6.10. FTIR spectra of human stratum corneum in the C-H stretching region between 
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Figure 6.11. FTIR spectra of human stratum comeum in the C-H stretching region 
untreated stratum comeum (a and b), and stratum comeum samples after 2 hours 
treatment with OA/PG (c and d), 70% water content (w/w). 
6.3.5.2 ATR-FTIR 
Enhancer treatment shifted the C-H stretching peaks to higher frequencies (illustrated m 
Figure 6.12). Table 6.5 summarizes the ATR-FTIR investigations. 
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Figure 6.12. Examples of ATR-FTIR spectra of human stratum comeum in the C-H 




























Table 6.7. Changes in frequency of symmetric and asymmetric C-H stretching vibration 
relating to enhancer treatment, hydration, and iontophoresis as detected by ATR-FTIR 
spectroscopy 







Treated (20 min) 
Untreated 
Treated (2 h) 
Untreated 
Treated (12 h) 
Untreated 
Iontophoresis (0.1 mA, 1 h) 
Untreated 
Treated (12 h) 
Treated plus Iontophoresis (0.02 mA, 1 h) 
Untreated 
Treated (12 h) 
Treated plus Iontophoresis (0.1 mA, 1 h) 
Asymmetric Symmetric 
stretching stretching 
(- 2920 cm-1t (- 2850 cm-1? 
2917.07 ± 0.00 2849.55 ± 0.01 
2918.87 ± 0.26 2851.30 ± 0.37 
2917.56 ± 0.01 2850.16 ± 0.01 
2918.39 ± 0.82 2850.76 ± 0.28 
2917.09 ± 0.03 2849.56 ± 0.01 
2920.39 ± 0.88 2851.95 ± 0.57 
2917.56 ± 0.01 2850.06 ± O.ol 
2917.87 ± 0.05 2850.16 ± 0.04 
2919.09 ± 0.32 2851.37 ± 0.26 
2923.87 ± 0.06 2854.18 ± 0.01 
2923.99 ± 0.15 2854.19 ± 0.01 
2919.49 ± 0.10 2851.06 ± 0.06 
2924.38 ± 0.04 2854.26 ± 0.01 
2924.50 ± 0.17 2854.29 ± 0.00 
"Sheets of stratum comeum werei>repared individually from same donor epidermis, each separate membrane 
was used to generate data for untreated, treated, and iontophoresis experiments (where applicable). This 
minimized variation within experiments and allowed each membrane to act as its own control (reducing day to 
day temperature variations) . 
~easured using Win-IR software, mean± SD, n ~ 3. 
Experiments one to three showed the duration of enhancer treatment influences the shift of the 
C-H stretch absorbances. The absorbance peak means after enhancer treatment were 
compared to control means using the Student's t-test. The level of significance was taken as 
P<0.05. Significant differences were found in all these experiments (1-3) when the treatment 
means were compared to the control (untreated) means. The largest difference between 
absorbance peaks was observed after the stratum comeum had been treated for 12 h. 
Iontophoresis experiments were also performed. Experiment 4 compared the IR absorption 
prior to iontophoresis to that observed during and after iontophoresis. No significant 
difference was found between control stratum comeum membranes and those treated with 



























(different electrical field strengths) no difference was detected in the absorbance frequencies 
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Figure 6.13 ATR-FTIR spectra of human stratum comeum in the C-H stretching region 
during iontophoresis in situ. From lower trace to upper trace: prior to iontophoresis, 
after 10 minutes iontophoresis, 30 minutes iontophoresis, and 60 minutes 
iontophoresis (0.1 mA). 
6.3.5.3 Diffuse reflectance FTIR 
The absorbance changes resulting from enhancer treatment of the stratum comeum, as 
analysed using diffuse reflectance FTIR, are summarised in Table 6.8. The variability of 
absorbance peaks was much higher using this technique relative to ATR and transmission 
spectra. Despite this variability, significant differences were detected for asymmetric 
stretching peaks. The symmetric stretching peaks at 2850 cm-1 were not significantly 
different. Of note was the appearance of peaks at 2860 cm-1, following treatment with 
enhancer. Typical diffuse reflectance spectra of the stratum comeum are shown in Figure 
6.14. The symmetric C-H stretch absorbance prior to enhancer treatment is illustrated in 






















Table 6.8. Changes in :frequency of symmetric and asymmetric C-H stretching vibration 
and appearance of additional absorbance band relating to permeation enhancer 
treatment as detected by diffuse reflectance-FTIR spectroscopy 
Stratum corneum Asymmetric stretching Symmetric stretching 
conditionsa (- 2920 cm-'l (- 2850 cm-') 
Untreated 2930.98 ± 6.12 2853.38 ± 1.83 
Treated-2 h 2938.08 ± 3.54 2855.34 ± 3.52 
• Stratum comeum prepared to approximately 70% water content (w/w). 
b Measured using Win-IR software, mean± SD, n = 11. 
Symmetric stretching 2c 
(- 2860 cm-1) 
no peak 
2861.16 ± 3.67 
c Symmetric stretching absorbance band appeared to divide into two separate peaks after enhancer treatment. 
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Figure 6.14. Diffuse reflectance FTIR spectra of untreated human stratum comeum in the 























Table 6.8. Changes in frequency of symmetric and asymmetric C-H stretching vibration 
and appearance of additional absorbance band relating to permeation enhancer 
treatment as detected by diffuse reflectance-FTIR spectroscopy 
Stratum comeum Asymmetric stretching Symmetric stretching 
conditions" (- 2920 cm·1)b (- 2850 cm·1) 
Untreated 2930.98 ± 6.12 2853.38 ± 1.83 
Treated-2 h 2938.08 ± 3.54 2855.34 ± 3.52 
aStratum comeu111 prepared to appro:x.linately 70% water content (w/w). 
b Measured using Win-IR software, mean± SD, n = 11. 
Symmetric stretching 2.c 
(- 2860 cm-1) 
no peak 
2861.16 ± 3.67 
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Figure 6.14. Diffuse reflectance FTIR spectra of untreated human stratum comeum in the 
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Figure 6.15. Diffuse reflectance FTIR spectra of untreated human stratum corneum in the 
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Figure 6.16 Diffuse reflectance FTIR spectra of enhancer treated human stratum corneum 
in the C-H stretching region between 2835 cm·1 and 2875 cm·1 (Peaks at 2851 and 























6.4.1 Mechanism of synergistic permeation enhancement of LHRH 
The permeability results observed for LHRH indicate that iontophoresis and chemical 
enhancement with OA/PG, are synergistic when used together (Figure 6.4). As discussed in 
Section 6.2, there may be several mechanisms responsible for synergistic permeation 
enhancement. These include: (1) charge or surface alterations; (2) solubility and/or 
conductivity associated synergism; and (3) pathway and pore related co-enhancement (Table 
6.2). The range of experimental approaches that were adopted were used to identify the most 
likely mechansim of synergy for LHRH. The merits of each mechanism with respect to 
LHRH permeability are discussed here. 
6.4.2 Charge and Surface Related Synergy 
This type of synergistic ( or inhibitory) mechansim primarily relates to electroosmotic flow 
through the skin. The change in surface charge that could result in an increase in 
electroosmosis is an increase in the pore wall negative charges (Peck et al., 1998). 
Structurally, the oleic acid/propylene glycol enhancer may have the potential to induce such 
changes in skin. Fatty acids are carboxylic acids with long hydrocarbon chains (Figure 6.17). 
The carboxylic acid group is polar and will favour placement in aqueous regions within the 
stratum comeum. The lipid chains of the enhancer will favour partitioning into the lipid 
regions of the stratum comeum lipid matrix (Friberg et al., 1990). A proposed arrangement of 
oleic acid in the lipid bilayers of the stratum comeum is represented below (Figure 6.18) . 
However there is convincing evidence to suggest that oleic acid does not increase 
electroosmosis. The sucrose iontophoresis permeability results indicate that electroosmosis 
was not increased by incorporation of the enhancer into the system (Figure 6.6) It is possible 
that the OA/PG pretreatment adversely effects electroosmosis so that solvent flow is reduced 
(although variability precludes statistical significance being detected between iontophoresis 
enhancement and iontophoresis plus chemical enhancer enhancement). Therefore, if 
electroosmosis is reduced, synergism for LHRH permeability between iontophoresis and the 




























Figure 6.17. Schematic representation of oleic acid. Polar carboxylic acid group attached to 
a monounsaturated hydrocarbon chain. 
Ceramide of stratum 
corneum lipid matrix 
Theoretical aqueous pore 




Oleic acid (negative head 
group) 
Figure 6.18. Schematic representation of oleic acid incorporation into the lipid bilayers of 
the stratum corneum. Although oleic acid could increase the negative charges in this 


























6.4.3 Solubility and conductivity mechanisms 
LHRH is very soluble and carries a net positive charge at physiological pH. From the 
partitioning studies performed in this study the unionized fraction of LHRH appears to be 
minimal. Therefore it is unlikely that the mechanism for synergism in LHRH permeation is 
either solubility or conductivity related. This mechanism would result if a greater fraction of 
the ionized species was present in solution in the donor due to the addition of the enhancer. 
Increasing the solubility of an ionic species will increase the fraction of drug available to 
carry current and therefore will increase solute iontophoresis. 
An alternative explanation is that the OA/PG enhancer may reduce the depot or reservoir of 
LHRH in the epidermis. The mechanism of OA enhancement is generally agreed to involve 
disruption of the lipid bilayers within the stratum comeum (Ongpipattanakul et al., 1991). 
Disruption of the lipid regions, and the resulting increases in bilayer fluidity, may facilitate a 
more rapid passage of LHRH molecules that interact with the lipid matrix. Also, it has been 
suggested that propylene glycol can occupy hydrogen bonding sites in the stratum comeum 
(Barry 1987). This may reduce tissue binding promoting permeation. However, no depot 
effects were investigated and it is difficult to draw conclusions regarding the significance of 
this effect. 
6.4.4 Pore and Pathway related mechanism 
An increase in the number of pores or pathways in the HEM; an increase in the effective size 
of the pathways in the skin; or a combination of the two effects could result in a synergistic 
enhancement of LHRH via a pore related mechanism. However the nature of pores in the 
stratum comeum is currently not clear. For pores which pre-exist in the membrane, the size of 
the apparent pore pathway appears reasonably well characterised (Section 3.2). These pores 
are estimated to be around 20 A in radius and have been used to explain the permeability of 
polar solutes across the stratum corneum (Peck and Higuchi 1998). The nature of the 
electrically induced pores has also been explored (Li et al .1998, 1999a, 1999b ). These pores 
appear to be significantly smaller than the pre-exisitng pores (around 12 A) (Li et al., 1999a). 
Electrically induced pores at voltages greater than 1 V appear to be negatively charged (Li et 





























6.4.4.1 Evidence for porosity changes 
The OA/PG enhancer may result in increases in porosity (total number of pores). However, it 
is then expected that the permeability of a small ion such as TEAB would also increase. This 
has not been observed and there appears to be no significant difference between TEAB 
iontophoretic permeability and TEAB permeability with a combination of enhancer and 
iontophoresis (Figure 6.5). Despite this, there is other evidence suggesting that porosity of the 
membrane does increase. 
Electrical investigations give insight into the porosity of the membrane during iontophoresis 
and following chemical enhancer pretreatement. Skin conductance is linearly related to 
sodium ion permeability (Kasting and Bowman 1990a). The results illustrated in Figure 6.8 
show significant conductance changes in the HEM in response to enhancer pretreatment and 
iontophoresis and probably reflect changes in the porosity of the membrane (Higuchi et al., 
1999). The increases in conductance after enhancer pretreatement (12.5 fold conductance 
increase) relate to increases in TEAB permeability enhancement (15 fold increase). However, 
it is interesting to note that these increases in skin conductance do not result in similar 
increases in TEAB permeability enhancement when iontophoresis and the enhancer are used 
together. Although the conductance of the membrane increases from a porosity ratio of 18.8 
to 36.1 after the addition of the enhancer to the iontophoresis system, the permeability 
enhancement ratio of TEAB remains unchanged at around 1400. The reasons for this are 
explored here with the assistance of the modified Nemst-Planck equation. 
Each permeation enhancement ratio, E, represents the flux that results from treatment, 
Jrreatment, divided by the passive flux, JPassive, 
E = J Treatment 
JPassive 
The iontophoretic flux ofTEAB is given by (Higuchi et al., 1999), 
&t,.q, { [de czF do/] } Jt,_q, =-- -Ht,_q,D -+---- ±W{l'pVC 
ili:t,.q, dx RT dx 
and the passive flux is, 





where J is the flux of the species in one dimension, & is the porosity factor, L1x is tortuosity 
(membrane thickness), Dis the diffusion coefficient of the penneant, Hand Ware hindered 
transport factors, CD is the donor compartment concentration, c is the solute concentration in 
























potential in the membrane, F is the Faraday constant, R is the gas constant, T is the 
temperature, and v is the average velocity of the convective solvent flow. 
The theory accounts for restriction of Brownian diffusion and electromotive migration using 
hindrance factor H and also the effects of hindrance on convective solvent flow using the 
hindrance factor W. These hindrance factors are functions of pore size (see Chapter 4). 
Similar expressions to Equations 6.3 and 6.4 can be written for the flux of TEAB when 
iontophoresis and permeation enhancers are used together. In this case the flux resulting from 
iontophoresis and enhancer treatment, J,1ip+£, is 
&Ll'f'+E { [de czF do/] } 
J Ll'f'+E = Llx Ll'f' - H Ll'f'+ED dx + RT dx ± WLl'f'+E v Ll'f'+Ec (6.5) 
These flux expressions can be simplified by making some assumptions for TEAB transport. If 
the passive permeability of TEAB is much less than iontophoretic permeability the dc/dx 
component can be ignored. This assumption should be valid given that the iontophoresis 
permeability coefficients were over 1000 times larger than passive permeability coefficients 
for TEAB (Figure 6.5). In addition, the electroosmotic transport of TEAB can be assumed to 
be insignificant relative to the electrorepulsion transport. The electroosmosis of small ions, 
such as TEAB is likely to be small relative to electrophoretic effects given that the TEA+ ion 
carries a small mass to charge ratio (i.e. electrorepulsion is dominant over convective 
transport) (Pikal 1992). Using these assumptions the enhancement ratio for TEAB 
iontophoresis becomes, 
&Ll'I' { 
E,~w ~ /•• ~ &.,, -H,,Dcv[~ d'-1']} 
P•"'" ( DCtH) dx . (6.6) 
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Similarly, for the enhancment ratio resulting from iontophoresis in combination with 





















Ill H!,.'P+E -~'I' _ 61:,.'P+E. H 
Et,.'P+E - 6 &A'P+E 
(6.8) 
Therefore the observations for TEAB permeability enhancement can now be reconciled 
qualitatively with these expressions. In particular, the observation that iontophoresis 
enhancement is not different from the enhancement resulting from the combination of 
iontophoresis and enhancer together is examined. Since these ratios were observed to be not 
significantly different (Table 6.3) it can be said that, 
EA'P+E =EA'P (6.9) 
therefore, 
6A'P+E • Ill . Ht,.'P+E • ~q., = 61:,.'P • ~. Ht,.'P • ~q., 
6 &t,.'P+E H 6 &A'P H 
(6.10) 
simplifying to 
6 A'P+E • H l:,.'f'+E _ 6 t,.'P • H t,.'P 
/llA'P+E /lll:,.'f' 
(6.10b) 
It was observed during iontophoresis and enhancer treatment that the porosity was greater 
than the porosity during iontophoresis alone (Table 6.4). Therefore, 
6 t,.'P+E > 6 t,.'P (6.11) 
This means, to ensure the expressions 6.9 and 6.10 remain equal, other differences in pore 
size and/or tortuosity of the membrane must also occur after enhancer pretreatment. i.e. the 
HEM pores are smaller after enhancer pretreatment (H decreases), and/or the tortuosity of the 
membrane is greater (L1x increases) relative to the pore size/tortuosity during iontophoresis 
alone. 
The situation where the mean pore size decreases while porosity increases appears plausible. 
In this case, the new pores induced by the enhancer in combination with iontophoresis may 
have smaller radii than those already present in the membrane. This would result in an overall 
decrease in the mean pore size. Therefore, if the pores created by enhancer-iontophoresis 
treatment are too small for TEAB transport, no co-enhancement of TEAB would result from 
the combination treatment. In support of this, Konturri et al., (1993) reported enhancer 
treatment opened new channels in the lipoidal matrix. These new channels did not permit the 
flux of electrolytes but did allow increased water flux. This suggests the pores induced by 
























Alternatively an increase in the pathlength of TEAB iontophoresis transport across the 
stratum comeum may also occur. This particular scenario may result from an increase in 
fluidity of the lipid bilayers in the stratum comeum barrier ( as per the mechansim of oleic 
acid) (Pechtold et al., 1996). Such a perturbation of the stratum comeum may disrupt the 
aqueous pores through which iontophoresis occurs. However similar increases in pathlength 
would also be expected during the passive diffusion of TEAB through enhancer treated HEM 
(E treatment group - Figure 6.5). What was observed was an increase in TEAB permeability 
and skin porosity (Figure 6.5 and 6.7). There was no evidence of increased pathlength. This 
may suggest that the TEAB iontophoresis pathway is different from the passive permeability 
pathway. 
To summarize, the conductance data show increases in porosity of the membrane following 
enhancer pretreatment alone, iontophoresis alone, and also following the combination of the 
two treatments. However TEAB permeability measurements, obtained simultaneously, 
suggest that the pores created by combination of the two treatments are smaller and/or more 
tortuous. In other words, the additional electrically-induced pores formed when there is 
enhancer pretreatment of the HEM, appear to be significantly smaller so that TEAB is not 
transported through them. 
6.4.4.2 Evidence for pore size changes 
Oleic acid is an 18 carbon monounsaturated fatty acid and has been shown to be taken up by 
the intercellular regions of the stratum comeum (Burnette & Ongpipantanukul 1987). Several 
studies document that the primary mode of action of QA is to increase the fluidity and 
disorder of the intercellular lipid lamellae and that it also acts via a phase separation 
mechanism (Burnette & Qngpipantanukul 1987, Francoeur et al., 1990, Naik et al., 1995). 
The "kinked" QA acid hydrocarbon chain appears to be responsible for inducing the greater 
motion in the crystalline intercellular lipid bilayers. Considering this mechanism of action, it 
is hypothesized that QA/PG enhancement may act synergistically with iontophoresis by 
influencing the aqueous regions of the lipid bilayers of the stratum comeum. Our results 
demonstrate that synergy occurs with the larger LHRH molecule but not with the smaller 
TEAB ion. Thus, it is conceivable that the enhancer pretreatment, producing an increased 
fluidity in the stratum comeum lipid bilayers, leads to a decrease in the diffusional resistance 
of the barrier for LHRH but not for TEAB. It is thought that this may occur if the pre-existing 





















We can illustrate effectively the result of pore size increases on the tranport of LHRH and 
TEAB using the hindered pore theory. This theory describes transport in liquid filled pores of 
molecular dimensions (Chapters 3 and 4). The basis of the theory is the calculation of 
hindrance factors, H and W, which effectively reduce the apparent bulk solution diffusion 
coefficient of a molecule in relation to the the geometry of the pore and solute (Deen 1987). 
When the ratio of solute radius to pore radius (rs/Rp) is less than 0.4, the hindrance factors are 
given by the following equations(Deen 1987): 
H(A) = (1-A)2(1-2.104A+2.09A3 -0.95A5 ) 
W(A) = (1-A)2(2-(1-A)2{1- ~ A2 -0.163A3 J 
(6.12) 
(6.13) 
where 11, = r5/Rp ( equations for case where O < 11, < 1 were also used and are shown in Chapter 
4). The theory accounts for restriction of Brownian diffusion and electromotive migration via 
H, and reduces convective solvent flow due to hindrance using W. Peck et al., (1996) 
successfully applied these hindrance factors to the modified Nernst-Planck equation (Equation 
6.3). When incorporated into this equation, Hand W reduce permeant flux as the values for 
hindrance factors are between O and 1. We calculated H and W for both our cationic 
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Figure 6.19. Effect of pore size on the magnitude of the hindrance factors calculated for 
LHRH (radius RI 23A) and TEAB (radius RI 3.75 A) 
Figure 6.19 shows that increases in the pore radius from around 30A to around lOOA have 
greater effects on the hindrance of LHRH compared with TEAB. At the lower pore sizes, 
LHRH transport is reduced dramatically, H and W being very close to zero ( at 25 A pore 
radius H is 7 .6 x 10-6 and W is 7 .1 x 1 o-3). However for TEAB at these smaller pore sizes the 
hindrance factors were calculated to be many fold higher (at 25 A pore radius, His 5 x 10-1 
and W is 9 x 1 o-1). Therefore subtle increases in pore size will have significant effects on 























Table 6.9. Hindrance factors H and W calculated for LHRH and TEAB over a range of 
pore radii. 
Pore size (Angstrom) TEAB LHRH 
H w H w 
25 0.50 0.92 7.6 X 10- 7.1 X 10· 
30 0.57 0.95 1.1 X 10·3 7.0 X 10"2 
50 0.73 0.99 6.1 X 10·2 0.43 
100 0.86 1.00 0.32 0.82 
The effect of increasing pore size is much less with a small molecule such as TEAB. This 
molecule has significantly less hindrance to transport because the pre-exisiting pores are 
much larger than the molecule. For example, increase the pore radius from 25 to 30 A 
increased the H of TEAB 1.1 fold. However, for LHRH such an increase in pore radius results 
in a 145 fold increase in H (Table 6.9). Therefore an increase in the effective pore size is also 
consistent with the TEAB results when examined in light of the hindered pore theory. 
To summarize, the permeability increases of LHRH due to iontophoresis and enhancer 
pretreatment can be reconciled with the TEAB permeability data (no increase in permeability) 
in terms of an increase of pore radius. These increases in pore size are proposed to effect the 
pre-existing pores so that the hindrance to LHRH transport is significantly decreased while 
TEAB transport is insignificantly effected due to low initial hindrance in these pathways. 
6.4.5 Effect of enhancer on electroosmosis 
Our investigations also looked at the effect of enhancer pretreatment on the electroosmotic 
flow during iontophoresis. This is important because the convective solvent flow that occurs 
during iontophoresis is believed to be a significant transport mechanism for larger molecules 
(Hirvonen and Guy 1998, Pikal 1992). Therefore, in order to explain the changes which occur 
in iontophoretic permeability of LHRH in response to enhancer pretreatment, we incorporated 
a electroosmotic probe into the flux studies. From these results it appears that OA/PG 
pretreatment does not improve electroosmosis and may actually cause solvent flow to be 
reduced (Figure 6. 7). 
Using the theoretical model described by Peck et al. (1998) it is possible to identify the 
physicochemical parameters that influence electroosmostic flow. The model, derived from the 
Poisson-Boltzmann equation and equations for fluid motion, gives a velocity profile of 













l d (dv) X 2neX . { } -- - = --p(r) = --smh elJl(r)/(kT) 
r dr dr 'TJ rJ 
(6.14) 
where v is the solvent flow velocity, r is the distance from the charged surface of the pore, 
p(r) is the excess charge density, Y/ is the coefficient of viscosity, Xis the applied electric 
field, n is the bulk concentration, e is the electronic charge, lfl(r) is the electric potential at r, k 
is Boltzmann's constant, and Tis the absolute temperature. 
According to Equation 6.14, a decrease in solvent velocity may be explained by: a reduction 
in the surface charge density; an increase in viscosity; or a detrimental change in the geometry 
of the pore resulting in an increase in pathlength, tortuosity or pore radius. 
It is unlikely that viscosity has a major influence on solute transport after enhancer 
pretreatment. Viscosity increases would be a factor during passive permeability experiments 
after enhancer pretreatment as well but decreases in passive permeability were not observed. 
All solutes had enhanced passive permeability after pretreatment. 
A similar reasoning suggests that the tortuosity of the membrane is not increased. The 
influence of the enhancer on the pathway tortuosity was discussed briefly in Section 6.5.4.1. 
The increases in fluidity of the membrane brought about by oleic acid perturbation of the 
intercellular lipid matrix could conceivably result in a more tortuous aqueous route for 
iontophoresis transport. However during passive permeation, none of the solutes was inhibited 
by pretreatment of the HEM. 
Another explanation which may account for the reduction in electroosmosis is a reduction of 
the surface charge density of the membrane. In a recent study, anionic surfactants were used 
to alter electroosmotic flow across the stratum comeum by adsorption to the stratum comeum, 
thus altering the surface charge density. The anionic surfactant increased the net negative 
surface charge and promoted greater solvent flow velocity (Peck et al., 1998). Similar 
increases in electroosmosis might be expected with oleic acid since the molecule has a 
comparable structure to these surfactant molecules (lipophilic hydrocarbon chain attached to a 
negatively charged carboxyl group). However, our observations do not support this. In fact 
our results suggest that the fixed surface charge actually decreases in response to enhancer 
pretreatment. A possible explanation is that pretreatment leads to greater fluidity within the 
lipid bilayers and causes disruption of the stationary surface charges embedded along the pore 
pathway. The increase in disorganisation of these charged groups may effectively decrease the 
available fixed charges that are responsible for electroosmotic solvent flow. The observation 
that electroosmosis, an important iontophoresis transport phenomenon for large molecules 



















paradoxical. However this apparent paradox is due to the fact that the permeability of LHRH 
is influenced to a greater extent by enhancer induced changes in the membrane compared to 
the detrimental effects the enhancer has on electroosmotic flow. 
6.4.6 DSC and FTIR 
6.4.6.1 DSC 
DSC experiments together with other physical characterisation techniques (infrared 
spectroscopy, and X-ray diffraction) provide evidence on the structure of the stratum comeum 
and how enhancers modify phase transitions in the barrier (Potts 1989).·Four main transitions 
were demonstrated in the stratum comeum samples analysed in this study (Figure 6.8). The 
first three transitions, Tl, T2, and T3, are attributed to phase changes in the intercellular lipid 
bilayers (Naik and Guy 1998). T4 is associated with protein denaturation (Golden et al., 
1987a). DSC has been widely used in studies investigating chemical permeation enhancement 
of the stratum comeum and was recently reviewed by Naik and Guy (1998). Chemical 
permeation enhancers often decrease the transition temperature of T2 and/or 3, indicating 
perturbation of the intercellular lipid region. The effect of oleic acid on stratum comeum 
transitions in this study was limited to T2 which decreased significantly following enhancer 
treatment. This observation is consistent with other DSC reports using oleic acid in stratum 
comeum tissues (Goodman and Barry 1986, Francoeur et al., 1990, Yamane et al., 1995). 
No changes were observed in the DSC analysis of human stratum comeum after 
iontophoresis. In addition, there were no differences between pre-treated stratum comeum and 
pre-treated stratum comeum after iontophoresis. This is despite other investigations 
( conductance measurements and electrochemical techniques) consistently demonstrating 
structural changes in the skin (Scott et al., 1995, Inada et al., 1994). However it is thought that 
the local action of iontophoresis on the lipids of the stratum comeum leads to changes that 
cannot be detected at a macroscopic level by thermal techniques (Jadoul et al., 1999). 
Generally, electrical fields have not demonstrated significant effects on the thermal transitions 
of the stratum comeum (Jadoul et al., 1999). 
6.4.6.2 FTIR 
The IR spectroscopy provides information on the vibrational modes of the structures of the 
stratum comeum at a molecular level. Several investigators have shown that this technique 



















proteins of the stratum corneum barrier (Goodman and Barry, 1986, Williams and Barry, 
1989, Mak et al 1990, Bommannan et al 1991). Stratum corneum IR spectra are typical of 
hydrated biological materials (Clancy et al 1994). Strong amide and water absorbances occur 
in the regions of 1500-1700 and 3000-3600 cm-1 respectively. The pealcs of interest for 
investigating skin structural changes are near 2850 and 2920 cm-1• These are due to symmetric 
and asymmetric carbon-hydrogen stretching respectively. These stretching peaks are primarily 
the result of the hydrocarbon chains present in the lipid bilayers of the stratum corneum 
(Golden et al 1986). Delipidization of the stratum comeum using organic solvents like 
chloroform and methanol (2:1 v/v) dramatically reduce the absorbance of IR in the C-H 
stretching regions (Clancy et al., 1994). Chemical permeation enhancement may induce 
disorder in the normally highly structured intercellular lipid regions, and thereby increase 
diffusion of solutes through the skin. Increases in disorder result in a shift of C-H stretching 
absorbances to higher wave numbers (blue shift) (Casal and Mantsch 1984). The three modes 
of IR spectroscopy that were used in this study all showed evidence of permeation enhancer 
disruption of the stratum comeum lipid (Tables 6.6, 6.7, 6.8). Transmission FTIR 
demonstrated an increase in the wavenumber of both the asymmetric and symmetric C-H 
stretching absorbance regions. The frequency shifts were also observed using ATR-FTIR, all 
shifts being significant, irrespective of the duration of enhancer treatment. The magnitude of 
the shift appeared to be related to the duration of treatment, indicating that the full effect of 
oleic acid was not achieved after 2 hours treatment. The initial interpretation of the shift of the 
C-H absorbance peaks suggests that incorporation of the mono unsaturated oleic acid molecule 
into the primarily saturated lipids of the stratum comeum increases fluidity due to 
perturbation of the packing in this region (Clancy et al., 1994). Another explanation given for 
this shift is the presence of phase separated domains of oleic acid within the stratum comeum 
following enhancer treatment (Ongpipattanalrnl et al. 1991). The third technique used was 
diffuse reflectance FTIR. It was shown that this method was more variable than transmission 
and ATR methods but was able to distinguish two distinct C-H stretching regions after 
enhancer treatment of the stratum comeu.m. This observation may indicate simultaneously the 
presence of regions that are unaffected by the enhancer treatment, and regions of enhancer 
action. 
During iontophoresis no C-H absorbance shifts were observed in the ATR spectra of the 
stratum comeum. In addition, ATR spectra after iontophoresis, in combination with 
enhancers, was not significantly different from that seen in enhancer treated stratum comeum. 























stratum comeum occurring during iontophoresis are localised and relatively insignificant 
compared to permeation enhancer effects on the stratum comeum lipid matrix. 
6.6 Chapter Summary 
OAJPG pretreatment of the HEM synergistically increased iontophoretic permeability of 
LHRH. In accordance with previous literature reports, oleic acid induced significant changes 
in the lipid matrix of the stratum comeum as measured by DSC and FTIR investigations. 
These structural changes coincided with increases in permeability and electrical conductance 
across the membrane. This suggests that enhancer pretreatment increased the porosity of the 
skin, presumably via a disruption of the intercellular lipid matrix of the stratum comeum. 
There is also evidence to suggest the pre-existing pores in the stratum comeum were 
increased in diameter following oleic acid pretreatment. 
Iontophoresis also increased the permeability and conductance of the membrane to all solutes. 
However, unlike chemical enhancement, no structural changes in the membrane could be 
detected using DSC or FTIR spectroscopy. This indicates that electrically induced changes in 
the membrane (porosity increases) occur in localised regions and cannot be detected by these 
techniques. 
When iontophoresis was combined with a chemical permeation enhancer, the permeability of 
the larger solute, LHRH was synergistically enhanced. Conductance measurements indicated 
that the use iontophoresis and oleic acid also acted synergistically to cause greater porosity 
changes in the membrane. However, TEAB permeability was not promoted compared with 
that observed when iontophoresis was used separately. This gives rise to the suggestion that 
the pores induced after iontophoresis and oleic acid treatments together, are not available for 
ion transport (other than very small conducting ions). Furthermore, the synergistic 
enhancement of LHRH must arise from an increase in pore radius of pre-existing pores. This 
hypothesis is consistent with TEAB observations when qualitatively analyzed using the 
hindered pore theory. From these studies we propose a range of pores are formed within the 
stratum comeum in response to electrical and chemical enhancer treatment. The 
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Other mechanisms of synergy such as surface charge alterations and solubility changes 
brought about by the enhancer are unlikely. Increases in fluidity of the stratum comeum may 
reduce the reservoir effect ofLHRH adsorption to the stratum comeum. Further investigations 
need to be performed to ascertain the significance of this during iontophoresis. 
It was also observed that pretreatment with enhancer leads to a possible decrease in 
electroosmotic flow (although this was not not statistically significant). Mechanistically the 
disruption of the lipid bilayers by the enhancer may facilitate a decrease in solvent flow by 
causing a decrease in the fixed surface charge. Simultaneously with the decrease in 
electroosmosis, LHRH permeability was increased. This suggests that the effect of membrane 
alterations, caused by the application of direct current and enhancer pretreatment, dominate 
the changes in electroosmotic flow during LHRH transport. The effect of membrane 
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During iontophoresis energy is applied across a system that consists of the skin barrier, 
electrodes, and drug contained within a buffer. This electrical energy acts as the primary 
driving force for transport through the skin barrier but it can also be responsible for effects 
other than permeation enhancement including electrically induced changes in the skin which 
has already been discussed. The question of how the electrical field affects the drug and the 
solution that contains the drug is another important consideration. Despite great interest in 
peptide iontophoresis little is known about the effect of the electrical profiles during 
iontophoresis on the stability and degradation of these bioactive molecules. 
7.1.1 Mechanisms of degradation 
Electrochemical decomposition may arise due to a variety of different mechanisms during 
iontophoresis and will depend on several factors such as pH changes, buffer composition, 
electrical field strength, duration of iontophoresis, electrode type and the peptide molecule 
stability. A number of iontophoresis investigations using LHRH have been described in the 
literature (Miller et al., 1990, Heit et al., 1993, Heit et al., 1994, Bommannan et al., 1994, 
Bhatia and Singh 1999). However, little information has been published with regard to the 
physical stability of the peptide during electrical field application. Miller et al. (1990) and 
Bhatia et al. (1997b) report that the electrochemical degradation of LHRH during 
iontophoresis is minimal. The breakdown of LHRH by electrolysis or cutaneous metabolism 
was evaluated in an iontophoresis investigation through porcine epidermis (Bhatia et al., 
1997b). Using thin-layer chromatography (TLC) to differentiate degradation products, 
degradation due to electrolysis was found to be around 7.5% after 0.2 m.A/cm2 iontophoresis 
for 8 hours using Ag/ AgCl electrodes in a donor solution consisting of 0.9% NaCL A more 
extensive study of iontophoretic electrolysis was reported by Cheng et al. (1995). In this study 
growth hormone releasing peptide (GHRP) was shown to undergo degradation via electrolytic 
oxidation. It is likely that this effect was caused by water electrolysis giving rise to eiectro-
generated oxygen radicals. 
7.1.2 Electrode reactions and energy 
An integral component of the iontophoresis system is the electrodes. These are responsible for 


























published in the area of peptide iontophoresis have used either silver/silver chloride 
(Ag/ AgCl) or platinum (Pt) electrodes. Generally, the electrolysis of water that occurs with Pt 
electrodes discourages their use in systems containing peptide molecules. Changes in pH 
induced as are result of electrolysis of water (via H30+ and OH- ions) can lead to instability of 
the peptide, skin irritation, and unpredictable transport due to related changes to skin surface 
charge (Delgado-Charro and Guy 1998). The electrical reaction that occurs at the Ag/AgCl 
electrodes is shown below in Figure 7.1. The electrons provided to the cathode (AgCl) cause 
reduction with Al and c1- formation, while oxidation at the anode produce.? Ag+ which forms 
a precipitate with er. 
i+ i-




Figure 7.1. Electrode reactions that occur with a silver/silver chloride electrode system 
during electrical field application (Derived from Riviere and Heit 1997). 
Iontophoresis across the skin can be represented as a simple electrolytic cell which performs 
chemical reactions at the expense of energy. The energy introduced into the system by the 
electrical field is described by Joules law. The strength of the electric current is the flow rate 
of electricity ( coulombs, Q, per unit time, t) and is given by current, 
I= Q/t (7.1) 
The power is the product of electric current (I) and the applied voltage (E), 
Electric Power = EI = 12 R (7.2) 
This is Joules law. Electrical power is the rate of doing work or rate of expenditure of energy. 
Power dissipated in a circuit can be thought of as the rate at which energy (work in this case) 



















during inelastic collisions. Electrical energy (W), expressed in joules, is the product of 
electrical power and time, 
W=Elt (7.3) 
where t is time in seconds, E is volts and I is amperes. These expressions can be used to 
calculate the energy used during iontophoresis experiments. 
7.1.3 Aims 
In this study we aimed to identify possible degradation· of LHRH in the presence of an 
electrical field. Specifically, the primary focus was on the potential degradation resulting from 
the electrical conditions present during in vitro iontophoresis experiments. Since radiolabeled 
LHRH was used in flux experiments performed in Chapters 4 and 6, these investigations were 
necessary to ensure that LHRH remained intact during in vitro iontophoresis. The electrical 
energy introduced into the system is related to the electrical field strength and the duration of 
iontophoresis. These variables were controlled in the present experiments in order to relate 
these findings to those observed during typical iontophoresis flux studies. Firstly the 
contribution of pH changes that occur due to electrode effects were studied, then in vitro 
peptide degradation in the presence of an electrical field was monitored. Analysis of samples 



























7 .2 Experimental Strategy 
7.2.1 Materials 
Luteinizing hormone releasing hormone (LHRH) was obtained from American Peptide 
Company (Sunnyvale, CA), all other reagents were obtained from Sigma Chemicals or were 
of reagent grade. 
7.2.2 Electrodes 
Ag/ AgCl electrodes were assembled from Ag wire. The AgCl electrode was prepared by 
electroplating Ag wire in 4N hydrochloride solution to form a layer of AgCl (Craane-Van 
Hinsberg et al., 1994b). The electrode ends were coiled to provide adequate surface area. 
7.2.3 pH alterations caused by electrical field 
Experiments were performed in 0.1 M phosphate buffered saline (PBS), pH 7.4, to determine 
the influence of electrical fields and duration of electrical field application on the buffer 
solution pH. Silver/SilverChloride (Ag/ AgCl) electrodes were used throughout and were 
connected to a power source supplying constant voltage (Thurlby Thandar Instruments 
PL310QMD power supply). The electrical potential difference selected was 1 V and was 
applied for 1 hour duration through a constant volume of buffer solution. At pre-selected time 
points the electrical field was momentarily switched off (to avoid electrical field interference 
with the pH meter electrode) and the pH of the solution was measured. A Metrohm 7 44 pH 
meter was used for all pH experiments. Throughout the experiments the magnitude of the 
resulting current was also recorded using a Fluke 89 IV true RMS multimeter linked to a 
computer using an infrared-eye. This allowed electrical measurements to be monitored 
continuously and rapidly. All in vitro experiments using the apparatus shown in Figure 7 .2 
were performed in a volume approximating the volume of the donor and receptor chambers of 
the side-by-side diffusion cells (7 ml). 
7.2.4 Short-term pH stability ofLHRH 
PBS solutions of different pH (4, 7, and 9.2) were prepared containing known am01mts of 
LHRH. The initial LHRH concentration was 6 µg/ml. Solutions were analysed periodically 



























7.2.5 Stability in an electrical field 
Solutions of LHRH were prepared (15 µg/ml) in PBS pH 7.4 and placed in an electrical field. 
In the first study, the field strength was set at 1 V and samples were taken over the course of 1 
hour. The current resulting from the electrical field was also measured. The pH of the buffer 
solution was measured before and after application of the electrical field. Samples were 
centrifuged (1 Omin at 15000 rpm) and analysed using HPLC and UV detection. Figure 1 
schematically shows the experimental set up. This experiment was performed in triplicate. 
The experiment was repeated at an electrical field strength of 2 V for comparison to the 1 V 
Power Supply 
Ag/ AgCl Electrodes 
data. 
Figure 7 .2. Schematic diagram of the in vitro electrode set up used to apply electrical 
fields to the peptide and buffer solution. 
To facilitate mass spectrometry analysis, similar experiments were also performed in an 
acetate buffer (ammonium acetate buffer 0.1 M). This buffer is volatile and·therefore does not 
interfere with electrospray ionisation in the mass spectrometer. 
7.2.6 HPLC Analysis 
LHRH and LHRH degradation products were measured using HPLC through a Jupiter C 18 
column (Phenomenex U.S.A., Torrance, CA). The mobile phase consisted of 0.1% TFA and 
21 % acetonitrile in water. The standard curve range for this method was between 1 - 30 
µg/ml. The injection volume was 100 µl, injected using a Jasco autosampler. The retention 
time for LHRH parent molecule was 15 minutes. No interference from buffers was identified. 





























analysed and monitored for changes over the time course of the experiments. Validation of the 
methods was performed to ensure that the coefficient of variation was less than 5, both 
within-day and inter-day (4.9 and 3.0 respectively). UV spectra were obtained to ensure no 
changes in the UV spectrum of the parent peak (LHRH) occurred in the degradation 
experiments. 
7.2. 7 Mass spectrometry analysis 
Samples were submitted to the Protein Microchemistry Facility, Department of Biochemistry, 
University of Otago for mass spectrometry. Analyses were undertaken using a Finnigan LCQ 
DECA ion trap mass spectrometer ( electrospray ionisation source). Samples obtained from 
electrochemical studies were around 10 pmol/µL and were diluted by 50% in methanol and 
acetic acid (1 %). Infusion rates wete 5 µL / min during sample analysis. The scanned mass 






















7.3.1 Electrical conditions during in vitro iontophoresis experiments 
Observations made in Chapter 4 were reanalyzed to demonstrate the typical electrical 
conditions that occur during transdermal iontophoresis in vitro across side-by-side diffusion 
cells. The average energy consumption data for experiments performed at moderate voltage 
iontophoresis electrical fields are shown in Figure 7.3. It is observed that during iontophoresis 
at 1 to 3 Volts, the total energy expended after a 5 hour experiment is in the order of a few 
joules (up to around 10 joules). The electrical fields measured during the 4 Volt experiments 
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Figure 7.3 The cumulative energy expenditure observed during LHRH experiments 
performed in Chapter 4. During iontophoresis at voltages up to 3 Volts the mean joule 
expenditure was less than or around 10 joules after 5 hours. The 4 Volt iontophoresis 
experiments had significantly higher energy consumption, particularly at longer time 
periods. 
The during these iontophoresis flux experiments the time periods at which steady-state flux 
was determined (straight-line portion of the cumulative amount in the receptor compartment 
over time) was related to the magnitude of the electrical field strength. For example, those 
experiments that were performed using 1 V across the membrane usually attained steady-state 




















used as the portion of the graph from which flux was calculated. Alternatively, the 
experiments performed using high electrical fields usually required a much shorter time to 
reach steady-state. For example, during the 4 volt experiments, the steady-state flux region 
began at approximately 30 minutes after the electrical field was applied. The steady-state flux 
was calculated from the time period spanning 30 minutes to 2 or 3 hours. Given this, the 
energy consumption that is of interest for peptide degradation during in vitro iontophoresis 
relates to these time periods. This means all LHRH steady-state flux calculations were 
performed when around 10 joules or less had been applied to the system. The energy 
consumption levels of interest are summarized in Table 7.1. 
Table 7.1 Energy consumption of in vitro iontophoresis experiments over the time period 
that steady-state flux calculations were made. 
Voltage level 
(Volts) 





t= 30 t=60 t= 120 t= 180 t=240 t=300 
44.0 
Shaded area represents, in general, the time period over which the steady-state flux was determined. 
7.3.2 pH changes in the in vitro system 
The pH of the buffer solution during exposure to the electrical field strengths is shown in 
Table 7.2. At an electrical field strength of 1 V, pH changes were small. 
Table 7.2 Observed pH changes resulting from electrical field application to 0.1 M 
phosphate buffer saline (25 °C). 
Voltage applied Initial pH pH at20min pH at 40min pH at 1 hour Total Electrical 
(volts) Energy Input 
Uoules) 











7.3.3 pH stability of LHRH in solution 
The short term pH stability study of LHRH showed that degradation of the peptide at all pH 
levels was nil or minimal (Table 7.3). 
Table 7.3. Short-term pH stability study of LHRH showing percentage remaining as a 
function of time (hours) (n=3). 
Time pH4 pH7 
0 100 ± 0.3 100 ± 0.2 100 
2 101.1 ± 0.4 101 ± 0.2 102 
24 99.9 ± 0.4 98.5 ± 0.7 102 
48 101.4 ± 0.7 101 ± 0.4 103 
72 100.2 ± 0.6 100.4 ± 0.4 102.6 
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Figure 7.4a & b. Typical chromatogram of LHRH before electrical field application 




















7.3.4 Stability in an electrical field 
Figure 7.4a shows a typical HPLC chromatogram obtained for the parent LHRH compound. 
A chromatogram of the samples taken from the higher voltage (2V) electrochemical cell is 
shown in Figure 7.4b. The parent peak of LHRH is located at 15.7 minutes. Degradation 
products were identified at 17.6, 14.3, 13, and 11.7 minutes. Samples from the lower voltage 
(1 V) experiments electrochemical cell did not show any degradation peak, although a 
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Figure 7.5. Plot of LHRH degradation (% remaining) in a 1 V electrical field in aqueous 
solution (0.1 M PBS, 37 °C) with energy input (joules) plotted on the opposite axis. 
One hour duration (n=3). 
Figure 7.5 demonstrates the gradual decrease of the LHRH parent peak over the time course 
of the 1 V electrochemical degradation experiments. No change in LHRH concentration was 
detected after 20 minutes of the experiment. This time point corresponds to around 15 joules 
of electrical energy input into the system. Approximately 80% of the LHRH remained intact 
after a one hour exposure to the 1 V electrical field that provided around 30 joules of energy. 
The HPLC assay did not detect any peaks corresponding to degradation products during this 
experiment, although a decrease in the height of the parent peak was observed. A higher 
energy degradation experiment was performed in vitro at 2 V for comparison. Approximately 

















experiment electrical current intensity was high relative to the 1 V experiments and the 
calculated total energy was around 60 joules. The amount of energy input that corresponded 
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Figure 7.6. Plot of LHRH degradation (% remaining) in a 2 V electrical field in aqueous 
solution (0.1 M PBS, 37 °C) with energy input (joules) plotted on the opposite axis. 
One hour duration (n=3). 
Analysis of the degradation experiment using mass spectrometry yielded three mam 
degradation products. These are summarised in Table 7.4 and Figure 7. 7. A volatile buffer 
(ammonium acetate buffer) was required to enable samples to be analysed via mass 
spectrometry. An additional problem encountered was the tendency for the buffer to 
precipitate with the migrating silver ions when the electrical field was applied. This was due 
to the absence of er ions in the system. For this reason the experiment was performed for 









Table 7.4. m/z ratios for degradation products identified by mass spectrometry. 
Relative 
TheorM+W Abundance 
Product Value (m/z) (t = 0) 
LHRH 1182.5 100 
Pl 1183.6 67 
p4• 748.4 20 
P5" 453 0 
"from Hoitink et al. (1996) and Motto et al. (1991). 
00-027_HS000629#123 RT: 5.74 AV: 1 NL: 1.66E7 
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Figure 7.7. Raw scan mass spectrum of parent LHRH and degradation products resulting 

















LHRH is stable in buffered physiological solutions. Native LHRH stored at pH 5.4 has a 
shelf-life (t90) of 5 years (Powell et al., 1991). Stored at minus 20°C, the decomposition of 
LHRH proceeds at the rate of 1 % every 4 months (NEN Certificate of Analysis, NET-538). 
Degradation of LHRH in aqueous solution was investigated by Hoitink et al. (1996). pH 
influenced accelerated decomposition studies found LHRH was most stable between pH 4 and 
pH 6.5. Temperature degradation kinetics were found to fit the Arrhenius equation. Other 
influences on degradation such as concentration, buffer ions, and ionic strength had little or 
no effect on the rate of decomposition (Hoitink et al., 1996). 
During iontophoresis there are additional stability concerns. pH changes induced in the anode . . 
compartment may have an influence on the stability of LHRH. Our investigations 
demonstrated that Ag/AgCl electrodes result in minimal pH changes. In any case, the short-
term pH dependent degradation was insignificant (Table 7.3). 
Ag/ AgCl electrodes have other possible disadvantages for use with peptides including the 
potential for reactions of peptides to occur at the surface of the electrode. Therefore the 
stability of LHRH was assessed during electrical field application. Evidence of electrolytic 
degradation of LHRH was detected but only after considerable energy was expended in the in 
vitro system. At 1 V experiments degradation of20% of the LHRH was observed after 1 hour. 
To relate this to the experimental conditions during in vitro iontophoresis, the energy 
consumption that occurred in the LHRH experiments performed in Chapter 4 was analysed. 
During the iontophoresis experiments performed in side-by-side diffusion cells, all steady-
state flux determinations were obtained when up to 10 joules of electrical energy had been 
supplied to the system. From Figures 7.5 and 7.6, the amount of LHRH degradation at this 
energy level is not significant regardless of the voltage level applied. 
When the energy input to the system was higher, degradation of LHRH was detected. These 
electrical conditions represent electrical energy levels that are significantly greater than those 
used in in vitro iontophoresis electrical protocols. Under these stress conditions considerable 
decreases in peptide concentration were observed (20% decrease in LHRH after the 1 V 
experiment and 60% following the 2 V experiment). Therefore electrical breakdown of the 
peptide may occur if iontophoresis is performed at higher voltages or for longer durations. 
Previous reports looking at the electrochemical stability of peptides have suggested various 




















most likely mechanism for growth hormone releasing peptide. Hydroxyl-mediated attack of 
indole (Trp) and imidazole (His) groups was proposed. Nakakura et al. (1996) found that 
chlorine formation may be responsible for the decomposition of desmopressin acetate 
(DDA VP) during iontophoresis. They also suggested that Ag/ AgCl e,lectrodes may remove 
DDAVP from the anode compartment when NaCl is not present because Ag2+ is released into 
solution. Silver ions are well lmown to have strong affinity for many proteins (Merril et al., 
1981). 
The HPLC chromatograms revealed 4 possible degradation products that may occur during 
electrical field application. The peak eluting after the parent peptide at 17.6 minutes (Pl) is 
probably deamidated LHRH (Hoitink et al., 1996). Peaks at 14.3 and 13 minutes (P2 and P3 
respectively) are likely to be the hydroxyl-catalysed degradation products identified by Motto 
et al. (1990) and Hoitink et al. (1996). In their studies P3 showed the presence of D-Ser 
instead ofL-Ser and similarly P2 was shown to contain D-His instead of L-His. The peak that 
eluted first at 11.7 minutes (P4) is thought to be the result of solvent catalysis degradation. 
Motto et al. (1990) and Hoitink et al. (1996) both report similar degradation product analysis 
involving the heptapeptide Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 and the corresponding 
pyroGlu-His-Trp fragment. These fragments are thought to be due to hydrolysis of the peptide 
bond on the amino side of the serine residue (Hoitink et al., 1996). These degradation 
products (Pl-P4) were only found in the high electrical field experiments when analysed 
using the HPLC assay. 
In order to reconcile the disappearance of LHRH during 1 V experiments without the 
appearance of corresponding peaks related to degradation products it has been suggested that 
the peptide may precipitate with the electrode materials (Nakakura et al., 1996, Miller and 
Smith 1989, Lelawongs et al., 1989). 
Mass spectra analyses yielded similar degradation m/z ratios to those reported by Motto eta!., 
(1990) and Hoitink et al. (1996). These spectra showed the presence of Ser-Tyr-Gly-Leu-Arg-
Pro-Gly-NH2 and pyroGlu-His-Trp fragments both before and after the application of typical 
iontophoresis electrical fields (in the order of a few joules electrical energy). In addition, the 




















7.5 Chapter Summary 
The experiments performed in chapters 4 and 6 used iontophoresis in combination with 
LHRH. Because the peptide in the iontophoresis flux experiments was analysed using 
radiolabeled LHRH it was necessary to confirm there was no significant breakdown of the 
parent molecule. In the degradation investigations performed in this chapter, the electrical 
energy input into a simulated iontophoresis system was monitored alongside LHRH 
degradation. This confirmed the degradation of LHRH during in vitro iontophoresis 
experiments is insignificant. However, the possibility of electrochemical degradation is more 
likely if the electrical field strength or the duration of electrical field application is increased. 
If prolonged iontophoresis delivery system is used to administer protein and peptide 
molecules this degradation should be considered. When electrochemical degradation does 
occur, it appears to be primarily due to hydroxyl-catalysed reactions and by the hydrolysis of 
the serine residue of the peptide. In the in vivo iontophoresis situation, or if viable skin tissue 










































The aim of this study was to investigate the mechanism of iontophoresis for a small peptide, 
LHRH with the plan to promote its delivery across the skin. In addition, the possibility that 
iontophoresis of peptides could be improved by combining electrically-mediated delivery 
with a chemical permeation enhancer was considered. 
The best available skin tissue for these studies was considered to be surgically excised human 
skin and cadaver skin. Human skin, whether full thickness or separated epidermal membrane, 
demonstrated large electrical and permeability variability both within and between samples. 
Careful membrane selection criteria were used to improve uniformity between skin samples 
and to ensure membrane integrity. The peptide, luteinizing hormone releasing hormone 
(LHRH) was selected because of its favourable molecular size relative to estimates of the skin 
pore size. This characteristic permitted use of the hindered pore theory to effectively predict 
permeability changes during transport studies since small effects on pore size will 
significantly affect LHRH hindrance within the pores. Therefore, LHRH permeability 
changes are able to reflect changes in pore size that may be relevant for the delivery of other 
peptides. LHRH also demonstrated good stability both in buffered solution, and under typical 
iontophoretic conditions. 
Transport studies, investigating the effect of electrical field strength, demonstrated marked 
porosity changes when potential differences above 1 V were used across human epidermal 
membranes. These observations were consistent with studies that have investigated electrical 
field influences on the HEM (Inada et al., 1994, Li et al., 1998). Porosity changes were 
measured in accordance with recent reports that have shown that changes in the conductance 
of the skin relate to the creation of new pathways in the membrane (Li et al., 1999a, Higuchi 
et al., 1999). The marked increases in porosity that were observed translated into dramatic 
increases in permeability enhancement of tetraethylammonium bromide (TEAB), a small 
ionic solute. However the increases observed in LHRH permeability enhancement were 
several orders of magnitude less. When compared to the results of the modified Nemst-Planck 
model corrected for porosity changes, observed TEAB enhancement was well predicted. 
However, the predictions for LHRH enhancement were markedly different from observed 
values. By including the correction for electrically-induced pores into the model, the Nemst-
Planck predictions diverged even further from the observed permeability enhancement values. 
This indicates that pathways created during moderate voltage iontophoresis are largely 
unavailable for LHRH transport. 
The influence of the voltage-induced pores on electroosmosis was considered since this 



















study, which was conducted in parallel to the LHRH permeability studies, the membrane 
porosity was seen to increase dramatically at voltages above 1 V. Sucrose, a small non-ionic 
polar solute, was used as an electroosmotic flow marker during these investigations. Sucrose 
was chosen because it is an uncharged polar solute that is not transported due to electro-
repulsive forces. Therefore, during moderate voltage iontophoresis, sucrose will be 
transported through the HEM due to electroosmosis and porosity changes. Furthermore, 
sucrose is relatively small ( compared to the pores in the skin) and therefore this molecule can 
be transported through the smaller electrically-induced pathways. This study showed that 
sucrose permeability increased as the electrical field increased. The enhancement of sucrose 
closely mirrored porosity increases in the membrane indicating that considerable 
electroosmosis occurs within electrically-induced pores. 
These two parallel investigations showed moderate voltage iontophoresis, above 1 V, results 
in the induction of pores proportional to the strength of the electrical field applied. However, 
transport through these pores, despite significant electroosmosis, is limited to small solutes. 
This is consistent with recent work characterising the strnctural changes that occur in human 
skin following iontophoresis at moderate voltages (Li et al., 1998). Using alternating current 
constant voltage iontophoresis, Li et al. (1999a) provided the first direct evidence of pore 
formation in the skin. Several workers have characterised the pores of the stratum comeum. 
These studies indicate pre-existing pores are in the order of 20 - 30 A (Table 3.1) while 
voltage induced pores are significantly smaller (around 12 A) (Li et al., 1998, Higuchi et al., 
1999). These findings also suggest that the permeability enhancement of large molecules may 
be restricted by the small nature of the pores induced by electrical fields. 
Given this, other strategies have been investigated to explore the potential to improve 
iontophoresis of peptides. One of the most studied and understood enhancement strategies is 
the use of chemical permeation enhancers on the skin. Synergism between iontophoresis and 
chemical enhancers was investigated in an extensive review of the literature. Investigations 
using enhancers and iontophoresis have been reported as early as 1989. However there have 
only been a small number of studies published since then and the mechanisms of interaction 
are often unclear (Table 6.1). Synergistic enhancement of solutes through the skin using 
iontophoresis and chemical enhancers may occur by several mechanisms: 
a. Charge and/or surface related 
b. Solubility and/or conductivity related 


























With these mechanisms in mind, oleic acid in propylene glycol was selected as a model 
enhancer to be used in combination with iontophoresis of LHRH. Oleic acid has been well 
studied and appears to increase permeability by increasing the fluidity of the lipid matrix of 
the stratum comeum. On this basis it was hypothesised that oleic acid may facilitate the 
synergistic enhancement of larger molecules like LHRH during iontophoresis by increasing 
the pore sizes of the skin. 
Permeability experiments using oleic acid in combination with iontophoresis showed a 
synergistic increase in LHRH permeability enhancement. A variety of simultaneous 
determinations (sucrose permeability, TEAB permeability, and conductance changes) in 
addition to investigations into the structural effect of these enhancement techniques 
(differential scanning calorimetry and Fourier Transform infrared spectroscopy) were used to 
help explain these observations. Conductance measurements indicated that there are different 
magnitudes of porosity increases following enhancer pre-treatment alone, unassisted 
iontophoresis, and when the chemical enhancer was combined with iontophoresis. Pores 
formed after enhancer treatment of the skin promoted the permeability of LHRH, sucrose, and 
TEAB. This suggests that the pre-existing pores in the membrane increase in size. However, 
when the enhancer was used in combination with iontophoresis, the pores that were formed 
did not promote TEAB or sucrose permeability relative to the penneability enhancement from 
unassisted iontophoresis. LHRH permeability enhancement, however, was improved by the 
use of iontophoresis with the enhancer. These observations were explained using qualitative 
assessment via the hindered pore theory. The increase in LHRH permeability enhancement 
with no increase in TEAB permeability enhancement, was consistent with increases in pore 
size of the pre-existing pores in the stratum comeum .. An alternative mechanism of co-
enhancement when oleic acid is used in combination with iontophoresis may be a decrease in 
the reservoir accumulation in the stratum comeum. In these studies a possible decrease in 
sucrose permeability enhancement following enhancer pre-treatment was observed. This 
implies electroosmosis is decreased due to a disruption of the fixed negative charges on the 
skin by the enhancer. The oleic acid-induced disorder of the stratum corneum was confirmed 
using DSC and IR investigations. The second thermal transition of the stratum comeum 
(located at around 70°C) was shifted to a lower temperature following enhancer pre-treatment. 
Concurrently, the C-H stretching absorbance peaks, which were identified using several 
modes of FTIR spectroscopy, were shown to undergo a blue shift to higher wavenumbers. 





















these techniques. This suggests that alterations in the stratum comeum, caused by electrical 
fields, occurs in localised regions below the detection limits of DSC or IR spectroscopy. 
There remains a need for transdermal peptide delivery systems. The most likely candidate to 
achieve this goal is iontophoresis. This study was able to demonstrate experimentally the 
influence of porosity changes on the transport of a model peptide drug. These pores contribute 
minimally to large molecule permeability, as suggested by other recent investigations (Li et 
al., 1998). However, in vitro investigations performed using iontophoresis in combination 
with enhancers, have demonstrated the possibility of synergistic permeability enhancement of 
large molecules. Future studies would need to address the nature of the porosity increases that 
are caused by enhancer perturbation of the stratum comeum. Thermodynamic investigations 
of pore size and electrical characterisation of the pore charges will shed light on the exact 
nature of the interactions between iontophoresis and enhancers in the promotion of solute 
permeability. There is a need to perform more iontophoretic studies using alternative peptides 
and chemical enhancers to shed light on structure activity relationships in terms of this 
synergy effect. Furthermore, in vivo studies need to be carried out to confirm the presence of 
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